<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>KG Legal - KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</title>
	<atom:link href="https://www.kg-legal.eu/info/tag/kg-legal/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.kg-legal.eu/info/tag/kg-legal/</link>
	<description>KIELTYKA GLADKOWSKI LEGAL &#124; CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</description>
	<lastBuildDate>Wed, 18 Nov 2026 16:57:41 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>Winding Down a Hotel Business in Poland: Legal Obligations and Risks</title>
		<link>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/winding-down-a-hotel-business-in-poland-legal-obligations-and-risks/</link>
					<comments>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/winding-down-a-hotel-business-in-poland-legal-obligations-and-risks/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Wed, 18 Nov 2026 16:57:41 +0000</pubDate>
				<category><![CDATA[INVESTMENT LAW AND PROCESSES IN POLAND]]></category>
		<category><![CDATA[building maintenance]]></category>
		<category><![CDATA[change of use]]></category>
		<category><![CDATA[closing a hotel in Poland]]></category>
		<category><![CDATA[commercial leases]]></category>
		<category><![CDATA[company liquidation in Poland]]></category>
		<category><![CDATA[consumer claims]]></category>
		<category><![CDATA[CONSUMER PROTECTION]]></category>
		<category><![CDATA[contract termination]]></category>
		<category><![CDATA[corporate dissolution]]></category>
		<category><![CDATA[data retention]]></category>
		<category><![CDATA[employee records]]></category>
		<category><![CDATA[employee redundancies]]></category>
		<category><![CDATA[employment law in Poland]]></category>
		<category><![CDATA[franchise termination]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[guest bookings]]></category>
		<category><![CDATA[HACCP records]]></category>
		<category><![CDATA[hospitality investors]]></category>
		<category><![CDATA[hospitality law]]></category>
		<category><![CDATA[hotel business wind-down]]></category>
		<category><![CDATA[hotel classification]]></category>
		<category><![CDATA[hotel closure]]></category>
		<category><![CDATA[hotel franchise agreements]]></category>
		<category><![CDATA[hotel lease agreements]]></category>
		<category><![CDATA[hotel management agreements]]></category>
		<category><![CDATA[hotel operators]]></category>
		<category><![CDATA[hotel owners]]></category>
		<category><![CDATA[hotel registration]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[KRS]]></category>
		<category><![CDATA[liquidator liability]]></category>
		<category><![CDATA[Polish company law]]></category>
		<category><![CDATA[Polish hotel law]]></category>
		<category><![CDATA[Regulatory Compliance]]></category>
		<category><![CDATA[sanitary requirements]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9052</guid>

					<description><![CDATA[<p>Publication date: November 18, 2026 As at 17 November 2026 Closing a hotel in Poland is never a single act. It ends an administratively regulated activity, may require a change-of-use procedure for the building, means leaving the sanitary and tourism registers and, where the operating company is also dissolved, a formal liquidation under the Commercial [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/winding-down-a-hotel-business-in-poland-legal-obligations-and-risks/">Winding Down a Hotel Business in Poland: Legal Obligations and Risks</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 18, 2026</mark></strong></p>



<p><strong>As at 17 November 2026</strong></p>



<p>Closing a hotel in Poland is never a single act. It ends an administratively regulated activity, may require a change-of-use procedure for the building, means leaving the sanitary and tourism registers and, where the operating company is also dissolved, a formal liquidation under the Commercial Companies Code (KSH). Each step has its own authority, deadline and sanction.</p>



<p>Several obligations outlive both the closure and the company’s deletion from the National Court Register (KRS): building maintenance, data retention, employee records and exposure to consumer claims. Long-term franchise, management and lease contracts are often the largest financial risk. This note sets out the obligations and risks area by area and ends with a consolidated checklist. Where a local authority is named, it refers to hotels located in Kraków and Kołobrzeg.</p>



<span id="more-9052"></span>



<p>The law is stated as at 17 November 2026. An amendment to the Hotel Services Act (Sejm print no. 2865), passed by the Sejm on 8 October 2026 and voted by the Senate in early November, is not yet in force; it moves some rules from the 2004 hotel regulation into the statute and should be checked before any filing.</p>



<h1 class="wp-block-heading"><a>Ending hotel services: classification and the register</a></h1>



<h2 class="wp-block-heading"><a>A regulated activity</a></h2>



<p>Hotel services are administratively regulated. The core framework is the Act of 29 August 1997 on hotel services and the services of tour leaders and tourist guides (the “Hotel Services Act”) and the Regulation of the Minister of Economy and Labour of 19 August 2004 on hotel facilities and other facilities providing hotel services (the “2004 Regulation”).</p>



<p>Under Article 39(1) of the Hotel Services Act, hotel services may be provided only once the facility has been classified by type and category. The Act lists eight types of hotel facility (including hotel, motel and guesthouse). Each must meet two sets of requirements: industry standards (size, equipment, scope of services) and sanitary, fire safety and other requirements under separate laws. Failure to meet either may lead the authority to change or revoke the classification of its own motion.</p>



<p>Two features of the regime matter most on exit:</p>



<ul class="wp-block-list">
<li><strong>Protected names.</strong> Names such as “hotel” or “motel” and category signs may be used only by holders of the relevant classification. Use without a legal basis is an offence.</li>



<li><strong>Sanitary presumption.</strong> A facility providing hotel services without being entered in the relevant register is presumed not to meet sanitary requirements. The burden of rebutting this presumption rests on the business and is hard to discharge during an inspection.</li>
</ul>



<h2 class="wp-block-heading"><a>Classification and promissory decision</a></h2>



<p>Classification is made by decision of the Marshal of the Voivodeship where the facility is located. A new operator of a facility already classified for another business must apply to confirm or change that classification. Under §5 of the 2004 Regulation, the application covers the operator’s details, the facility’s name and location, a description showing compliance with the type and category requirements, and evidence of compliance with building, fire and sanitary rules. The facility is inspected before the decision.</p>



<p>Article 39a provides for a promissory decision (promesa) valid for up to 2 years, useful at the investment stage. It requires, among other things, a building permit or a change-of-use decision. During its validity hotel services may not be provided unless the Marshal permits it after a complete classification application has been filed (Article 39a(6)).</p>



<h2 class="wp-block-heading"><a>The register of hotel facilities</a></h2>



<p>Under Article 38(1), the Marshal keeps the register of hotel facilities as a card index, with a separate card per facility (§12 of the 2004 Regulation), and a separate list of promissory decisions. The register confirms the facility’s formal status and defines the lawful use of its name and category.</p>



<h2 class="wp-block-heading"><a>Grounds for removal</a></h2>



<p>Under §18 of the 2004 Regulation, the Marshal revokes the classification and category and removes the facility from the register of its own motion where:</p>



<ul class="wp-block-list">
<li>the operator has stopped providing hotel services for more than one year;</li>



<li>the operator has informed the Marshal that it no longer uses the type name and category sign;</li>



<li>the operator was an organisational unit that has been liquidated;</li>



<li>a new operator of a previously classified facility failed to apply for confirmation or change of classification within 3 months of starting services, or within 3 months of being notified by the Marshal;</li>



<li>the facility no longer meets sanitary, fire, building or other statutory requirements;</li>



<li>the condition of the facility prevents further hotel services.</li>
</ul>



<p>A facility is also removed from the list of promissory decisions if no classification application was filed in time, if a classification decision or refusal was issued, or at the operator’s request. The pending amendment to the Hotel Services Act transfers grounds of this kind, including the liquidation ground, into the statute itself.</p>



<h2 class="wp-block-heading"><a>Procedure on closure</a></h2>



<ol class="wp-block-list">
<li><strong>Notify the Marshal</strong> (Marshal’s Office) that hotel services have ended. The notice states the operator’s name and registered office, the end date, and the facility’s details: name, register entry number, type and category, address.</li>



<li><strong>Revocation decision.</strong> The Marshal revokes the classification decision on the basis of the notice.</li>



<li><strong>Removal entry.</strong> The Marshal records the removal on the facility’s register card and informs the operator.</li>



<li><strong>Appeal.</strong> An appeal lies to the Minister of Sport and Tourism, filed through the Marshal within 14 days of receiving the decision.</li>
</ol>



<h2 class="wp-block-heading"><a>Effects of removal</a></h2>



<p>Removal ends the right to use the type name and category sign. Continued services in an unregistered facility, or use of protected names without a legal basis, may lead to liability under Article 60¹ §1(2), (2a), (3) and (4) of the Code of Petty Offences (restriction of liberty or a fine). The sanitary presumption also revives. Formal closure therefore protects the business; it is not mere housekeeping.</p>



<h1 class="wp-block-heading"><a>The building: change of use and maintenance</a></h1>



<h2 class="wp-block-heading"><a>When a change of use must be notified</a></h2>



<p>Under Article 71(1)(2) of the Construction Law, a change of use includes starting or stopping an activity in a building or part of it if this affects fire safety, work safety, health, hygiene and sanitary conditions, environmental protection, or the size or layout of loads. The list is open, so what matters is the practical effect on safe use, assessed by comparing the building’s use before and after closure.</p>



<p>Closing the hotel without giving the building a new purpose will not necessarily meet this test. The obligation arises mainly when the building is to be used differently, for example as offices or housing. The notification must be made <strong>before</strong> any change is made.</p>



<h2 class="wp-block-heading"><a>Notification procedure (no building permit needed)</a></h2>



<ol class="wp-block-list">
<li>Notify the change of use to the Starosta of Kołobrzeg (hotels in Kołobrzeg) or the Mayor (Prezydent) of Kraków (hotels in Kraków), stating the current and intended use of the building or its part.</li>



<li>Attach:<ol><li>a description and drawing showing the building’s location relative to plot boundaries and other buildings, marking the part whose use changes;</li></ol><ol><li>a short technical description;</li></ol><ol><li>the building permit for the building;</li></ol><ol><li>a certificate (or copy) of compliance of the intended use with the local zoning plan or, if there is none, the zoning decision;</li></ol><ol><li>permits, approvals and opinions as needed;</li></ol>
<ol class="wp-block-list">
<li>a fire safety expert’s opinion where the change alters fire safety conditions.</li>
</ol>
</li>



<li>File on paper or electronically via the e-Budownictwo portal.</li>



<li>The authority objects if the intended use requires works subject to a building permit, breaches the zoning plan or other local law (or the zoning decision), or may cause unacceptable danger to people or property, environmental or heritage damage, worse health and sanitary conditions, or new or increased nuisance for neighbouring land.</li>



<li>The change may be made 30 days after filing if no objection is raised, or earlier on receipt of a certificate that there are no grounds to object. It must be carried out within 2 years of filing; otherwise a new notification is needed.</li>
</ol>



<h2 class="wp-block-heading"><a>Change of use requiring a building permit</a></h2>



<p>Where the new use needs works subject to a permit (construction, extension, raising, rebuilding or alteration), notification is not enough. A building permit application covering the change of use and the works is filed with the same authority (Starosta of Kołobrzeg or Mayor of Kraków), on paper or via e-Budownictwo, <strong>before any works begin</strong>. It must include the site development plan and architectural and construction design, a declaration of the right to use the property for building purposes and, where required, the zoning decision. The authority checks completeness and compliance with the zoning plan and local law and calls for corrections. It refuses the permit if gaps are not remedied, if works began before the decision, or if a final demolition order concerns a building on the site.</p>



<h2 class="wp-block-heading"><a>Consequences of skipping the procedure</a></h2>



<p>If the change is made without notification or despite an objection, the building supervision authority may suspend use of the building and require legalisation documents. If they are filed, a legalisation fee is charged. If not, or if the change was made despite an objection, the authority may order the previous use to be restored. Unauthorised works add the risk of a stop-works order, a legalisation fee and, in the worst case, a demolition order. In practice, this can delay or block the intended reuse of the property.</p>



<h2 class="wp-block-heading"><a>Maintenance duties continue</a></h2>



<p>Closure does not release the owner or manager from keeping the building in proper technical condition. Most hotels are large-area buildings (built-up area over 2,000 m²) and must be inspected at least twice a year, by 31 May and by 30 November. These inspections cover elements exposed to weather, fire protection installations, roofing and drainage. Every five years a broader inspection covers the whole building’s technical condition and fitness for use, and the electrical and lightning protection installations.</p>



<p>The inspector notifies the building supervision authority within 7 days of inspecting a large-area building and sends it a copy of the report without delay. The owner, manager or user must remove defects that could endanger life, health, property or the environment during or immediately after the inspection, and the authority then checks that this has been done.</p>



<p>Under Article 91a of the Construction Law, failure to keep the building in proper technical condition (including failure to arrange periodic inspections) or to ensure its safe use is punishable by a fine of at least 100 daily rates, restriction of liberty or imprisonment of up to one year. Failure to remove defects under Article 70(1) is punishable by detention, restriction of liberty or a fine. These duties last until the building is demolished or sold.</p>



<h1 class="wp-block-heading"><a>Food service: sanitary register and HACCP records</a></h1>



<p>A hotel restaurant is subject to the Act of 25 August 2006 on food and nutrition safety and Regulation (EC) No 852/2004. Food businesses must be entered in (or approved and entered in) the register of establishments kept by the competent state sanitary inspector. Just as the activity could start only after registration, its end requires removal from the register of establishments subject to official control by the State Sanitary Inspection.</p>



<ol class="wp-block-list">
<li>File an application for removal with the district (powiatowy) sanitary inspector who keeps the register, without delay after the activity ends.</li>



<li>File in writing or online, signed with a qualified electronic signature or the trusted profile (profil zaufany).</li>



<li>The application states the applicant’s name, registered office and tax number (NIP), the register entry number and the ground for removal.</li>



<li>An appeal against the decision lies to the voivodeship sanitary inspector within 14 days.</li>
</ol>



<p>If the establishment stays on the register as active, it remains exposed to inspections and to obligations imposed on an operating business.</p>



<p><strong>HACCP records.</strong> Under Article 5 of Regulation 852/2004, the hotel had to apply HACCP-based procedures: hazard analysis, critical control points (CCPs), critical limits, monitoring, corrective action, verification, and documentation and records. Closure does not end documentation duties for the period of operation. Records and attachments should be kept for at least one to five years, and longer retention is advisable. They prove HACCP compliance in a retrospective inspection; failure to implement HACCP is punishable by a fine under Article 100(1)(8) of the Food Safety Act.</p>



<h1 class="wp-block-heading"><a>Relations with the authorities during wind-down</a></h1>



<h2 class="wp-block-heading"><a>Fire safety: State Fire Service (PSP)</a></h2>



<p>Under §4 of the 2004 Regulation, compliance with fire requirements is confirmed by an opinion of the district (municipal) PSP commander, issued within 30 days of the application and obtained before hotel services start. An opinion is also needed where the hotel hosts organised recreation for children and young people; under Article 92c(3) of the School Education System Act it is then valid for 3 years, provided fire safety conditions have not changed (for example through a change of use or more guests). The opinion follows an inspection whose report lists all shortcomings.</p>



<p>Under the Regulation of the Minister of Infrastructure of 12 April 2002 on technical conditions for buildings, a hotel falls into fire category ZL V. Requirements vary with height:</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Height class</td><td>Height above ground</td><td>Residential equivalent</td></tr></thead><tbody><tr><td>Low (N)</td><td>up to 12 m</td><td>up to 4 storeys</td></tr><tr><td>Medium-high (SW)</td><td>12 to 25 m</td><td>4 to 9 storeys above ground</td></tr><tr><td>High (W)</td><td>25 to 55 m</td><td>9 to 18 storeys</td></tr><tr><td>High-rise (WW)</td><td>over 55 m</td><td>&#8211;</td></tr></tbody></table></figure>



<p>The commander considers safe evacuation, fire equipment, technical installations, storage of flammable materials, marking of escape routes and exits, fire instructions and extinguishers, and the fire alarm system (required above 51 beds). A negative opinion blocks entry in the register; operating without one risks a ban on use and PSP fines. PSP may inspect routinely or in response to reports, impose fines or order use to stop.</p>



<h2 class="wp-block-heading"><a>Sanitary safety: State Sanitary Inspection (Sanepid)</a></h2>



<p>No binding rules govern cleaning of rooms or common areas, but food hygiene is regulated by the Food Safety Act, Regulation (EC) No 178/2002 and HACCP. Minimum sanitary equipment of hotels is set out in Annex 1 to the 2004 Regulation, and Sanepid guidelines cover clean and soiled linen, swimming pools (chlorine levels), sandpits and playgrounds, and contamination of hot water systems.</p>



<p>Under Article 4(1)(6) of the State Sanitary Inspection Act, Sanepid supervises hygiene in holiday facilities, and also food and water hygiene. Inspectors may enter the hotel, request written or oral information and documents, and take samples. They order defects to be removed by decision and, where there is a direct threat to life or health, may order the establishment closed; they may also impose penalties and fines. An appeal lies to the voivodeship sanitary inspector within 14 days, followed by administrative court review.</p>



<p>During wind-down, reduced spending creates a real risk of sanitary standards slipping. HACCP records must be kept for retrospective inspections.</p>



<h2 class="wp-block-heading"><a>Building safety: building supervision</a></h2>



<p>Building supervision authorities oversee the technical condition of buildings whether or not any business is carried on in them. The district building supervision inspector is notified of every inspection of a large-area building and may open proceedings if irregularities are found. If use changes de facto without the required notification, the authority may act of its own motion, suspend use and order legalisation or restoration of the previous use. The relationship with this authority does not end when the hotel closes.</p>



<h1 class="wp-block-heading"><a>Tour operator register</a></h1>



<h2 class="wp-block-heading"><a>When a hotel needs an entry</a></h2>



<p>Organising package travel or facilitating linked travel arrangements requires an entry in the register kept by the Marshal of the Voivodeship. A travel service includes accommodation, transport, vehicle rental and other services for travellers. A <strong>package</strong> combines at least two different types of travel service for the same trip, put together by one trader before a single contract is concluded. It is also a package where services from separate providers are bought at one point of sale, offered or sold at an inclusive price, advertised or sold as a package, or booked through linked online processes where traders pass on the traveller’s data and the further contracts are concluded within 24 hours of confirming the first booking. The organiser is liable for the whole package. A <strong>linked travel arrangement</strong> arises where a trader facilitates, during a single visit to its point of sale, the separate purchase of further travel services, or where a contract with another trader follows within 24 hours of the first booking.</p>



<p>A hotel needs an entry if it creates and sells packages combining at least two services, for example accommodation with an airport transfer or with car hire, combined before the contract and offered as one package; or if it advertises or sells an offer as a package; or if it facilitates linked arrangements (such as car hire from another company). It needs no entry if it provides accommodation only or acts as a travel agent selling another organiser’s packages. Trips under 24 hours without overnight stay, occasional non-profit trips for a limited group, business travel under a general agreement, and trips for members of sports clubs and schools are also exempt.</p>



<h2 class="wp-block-heading"><a>What the entry entails</a></h2>



<p>The trader must secure the costs of continuing the package or repatriation and refunds of payments for unperformed services, through a bank or insurance guarantee, travellers’ insurance or a tourism escrow account. The Marshal enters the trader within 7 days, publishing the entry in the Central Register of Tour Operators and Linked Travel Arrangement Traders; if there is no entry, refusal or call for completion within 14 days, the trader may start. A refusal may be appealed to the Minister of Sport and Tourism within 14 days.</p>



<p>After registration the trader must file renewed security contracts no later than 14 days before the previous one expires, keep a list of package contracts, file monthly contribution declarations with the Insurance Guarantee Fund (UFG) and pay contributions to the Tourist Guarantee Fund (TFG), pay contributions to the Tourist Assistance Fund (TFP), and meet statutory information duties to travellers. Failures are a gross breach of the conditions of activity and may lead to a ban.</p>



<h2 class="wp-block-heading"><a>Removal on closure</a></h2>



<p>On liquidation and closure of the hotel business, an application for removal should be filed within 14 days of ending the activity and no later than 14 days before the security contract expires. Beforehand, all obligations to travellers and contributions to the TFG must be settled. Removal ends the duties of a registered organiser, including renewing security and paying contributions.</p>



<p>A trader that filed all declarations and paid all contributions may apply to the TFG for a refund of overpaid contributions within 14 days of the Marshal’s removal decision becoming final, stating the amount and attaching a copy of the final decision and a list of the contracts concerned. The Małopolska Marshal’s Office follows the general rules; the fee for each filing is paid to that office’s account.</p>



<h1 class="wp-block-heading"><a>Liquidating the operating company</a></h1>



<p>The scenario assumed throughout is a resolution to dissolve the company, the usual route for a controlled wind-down. Other grounds include those in the articles, transfer of the registered office to another EU or EEA state where its law allows, bankruptcy and other statutory causes (for an S.A., Article 459 KSH). What matters in practice is full formal correctness from the resolution until deletion from the KRS.</p>



<h2 class="wp-block-heading"><a>Limited liability company (sp. z o.o.)</a></h2>



<ol class="wp-block-list">
<li><strong>Resolution to dissolve</strong>, adopted by a 2/3 majority of shareholders’ votes. An absolute majority suffices where it follows a vote on the company’s continued existence under Article 233 KSH (losses exceeding the sum of supplementary and reserve capital and half the share capital).</li>



<li><strong>Opening of liquidation.</strong> The company’s name takes the suffix “w likwidacji” (in liquidation). From then on no profits may be paid or assets distributed before all liabilities are settled; additional contributions require the consent of all shareholders. Any commercial proxy (prokura) expires and none may be granted.</li>



<li><strong>Liquidators.</strong> Management board members become liquidators unless the articles or a resolution provide otherwise. Representation is set by the articles or resolution. Shareholders may dismiss liquidators unless the articles provide otherwise or they were appointed by the court. Rules on board members apply.</li>



<li><strong>KRS filing</strong> of the opening of liquidation, the liquidators’ details and the manner of representation, even if unchanged. Failing to file leaves the company without formal “in liquidation” status, exposes liquidators to liability and taints the process.</li>



<li><strong>Winding up business.</strong> Liquidators complete current business, collect receivables, pay liabilities and sell assets. New business may be started only to complete pending matters. Real estate may be sold by public auction, or by private sale only if a shareholders’ resolution allows it and sets a minimum price.</li>



<li><strong>Announcement</strong> of dissolution and opening of liquidation, calling on creditors to file claims within 3 months. Amounts due to known creditors who do not come forward, and to claims not yet due or disputed, are deposited with the court. Late or unknown creditors may claim only from assets not yet distributed.</li>



<li><strong>Opening balance sheet</strong>, prepared by the liquidators and approved by the shareholders’ meeting.</li>



<li><strong>Annual reporting.</strong> After each financial year liquidators submit a report on their activities and financial statements.</li>



<li><strong>Distribution</strong> of assets, no earlier than 6 months after the announcement. Assets are shared pro rata to shares unless the articles provide otherwise. Shareholders who receive their share in good faith after that period need not return it to satisfy creditors.</li>



<li><strong>Closing.</strong> Once the shareholders’ meeting approves the financial statements as at the day before distribution, liquidators publish them at the registered office and file them with the registry court with an application for deletion. A meeting that fails for lack of quorum does not release them from this duty. Books and documents are deposited with the person named in the articles or resolution or, failing that, by the registry court.</li>



<li><strong>Dissolution</strong> takes effect on deletion from the KRS. Until then, a unanimous resolution of all shareholders may reverse it, unless the registry court dissolves the company on statutory grounds.</li>
</ol>



<h2 class="wp-block-heading"><a>Joint-stock company (S.A.): what differs</a></h2>



<p>The S.A. sequence mirrors the sp. z o.o., but organisational complexity and risk are typically higher.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Point</td><td>sp. z o.o.</td><td>S.A.</td></tr></thead><tbody><tr><td>Dissolution resolution</td><td>2/3 of votes (absolute majority after an Article 233 vote)</td><td>3/4 of votes at the general meeting (absolute majority after an Article 397 vote: losses exceeding supplementary and reserve capital and 1/3 of share capital)</td></tr><tr><td>Removal of liquidators</td><td>by shareholders</td><td>by the general meeting; the registry court may also dismiss and replace them for important reasons at the request of an interested party</td></tr><tr><td>Unpaid capital</td><td>&#8211;</td><td>if capital is not fully paid and assets do not cover liabilities, liquidators call up the missing contributions (likewise to repay preferred shares)</td></tr><tr><td>Announcement to creditors</td><td>once; claims within 3 months</td><td>twice, the second 2 weeks to 1 month after the first; claims within 6 months</td></tr><tr><td>Earliest distribution</td><td>6 months after the announcement</td><td>1 year after the last announcement</td></tr><tr><td>Basis of distribution</td><td>pro rata to shares</td><td>pro rata to paid-in capital; preferred shares first up to amounts paid, then ordinary shares; the statute may provide otherwise</td></tr><tr><td>Reversal of dissolution</td><td>unanimous shareholders’ resolution</td><td>general meeting resolution by the majority required to amend the statute</td></tr></tbody></table></figure>



<h2 class="wp-block-heading"><a>General partnership (spółka jawna)</a></h2>



<p>Under Article 58 KSH, grounds for dissolution include those in the partnership agreement, a unanimous resolution, bankruptcy of the partnership, a partner’s death or bankruptcy, notice by a partner or a partner’s creditor, and a final court judgment (Article 63 lets a partner seek dissolution by the court). Liquidation follows unless the partners agree another way of ending the business. This is more flexible than for capital companies, but settlements between partners must be regulated carefully.</p>



<ol class="wp-block-list">
<li>All partners are liquidators unless they appoint only some of themselves or outsiders (unanimously, unless the agreement says otherwise). The non-compete applies only to liquidators. Liquidators represent jointly and decide by majority, unless decided otherwise.</li>



<li>Any liquidator files the opening of liquidation with the registry court, with the liquidators’ details and manner of representation. Any prokura expires.</li>



<li>The name takes the suffix “w likwidacji”.</li>



<li>Liquidators complete business, collect receivables, pay liabilities and sell assets. Amounts are set aside for claims not yet due or disputed. Any shortfall is shared between partners per the agreement or, failing that, by their share in losses. Surplus assets go first to repay partners’ contributions, then by share in profits, unless agreed otherwise.</li>



<li>Liquidators prepare balance sheets at the start and end of liquidation, plus financial statements for the last financial year if liquidation lasts over a year.</li>



<li>Liquidators report completion and apply for deletion.</li>



<li>The partnership is dissolved on deletion. Books and documents are kept by a partner or a third party for at least 5 years.</li>
</ol>



<h2 class="wp-block-heading"><a>Parent company of a group</a></h2>



<p>When a parent company is liquidated, its shares in subsidiaries become part of the liquidation estate and are distributed to its shareholders.</p>



<h1 class="wp-block-heading"><a>Liquidation risks: liability, tax, employees and social security</a></h1>



<h2 class="wp-block-heading"><a>Liability of liquidators</a></h2>



<p>Liquidation is not a mere registry procedure. Liquidators must close out business, collect receivables, perform obligations and unwind contracts, and in the hotel sector many contracts are long term. The risk grows when several group companies are liquidated at once.</p>



<p>Liquidation does not eliminate liquidators’ personal exposure. A company may be deleted from the KRS with debts outstanding, for example for lack of assets. Liquidators, to whom the rules on board members apply, are jointly liable for the company’s unpaid liabilities that arose while they held office if enforcement against the company proves ineffective (Article 299 KSH). They escape liability only by showing that a bankruptcy petition was filed in time, that restructuring proceedings were opened or an arrangement approved, that the failure to file was not their fault, or that the creditor suffered no loss as a result. The creditor must prove the existence, amount and date of its claim.</p>



<h2 class="wp-block-heading"><a>Tax</a></h2>



<ul class="wp-block-list">
<li><strong>CIT on unpaid debts.</strong> A liability still unpaid at deletion does not, as a rule, create taxable income, unless it was earlier written off or released under Article 508 of the Civil Code. On deletion the company ceases to exist, so the debt is not treated as an accretion. Individual rulings of the Director of National Tax Information confirm this view.</li>



<li><strong>Depreciation.</strong> Under Article 16c(5) of the CIT Act, depreciable assets such as the hotel building stop being depreciated from the first day of the month after the month in which the activity was suspended or ceased.</li>



<li><strong>VAT on dissolution.</strong> Under Article 14(1) of the VAT Act, goods of own production and goods not supplied after purchase may be taxed on dissolution of companies without legal personality.</li>



<li><strong>VAT refunds</strong> must be obtained before deletion from the KRS, as the company then ceases to exist.</li>



<li><strong>VAT deregistration.</strong> A company in liquidation that will no longer issue invoices may file form VAT-Z with the tax office within 7 days of ceasing taxable activities. Otherwise it must keep filing returns and may struggle to recover VAT.</li>



<li><strong>Distribution of assets.</strong> Transfer of assets to shareholders on liquidation of a capital company may be a taxable supply of goods where the transferor is a VAT taxpayer, the assets belong to its business, the transfer is for shareholders’ private purposes or by way of gift, and the company had the right to deduct input VAT on the goods or their components. This must be settled before deletion; otherwise a tax arrears arises.</li>



<li><strong>Real estate tax.</strong> Liquidation may open the way to lower real estate tax rates, but not automatically. The tax authority may argue that the property remains connected with business activity until deletion from the KRS.</li>
</ul>



<h2 class="wp-block-heading"><a>Employees</a></h2>



<p>Under Article 41¹ of the Labour Code, when an employer is liquidated certain protections against termination do not apply, including protection of employees approaching retirement age (Article 39). Employment does not end automatically; contracts must be terminated by agreement or notice, and the works council must be informed of the liquidation.</p>



<p>The notice period depends on length of service with the employer: 2 weeks (under 6 months), 1 month (at least 6 months) and 3 months (at least 3 years). On liquidation, Article 36¹ allows a 3-month notice to be shortened to 1 month, with compensation for the remainder.</p>



<p><strong>Collective redundancies</strong> apply where the employer has at least 20 employees, terminations are for reasons not concerning employees (such as liquidation of the workplace), and within a period of up to 30 days at least:</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Workforce</td><td>Threshold</td></tr></thead><tbody><tr><td>under 100</td><td>10 employees</td></tr><tr><td>100 to 299</td><td>10% of employees</td></tr><tr><td>300 or more</td><td>30 employees</td></tr></tbody></table></figure>



<ol class="wp-block-list">
<li>Consult the intended redundancies with trade unions or, where there are none, employee representatives.</li>



<li>Notify in writing the district labour office (PUP), giving the number of employees and of those to be dismissed with reasons, and the trade unions. Unions must agree a joint position independently; any pressure from the employer is prohibited.</li>



<li>Seek an agreement with the unions within 20 days of the notification.</li>



<li>Sign the agreement or, failing it, issue redundancy rules that take the unions’ position into account where possible. The agreement binds the employer and the unions. If no union agrees, the employer sets the rules; if only some agree, the content is agreed with the representative unions.</li>



<li>Pay statutory severance: 1 month’s pay (under 2 years’ service), 2 months’ (2 to 8 years) or 3 months’ (over 8 years). Statutory severance may not exceed 15 times the minimum wage; any higher amount can arise only from the agreement or another contractual source.</li>
</ol>



<p>Civil-law (mandate) contracts depend on their terms; absent special restrictions they can, as a rule, be terminated at any time.</p>



<h2 class="wp-block-heading"><a>Social security (ZUS)</a></h2>



<p>After employment ends, employees are deregistered on form ZUS ZWUA. Partners in certain partnerships and the sole shareholder of an sp. z o.o. must also file ZUS ZWPA to deregister the contribution payer, plus forms for themselves and family members. Partners’ contribution obligations generally continue until the company is deleted from the KRS.</p>



<h1 class="wp-block-heading"><a>Contracts: franchise, management, lease and tenancy</a></h1>



<p>Hotel contracts are typically long term and each sets its own exit rules. Premature termination may trigger contractual penalties or damages claims for the counterparty’s lost profits. Every contract should be reviewed before the closure decision is announced.</p>



<h2 class="wp-block-heading"><a>Franchise agreements</a></h2>



<p>Under a franchise the hotel operates under another company’s brand, receiving the brand, know-how, operating procedures and marketing support. The model dominates in the United States, where over 75% of hotels are franchised, because brand recognition attracts guests. The franchisor charges an entry fee, fees for adapting the hotel to brand standards, marketing and booking fees, and annual or monthly turnover-based fees.</p>



<p>Agreements with international chains are often in English and governed by English or US law, which raises the cost and complexity of review. They usually regulate early termination, contractual penalties, the ban on further use of the brand and trademarks, ongoing technical and operational standards, and franchisor consent to ownership or structural changes. Closing early may be treated as a breach, giving rise to damages for the remaining term. Royalty, marketing and booking fees may stay payable regardless of actual operation unless the agreement expressly releases the operator on liquidation. Each agreement should be analysed for termination conditions, potential penalties, governing law and forum.</p>



<h2 class="wp-block-heading"><a>Hotel management agreements</a></h2>



<p>The owner keeps title and the economic result, while a specialist manager runs the hotel: staff, budgeting, food and beverage, maintenance, marketing and revenue policy. The model is common among owners of several hotels and investors treating the hotel as an asset. The manager’s fee usually combines a base fee (a percentage of gross revenue) and an incentive fee tied to operating results.</p>



<p>These agreements are deliberately long term to give the manager stability. Early termination usually means a penalty or damages for the remaining term, and because fees track revenue, claims may be based on projected revenue over many years, which can reach very large amounts. Staff employed by the manager in its own name or on the owner’s behalf raise questions about who bears employee claims. Foreign governing law and international arbitration clauses are common, adding to cost and complexity.</p>



<h2 class="wp-block-heading"><a>Lease (dzierżawa) and tenancy (najem)</a></h2>



<p>Unlike franchise and management agreements, lease and tenancy are named contracts regulated in the Civil Code, which fills any gaps in the contract. The company may be the lessee or tenant of the hotel property, or may let the property to another hotel operator; each configuration needs separate analysis.</p>



<p><strong>Lease (dzierżawa)</strong> gives the hotel with its equipment for use and collection of profits in return for rent, and is increasingly common. An indefinite-term lease is generally easier to terminate, by either party in cases set by the contract or the law; a fixed-term lease depends on its terms, so early termination grounds must be checked before closure. Key Civil Code risks:</p>



<ul class="wp-block-list">
<li><strong>Change of purpose (Article 696).</strong> The lessee must operate in line with proper management and may not change the purpose of the property without the lessor’s consent. The lessor may treat closing the hotel as a change of purpose or breach and terminate without notice. Prior consent should be obtained before operations wind down.</li>



<li><strong>Repairs (Article 697).</strong> The lessee must make repairs needed to keep the property in an unimpaired condition, a wider duty than a tenant’s. Cost-cutting during wind-down risks damages claims on return.</li>



<li><strong>Return (Article 705).</strong> On termination the property must be returned in a condition consistent with proper management. After years of hotel use, this assessment is a common source of disputes, hard to value without a technical survey.</li>



<li><strong>Rent on early termination (Article 707).</strong> Rent is due in proportion to the profits the lessee collected or could have collected. The lessor may argue that profits would have been higher had the hotel been run properly in its final months.</li>



<li><strong>Statutory lien.</strong> The lessor’s lien covers items brought onto the property and items used to run the hotel business located there. Any rent arrears let the lessor block removal of all equipment. If the lessee bears taxes, insurance and other charges on the property, those claims are also secured by the lien (Article 702). All arrears should be cleared before movables are removed.</li>
</ul>



<p><strong>Tenancy (najem)</strong> under Article 659 of the Civil Code covers use of a thing for a definite or indefinite term for rent. In hotels it often concerns individual spaces such as a restaurant, service premises or a spa. An indefinite-term tenancy may, absent other terms, be terminated on statutory notice; a fixed-term tenancy depends on the contract. Each tenancy must be reviewed separately, as the freedom to exit may be very limited.</p>



<h1 class="wp-block-heading"><a>Consumers and the competition authority (UOKiK)</a></h1>



<p>Once a binding decision to close has been taken, the hotel should stop accepting bookings for stays after the planned closing date, including through external booking platforms. Continuing to sell stays it knows, or should know, it cannot provide may be an unfair market practice misleading consumers about availability (Article 4 of the Act on Counteracting Unfair Market Practices). If widespread and systemic, it may also be a practice infringing collective consumer interests (Article 24 of the Act on Competition and Consumer Protection).</p>



<p>The Consumer Rights Act imposes pre-contractual information duties, such as price, complaints procedure and withdrawal rights. Breach is punishable by a fine under Article 139b of the Code of Petty Offences and may lead to liability before the President of UOKiK.</p>



<p>For bookings already made for dates after closure, the Civil Code applies. Under Article 493 §1, where performance becomes impossible through circumstances for which the obliged party is responsible (here, the decision to close), the guest may claim damages for non-performance or withdraw from the contract. A withdrawing guest may claim a refund of payments such as deposits and, on general principles, damages.</p>



<p>Exposure for past practices survives closure: unfair terms in contracts and terms and conditions, and possible UOKiK proceedings (explanatory, antitrust, abstract review of standard terms, or collective consumer interests).</p>



<p>After deletion from the KRS the company ceases to exist and has no successor. Consumers not satisfied in liquidation may then pursue board members under Article 299 KSH, provided enforcement against the company proved ineffective, for example for lack of assets. After deletion the creditor need not produce an enforcement title against the company (Supreme Court, II CSK 790/13 and II CSK 300/06).</p>



<h1 class="wp-block-heading"><a>Personal data: retention, deletion and archiving (GDPR)</a></h1>



<h2 class="wp-block-heading"><a>Legal bases the hotel relied on</a></h2>



<ul class="wp-block-list">
<li><strong>Guests.</strong> Data needed to perform the contract or take steps at the guest’s request before contracting, such as a booking (Article 6(1)(b) GDPR): name, address, contact details and, for invoices to businesses, company name, registered address and NIP.</li>



<li><strong>Legitimate interests (Article 6(1)(f)).</strong> For example a PESEL number or ID card, solely to verify and record necessary data; data of conference invitees and of customers of non-accommodation services; CCTV footage (image, distinguishing features, identifiers such as number plates). CCTV may not be used to supervise employees and may not record sound.</li>



<li><strong>Employees.</strong> The data listed in Article 22¹ of the Labour Code: name, date of birth, contact details, education, qualifications, employment history, address, PESEL and payment account number.</li>



<li><strong>Booking platforms.</strong> An external booking intermediary is the controller of the customer’s data; once it passes data to the hotel, the hotel also becomes a controller and must meet the Article 14 GDPR information duty (for example by naming the hotel and its contact details in the platform’s notice).</li>
</ul>



<h2 class="wp-block-heading"><a>What must be kept, for how long</a></h2>



<p>Under the storage limitation principle (Article 5(1)(e)), data may be kept in identifiable form only as long as needed. Further retention may be required by law (Article 6(1)(c)).</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Data</td><td>Retention</td><td>Basis</td></tr></thead><tbody><tr><td>Accounting records</td><td>5 years from the start of the year after the financial year concerned</td><td>Article 74 Accounting Act</td></tr><tr><td>Tax records</td><td>5 years from the end of the year in which the tax payment deadline fell (limitation)</td><td>Article 70 §1 Tax Ordinance</td></tr><tr><td>Invoices</td><td>until the tax limitation period expires</td><td>Article 112(1) VAT Act</td></tr><tr><td>Guest contract data</td><td>term of the contract plus up to 6 years, where needed to pursue or defend claims</td><td>Article 118 Civil Code</td></tr><tr><td>Employee records (hired from 2019)</td><td>10 years from the end of the year employment ended</td><td>Article 94(9b) Labour Code</td></tr><tr><td>Employee records (hired 1999 to 2018)</td><td>50 years, or 10 years from the end of the year of filing ZUS OSW and ZUS RIA</td><td>Labour Code, transitional rules</td></tr><tr><td>Employee records (hired before 1999)</td><td>50 years</td><td>Labour Code, transitional rules</td></tr><tr><td>Employer CCTV footage</td><td>up to 3 months, or until proceedings end if it is evidence; then destroyed</td><td>Article 22² §3 to §5 Labour Code</td></tr></tbody></table></figure>



<p>Guest data as such is not subject to mandatory archiving; retention follows only from these specific bases. Once the purpose ends, data must be erased, including at the data subject’s request (Article 17), for example where it is no longer needed or the person objects to marketing. The controller may refuse erasure where retention is required by law or needed to secure claims.</p>



<p>Employee records must be kept confidential, intact, complete and available. On liquidation, liquidators should appoint a professional records storage provider and fund the storage; if no funds are available, the State Archives take over the records at the employer’s request. The Head of the State Archives may also order paid deposit of records of a KRS-registered employer where they are at risk of destruction or unlawful interference and cannot be passed to another entity. Costs of takeover and registration are borne jointly and severally by the managers or liquidators. Records should be transferred <strong>before</strong> deletion from the KRS.</p>



<h2 class="wp-block-heading"><a>Anonymisation and pseudonymisation</a></h2>



<p>Anonymisation removes or permanently alters identifying data (name, PESEL, email, phone number) so that the person cannot be identified, even with additional data. It is irreversible. Effectively anonymised data is no longer personal data under Article 4(1) GDPR, so it may be analysed or shared more freely, for example with partners or for research. Historical data such as occupancy statistics or booking history may be anonymised as an alternative to deletion. The process requires a re-identification risk analysis and documentation.</p>



<p>Pseudonymisation (for example replacing names with random keys or tokens) is reversible, so the data remains personal data and fully protected.</p>



<h2 class="wp-block-heading"><a>Disclosure to authorities</a></h2>



<p>Any transfer must have a legal basis, be limited to what is necessary and remain confidential. In criminal and petty offence proceedings, the controller must disclose data under Article 6(1)(c) GDPR to the body conducting the proceedings, such as the prosecutor, the police (and bodies with police powers, such as the CBA) or the court, within the scope and time set by that body, where the step would otherwise be impossible or seriously hindered (Article 15 §3 of the Code of Criminal Procedure). Refusal may lead to a penalty of up to PLN 3,000. The police may also request electronic service data under Article 20c of the Police Act (data listed in Article 18 of the Act on Electronic Services), request data under Article 15(1)(7) of the Police Act, or seize items and IT data in criminal proceedings (Articles 217, 218a and 236a of the Code of Criminal Procedure).</p>



<h2 class="wp-block-heading"><a>Duties survive the company</a></h2>



<p>The duty to erase data once its purpose ends does not lapse with liquidation; it rests on the liquidators. Improper retention after closure (failure to erase after retention periods, inadequate technical security, transfer without a legal basis) risks administrative fines from the President of the Personal Data Protection Office (UODO) of up to EUR 20 million or 4% of annual turnover, and compensation claims from data subjects.</p>



<h1 class="wp-block-heading"><a>Consolidated risk checklist</a></h1>



<p>The table lists each step in the order it usually arises, with the authority, timing and the consequence of omission.</p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<thead>
<tr>
<td>Obligation</td>
<td>Authority / addressee</td>
<td>Timing</td>
<td>Consequence of omission</td>
</tr>
</thead>
<tbody>
<tr>
<td>Review franchise, management, lease and tenancy contracts; obtain lessor’s consent to change of purpose</td>
<td>counterparties</td>
<td>before announcing closure</td>
<td>penalties, damages for remaining term, termination without notice, lessor’s lien on equipment</td>
</tr>
<tr>
<td>Stop accepting bookings for dates after closure (incl. platforms)</td>
<td>&#8211;</td>
<td>on the binding closure decision</td>
<td>unfair market practice, UOKiK proceedings, guests’ damages claims (Article 493 Civil Code)</td>
</tr>
<tr>
<td>Notify the Marshal of the end of hotel services; obtain revocation of classification and removal from the register; stop using “Hotel” and the category sign</td>
<td>Marshal of the Voivodeship</td>
<td>on ending services</td>
<td>continued listing, sanitary presumption, ex officio revocation; restriction of liberty or fine (Article 60¹ Code of Petty Offences)</td>
</tr>
<tr>
<td>Apply for removal from the register of establishments under sanitary control</td>
<td>district sanitary inspector</td>
<td>without delay after food service ends</td>
<td>remains listed as active; inspections and obligations as an operating business</td>
</tr>
<tr>
<td>Archive HACCP and CCP records</td>
<td>&#8211;</td>
<td>at least 1 to 5 years after closure</td>
<td>no records in a retrospective inspection; fine (Article 100(1)(8) Food Safety Act)</td>
</tr>
<tr>
<td>Apply for removal from the tour operator register; settle travellers and TFG contributions (if registered)</td>
<td>Marshal of the Voivodeship</td>
<td>within 14 days of ending the activity and at least 14 days before the security contract expires</td>
<td>continuing duties to renew security and pay contributions</td>
</tr>
<tr>
<td>Notify change of use (if the building gets a new purpose)</td>
<td>Mayor of Kraków / Starosta of Kołobrzeg</td>
<td>before any actual change</td>
<td>suspension of use, legalisation fee, order to restore previous use</td>
</tr>
<tr>
<td>Apply for a building permit (if the change requires works)</td>
<td>Mayor of Kraków / Starosta of Kołobrzeg</td>
<td>before any works begin</td>
<td>stop-works order, legalisation fee, possible demolition order</td>
</tr>
<tr>
<td>Keep up periodic building inspections and remove defects</td>
<td>building supervision</td>
<td>by 31 May and 30 November each year; 5-year inspection</td>
<td>fine, restriction of liberty or imprisonment up to 1 year (Article 91a Construction Law)</td>
</tr>
<tr>
<td>Adopt the dissolution resolution</td>
<td>shareholders (2/3) / general meeting (3/4)</td>
<td>at the start</td>
<td>no basis to open liquidation; liquidation acts invalid</td>
</tr>
<tr>
<td>File the opening of liquidation</td>
<td>registry court (KRS)</td>
<td>without delay after opening</td>
<td>no formal “in liquidation” status; liquidators’ liability; defective process</td>
</tr>
<tr>
<td>Terminate employment; collective redundancy procedure (20+ employees)</td>
<td>employees, trade unions, district labour office</td>
<td>per notice periods; agreement within 20 days of notification</td>
<td>invalid or challengeable dismissals, employee claims</td>
</tr>
<tr>
<td>Deregister employees and payer (ZUS ZWUA, ZUS ZWPA)</td>
<td>ZUS</td>
<td>after employment ends</td>
<td>continued contribution obligations</td>
</tr>
<tr>
<td>Deregister from VAT (form VAT-Z)</td>
<td>tax office</td>
<td>within 7 days of ceasing taxable activities</td>
<td>continued returns; difficulty recovering VAT</td>
</tr>
<tr>
<td>Settle VAT on assets distributed and obtain VAT refunds</td>
<td>tax office</td>
<td>before deletion from the KRS</td>
<td>tax arrears; refund lost</td>
</tr>
<tr>
<td>Transfer employee records to a storage provider and fund it</td>
<td>storage provider / State Archives</td>
<td>before deletion from the KRS</td>
<td>records taken over by the State Archives at liquidators’ cost; administrative and civil exposure</td>
</tr>
<tr>
<td>Erase or anonymise personal data once retention periods end</td>
<td>President of UODO (supervision)</td>
<td>on expiry of each retention period</td>
<td>fines up to EUR 20 million or 4% of turnover; compensation claims</td>
</tr>
<tr>
<td>Deposit the company’s books and documents</td>
<td>person named in the articles or resolution, or by the court</td>
<td>after liquidation ends</td>
<td>evidentiary problems; no corporate or financial records</td>
</tr>
</tbody>
</table>
</figure>
<p> </p>



<p>Services</p>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>



<p></p>



<p></p>



<p></p>


<p>Artykuł <a href="https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/winding-down-a-hotel-business-in-poland-legal-obligations-and-risks/">Winding Down a Hotel Business in Poland: Legal Obligations and Risks</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/winding-down-a-hotel-business-in-poland-legal-obligations-and-risks/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Bringing Photos to Life with AI: Image Rights, Deepfakes and the Law in Poland and the EU</title>
		<link>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/bringing-photos-to-life-with-ai-image-rights-deepfakes-and-the-law-in-poland-and-the-eu/</link>
					<comments>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/bringing-photos-to-life-with-ai-image-rights-deepfakes-and-the-law-in-poland-and-the-eu/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 20:10:35 +0000</pubDate>
				<category><![CDATA[IT, NEW TECHNOLOGIES, MEDIA AND COMMUNICATION TECHNOLOGY LAW]]></category>
		<category><![CDATA[AI marketing compliance]]></category>
		<category><![CDATA[AI photo animation]]></category>
		<category><![CDATA[AI photo animation in Poland]]></category>
		<category><![CDATA[AI provider contracts]]></category>
		<category><![CDATA[AI-generated video]]></category>
		<category><![CDATA[Article 50 AI Act]]></category>
		<category><![CDATA[biometric data]]></category>
		<category><![CDATA[consent to image use]]></category>
		<category><![CDATA[content licensing]]></category>
		<category><![CDATA[deepfake labelling]]></category>
		<category><![CDATA[deepfake law in Poland]]></category>
		<category><![CDATA[deepfakes]]></category>
		<category><![CDATA[digital impersonation]]></category>
		<category><![CDATA[Digital Services Act]]></category>
		<category><![CDATA[DSA notice and action]]></category>
		<category><![CDATA[EU AI Act]]></category>
		<category><![CDATA[facial animation]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[identity theft]]></category>
		<category><![CDATA[image rights]]></category>
		<category><![CDATA[image rights after death]]></category>
		<category><![CDATA[image-to-video AI]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[online content removal]]></category>
		<category><![CDATA[online defamation]]></category>
		<category><![CDATA[parody and satire]]></category>
		<category><![CDATA[personal data protection]]></category>
		<category><![CDATA[personality rights]]></category>
		<category><![CDATA[photograph copyright]]></category>
		<category><![CDATA[Polish copyright law]]></category>
		<category><![CDATA[reputation protection]]></category>
		<category><![CDATA[right to one's image]]></category>
		<category><![CDATA[synthetic content marking]]></category>
		<category><![CDATA[synthetic media]]></category>
		<category><![CDATA[voice cloning]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9044</guid>

					<description><![CDATA[<p>Publication date: November 17, 2026 A single uploaded photograph is now enough to make a face blink, smile and speak. Since 2 August 2026, EU law for the first time defines a “deepfake” and requires such content to be labelled. For the person whose face is animated, however, the most effective protection still comes from [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/bringing-photos-to-life-with-ai-image-rights-deepfakes-and-the-law-in-poland-and-the-eu/">Bringing Photos to Life with AI: Image Rights, Deepfakes and the Law in Poland and the EU</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color"><strong>Publication date: November 17, 2026</strong></mark></p>



<p><strong>A single uploaded photograph is now enough to make a face blink, smile and speak. Since 2 August 2026, EU law for the first time defines a “deepfake” and requires such content to be labelled. For the person whose face is animated, however, the most effective protection still comes from well-established Polish rules on image rights, copyright, data protection, personal rights and criminal law. This article explains how the old and new layers fit together, where the 2024 analysis needed correcting, and when animating a photo remains lawful.</strong></p>



<span id="more-9044"></span>



<h1 class="wp-block-heading">How photo animation works, and when it becomes a deepfake</h1>



<p>Animating a still image typically combines AI models that map facial features with generative models that produce motion, facial expression and lip movement synchronised with supplied text or audio. Services such as D-ID allow a user to upload a photo, type a script or upload a voice recording, and receive a short video in which the person in the photo appears to speak; a synthetic face or a stock image can be used instead of a real photograph.<a href="#_ftn1" id="_ftnref1">[1]</a> Comparable functions are now built into general-purpose image-to-video tools and social media apps.</p>



<p>Not every animation is a deepfake. The EU Artificial Intelligence Act (AI Act) now defines a deepfake as AI-generated or manipulated image, audio or video content that resembles existing persons, objects, places, entities or events and would falsely appear to a person to be authentic or truthful.<a href="#_ftn2" id="_ftnref2">[2]</a> An animated face invented by the software, or an obviously stylised cartoon, will usually fall outside that definition. The legal questions start when the animation is linked to an identifiable real person or a real event, and they become acute when it is used to deceive, for example in election disinformation, investment scams using a celebrity’s face, or sexualised fakes.<a href="#_ftn3" id="_ftnref3">[3]</a></p>



<h1 class="wp-block-heading">The image and the photograph: Polish copyright law</h1>



<p><strong>Image right.</strong> Under Article 81(1) of the Polish Copyright Act, disseminating a person’s image requires that person’s permission; unless expressly reserved otherwise, permission is presumed where the person was paid for posing.<a href="#_ftn4" id="_ftnref4">[4]</a> Permission is not required for the image of a commonly known person where the image was made in connection with that person’s public functions, nor for a person who is merely a detail of a larger whole such as a gathering, landscape or public event (Article 81(2)). The right is infringed by dissemination: animating a photograph for oneself is not dissemination, whereas posting the result on social media is. In our view, the public-figure exception does not cover an animation that puts invented words into a politician’s or celebrity’s mouth, because the exception concerns authentic images of public activity, not fabricated statements.</p>



<p>A clarification of the 2024 version of this article is needed here. The image right does not “arise” when a photograph is taken; it is a personal right of the person depicted, existing independently of any photograph. Copyright in the photograph is a separate right belonging to the photographer, and it exists only where the photograph meets the originality threshold of Article 1(1) of the Copyright Act. That threshold is low, but not every automatic snapshot will meet it.</p>



<p><strong>Copyright in the photograph.</strong> Animating a protected photograph will usually produce an adaptation (<em>opracowanie</em>) within the meaning of Article 2 of the Copyright Act. Creating an adaptation is free, but disposing of and using it requires the consent of the author of the original work (Article 2(2)). The permitted personal use exception in Article 23 allows free use of a disseminated work within a circle of persons connected by personal relationships, such as family or friends; publishing the animation online goes beyond that circle.</p>



<p><strong>Deceased persons.</strong> Animating photographs of deceased relatives is one of the most popular uses of these tools. Under Article 83 of the Copyright Act, claims for unauthorised dissemination of an image may be pursued for up to 20 years after the death of the person depicted. Close relatives may also rely on their own personal right to cherish the memory of the deceased (<em>kult pamięci osoby zmarłej</em>) under the Civil Code.</p>



<h1 class="wp-block-heading">Personal data: what the GDPR does and does not cover</h1>



<p>The image of an identifiable person is personal data under Article 4(1) GDPR.<a href="#_ftn5" id="_ftnref5">[5]</a> Here too the 2024 analysis needs refining: a facial image is not automatically biometric data. Under Article 4(14) and Recital 51 GDPR, photographs are biometric data only when processed through specific technical means allowing the unique identification or authentication of a person. Animation tools map facial features in order to generate movement rather than to identify, so whether Article 9 applies is debatable and depends on the technology used; where it does, explicit consent will in practice be required.</p>



<p>Outside Article 9, processing needs a legal basis under Article 6, which for animating someone’s face will usually be consent (Articles 6(1)(a) and 7). Two limits on the GDPR’s reach are important. First, it does not apply to processing by a natural person in the course of a purely personal or household activity (Article 2(2)(c)); however, the Court of Justice has held that publishing data on the internet so that it is accessible to an indefinite number of people falls outside that exemption.<a href="#_ftn6" id="_ftnref6">[6]</a> Second, the GDPR does not apply to deceased persons (Recital 27), so relatives must rely on the copyright and civil-law routes described above.</p>



<p>Where a person’s image has been processed unlawfully, they may demand erasure under Article 17(1)(d) GDPR, or under Article 17(1)(b) after withdrawing consent, and may complain to the President of the Personal Data Protection Office (UODO). In serious cases, unlawful processing is also a criminal offence under Article 107 of the Polish Personal Data Protection Act.<a href="#_ftn7" id="_ftnref7">[7]</a> The UODO President has publicly called for dedicated rules on deepfakes.<a href="#_ftn8" id="_ftnref8">[8]</a></p>



<h1 class="wp-block-heading">The new EU layer: AI Act transparency obligations</h1>



<p>The most significant change since 2024 is that the AI Act’s transparency obligations in Article 50 have applied since 2 August 2026. They were not postponed by the Digital Omnibus on AI (Regulation (EU) 2026/1744), which entered into force on 27 July 2026 and deferred mainly the high-risk rules.<a href="#_ftn9" id="_ftnref9">[9]</a> Two obligations matter most for photo animation:</p>



<ul class="wp-block-list">
<li><strong>Providers</strong> of AI systems generating synthetic image, audio or video content must ensure that outputs are marked in a machine-readable format and detectable as artificially generated or manipulated (Article 50(2)). For systems placed on the market before 2 August 2026, the Omnibus allowed a transitional period until 2 December 2026.</li>



<li><strong>Deployers</strong> of an AI system that generates or manipulates content constituting a deepfake must disclose that the content has been artificially generated or manipulated (Article 50(4)). Where the content forms part of an evidently artistic, creative, satirical or fictional work, the obligation is limited to disclosure in a manner that does not hamper its display or enjoyment.</li>
</ul>



<p>A key nuance: the AI Act’s definition of a deployer excludes use of an AI system in the course of a personal, non-professional activity (Article 3(4)). A private individual animating a grandmother’s photograph for the family is therefore not bound by Article 50(4), although the app provider remains bound by Article 50(2). Businesses, advertisers, media, influencers acting commercially and political campaigns are bound. Breaches of Article 50 may attract fines of up to EUR 15 million or 3% of total worldwide annual turnover, whichever is higher (Article 99(4)).</p>



<p>Practical guidance is provided by the Commission’s Code of Practice on marking and labelling of AI-generated content, published on 10 June 2026, and by the Commission’s guidelines on the Article 50 transparency obligations.<a href="#_ftn10" id="_ftnref10">[10]</a> The Code is voluntary, but the Commission has confirmed it as an adequate means of demonstrating compliance. The Omnibus also added to the list of prohibited AI practices systems designed to generate non-consensual intimate imagery or child sexual abuse material, with a transitional period ending on 2 December 2026.</p>



<p>In Poland, the Act of 3 July 2026 on Artificial Intelligence Systems entered into force on 11 August 2026.<a href="#_ftn11" id="_ftnref11">[11]</a> It establishes the Commission for the Development and Security of Artificial Intelligence (KRiBSI) as the market surveillance authority, which accepts complaints and imposes administrative fines; its provisions on inspections, proceedings and penalties have applied since 28 October 2026.</p>



<h1 class="wp-block-heading">Platforms: the Digital Services Act and its implementation in Poland</h1>



<p>The Digital Services Act (DSA) has applied in full since 17 February 2024.<a href="#_ftn12" id="_ftnref12">[12]</a> Every hosting provider must operate a notice-and-action mechanism (Article 16) and give reasons for its moderation decisions (Article 17), which gives victims a direct route to have a deepfake reviewed and removed. Very large online platforms must also assess and mitigate systemic risks; among the mitigation measures, Article 35(1)(k) expressly refers to ensuring that generated or manipulated images, audio or video that appreciably resemble existing persons or events are distinguishable through prominent markings.</p>



<p>Poland’s national implementation has been slow. After the President vetoed the first implementing act on 9 January 2026, the Government split the reform into two bills. The first, the Act of 4 September 2026 amending the Act on the Provision of Electronic Services, which designates the President of the Office of Electronic Communications (UKE) as Digital Services Coordinator, was signed in September 2026. The second, introducing a national procedure for orders to disable access to illegal content (including content relating to identity theft and fraud), has been passed by Parliament and sent to the President for signature.<a href="#_ftn13" id="_ftnref13">[13]</a> The DSA itself applies directly regardless of these national acts.</p>



<h1 class="wp-block-heading">Criminal liability</h1>



<p>Polish law still contains no stand-alone deepfake offence, but several existing provisions apply.<a href="#_ftn14" id="_ftnref14">[14]</a> (The 2024 version of this article referred to Article 212 §6; the correct provision on defamation through the mass media is Article 212 §2.)</p>



<ul class="wp-block-list">
<li><strong>Defamation</strong> (Article 212 §2 of the Criminal Code): imputing to a person, group of persons, institution, legal person or organisational unit conduct or characteristics that may lower them in public opinion, committed through the mass media, including the internet, is punishable by a fine, restriction of liberty or imprisonment of up to one year.</li>



<li><strong>Insult</strong> (Article 216 §2): insulting a natural person through the mass media carries the same penalty. Both offences are prosecuted by private indictment.</li>



<li><strong>Identity theft</strong> (Article 190a §2): impersonating another person by using their image, other personal data or other data by which they are publicly identified, and thereby causing them material or personal harm, is punishable by imprisonment of six months to eight years; if the victim attempts suicide as a result, two to fifteen years (Article 190a §3). Prosecution takes place at the victim’s request.</li>



<li><strong>Fraud</strong> (Article 286 §1): using an animated face or cloned voice to mislead someone into disposing of property, as in “CEO fraud” or fake celebrity investment adverts, is punishable by imprisonment of six months to eight years. Where the property is of significant value (over PLN 200,000), the penalty is one to ten years (Article 294 §1), with more severe tiers for property of great value.</li>



<li><strong>Intimate images</strong> (Article 191a): disseminating, without consent, the image of a naked person or a person during sexual activity is punishable by three months to five years. Whether a synthetic image is covered is disputed, which is why a bill submitted on 7 October 2026 (Sejm print no. 3268) would add §1a expressly covering images created or altered with digital techniques, including AI, and new provisions on AI-generated sexual content involving minors.<a id="_ftnref15" href="#_ftn15">[15]</a> Producing and disseminating pornographic content showing a created or processed image of a minor is already an offence under Article 202 §4b.</li>
</ul>



<p>EU law will soon require further change. Directive (EU) 2024/1385 on combating violence against women and domestic violence obliges Member States to criminalise producing or manipulating, and then making accessible to the public, material that makes it appear that a person is engaged in sexually explicit activities, without that person’s consent, where likely to cause serious harm. The transposition deadline is 14 June 2027.<a href="#_ftn16" id="_ftnref16">[16]</a></p>



<h1 class="wp-block-heading">Civil-law protection of personal rights</h1>



<p>Articles 23 and 24 of the Civil Code remain the most flexible tool for victims.<a href="#_ftn17" id="_ftnref17">[17]</a> The catalogue of personal rights is open: it expressly includes image, name, pseudonym and honour, and voice is widely recognised as protected as well, which matters for voice-cloning. A person whose personal rights are threatened or infringed may demand that the conduct cease, that its effects be removed (for example by deleting the material and publishing a statement or apology), and monetary compensation for non-material harm or payment to a social cause (Articles 24 §1 and 448), as well as damages for any financial loss. Unlawfulness is presumed, so it is for the creator or publisher of the animation to prove a justification such as valid consent.</p>



<h1 class="wp-block-heading">What comes next</h1>



<p>The legislative picture is still moving. Besides the criminal-law bill and the Directive mentioned above, the Polish Ministry of Culture has indicated that it is considering deepfake-related provisions in the planned amendment of the Copyright Act.<a href="#_ftn18" id="_ftnref18">[18]</a> Elsewhere in the EU, a Danish bill introduced on 8 October 2026 would give individuals copyright-style control over realistic digital imitations of their face and voice, an approach that may influence the debate in Poland.</p>



<h1 class="wp-block-heading">When is animating a photo lawful?</h1>



<p>Not every animation is unlawful. In summary:</p>



<ul class="wp-block-list">
<li><strong>Consent is decisive.</strong> It must be freely given and informed: the person must understand that their image will be animated, what they will be shown saying or doing, and where the result will be published. Consent to being photographed is not consent to synthetic speech.</li>



<li><strong>Private use</strong> within a circle of family and friends, without publication, will not normally infringe image rights or copyright, and falls outside the GDPR and the AI Act’s deployer obligations.</li>



<li><strong>Invented or non-identifiable faces</strong> do not engage image rights or data protection law, although the provider’s marking obligation still applies.</li>



<li><strong>Satire and parody</strong> of public figures may be lawful if they are evidently satirical, are not defamatory or insulting, and, where the AI Act applies, are labelled as AI-generated.</li>



<li><strong>Businesses</strong> using animated faces in marketing, training or communications should obtain written consent that covers AI animation specifically, label deepfakes under Article 50(4) AI Act, verify the provider’s marking under Article 50(2), and document a GDPR legal basis. For images of deceased persons, the consent of close relatives is the safest course.</li>
</ul>



<p><strong>Legal sources</strong></p>



<ol class="wp-block-list">
<li>Act of 4 February 1994 on Copyright and Related Rights (consolidated text: Dz.U. 2025, item 24, as amended).</li>



<li>Act of 23 April 1964 – Civil Code (consolidated text: Dz.U. 2026, item 795).</li>



<li>Act of 6 June 1997 – Criminal Code (consolidated text: Dz.U. 2025, item 383, as amended).</li>



<li>Act of 10 May 2018 on the Protection of Personal Data (consolidated text: Dz.U. 2019, item 1781, as amended).</li>



<li>Act of 3 July 2026 on Artificial Intelligence Systems (Dz.U. 2026, item 1003).</li>



<li>Regulation (EU) 2016/679 (General Data Protection Regulation), OJ L 119, 4.5.2016, p. 1.</li>



<li>Regulation (EU) 2022/2065 (Digital Services Act), OJ L 277, 27.10.2022, p. 1.</li>



<li>Regulation (EU) 2024/1689 (Artificial Intelligence Act), OJ L, 2024/1689, 12.7.2024, as amended by Regulation (EU) 2026/1744 (Digital Omnibus on AI).</li>



<li>Directive (EU) 2024/1385 on combating violence against women and domestic violence, OJ L, 2024/1385, 24.5.2024.</li>



<li>European Commission, Code of Practice on marking and labelling of AI-generated content, 10 June 2026.</li>
</ol>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p><a href="#_ftnref1" id="_ftn1">[1]</a>D-ID, Creative Reality Studio, https://www.d-id.com/creative-reality-studio/ (accessed 5 August 2024).</p>



<p><a href="#_ftnref2" id="_ftn2">[2]</a>Article 3(60) of Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), OJ L, 2024/1689, 12.7.2024.</p>



<p><a href="#_ftnref3" id="_ftn3">[3]</a>See e.g. Communication from the Commission – Commission Guidelines for providers of Very Large Online Platforms and Very Large Online Search Engines on the mitigation of systemic risks for electoral processes pursuant to Article 35(3) of Regulation (EU) 2022/2065, C/2024/3014, OJ C, 26.4.2024.</p>



<p><a href="#_ftnref4" id="_ftn4">[4]</a>Act of 4 February 1994 on Copyright and Related Rights (consolidated text: Journal of Laws (Dz.U.) 2025, item 24, as amended), hereinafter the “Copyright Act”.</p>



<p><a href="#_ftnref5" id="_ftn5">[5]</a>Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation), OJ L 119, 4.5.2016, p. 1.</p>



<p><a href="#_ftnref6" id="_ftn6">[6]</a>Judgment of the Court of Justice of 6 November 2003, <em>Lindqvist</em>, C-101/01, EU:C:2003:596.</p>



<p><a href="#_ftnref7" id="_ftn7">[7]</a>Act of 10 May 2018 on the Protection of Personal Data (consolidated text: Journal of Laws (Dz.U.) 2019, item 1781, as amended).</p>



<p><a href="#_ftnref8" id="_ftn8">[8]</a>“Deepfake a prawo – prezes UODO apeluje o nowe regulacje”, Prawo.pl, https://www.prawo.pl/biznes/deepfake-a-prawo-prezes-uodo-apeluje-o-nowe-regulacje,535237.html.</p>



<p><a href="#_ftnref9" id="_ftn9">[9]</a>Regulation (EU) 2026/1744 (Digital Omnibus on AI), adopted by the European Parliament on 16 June 2026 and by the Council on 29 June 2026; see e.g. Goodwin, “Not Delayed, Not Deferred: EU AI Act Transparency Obligations Are Now in Force”, August 2026.</p>



<p><a href="#_ftnref10" id="_ftn10">[10]</a>European Commission, Code of Practice on marking and labelling of AI-generated content, 10 June 2026 (press release IP/26/1328), https://digital-strategy.ec.europa.eu/en/policies/code-practice-ai-generated-content.</p>



<p><a href="#_ftnref11" id="_ftn11">[11]</a>Act of 3 July 2026 on Artificial Intelligence Systems (Journal of Laws (Dz.U.) 2026, item 1003).</p>



<p><a href="#_ftnref12" id="_ftn12">[12]</a>Regulation (EU) 2022/2065 of the European Parliament and of the Council of 19 October 2022 on a Single Market For Digital Services and amending Directive 2000/31/EC (Digital Services Act), OJ L 277, 27.10.2022, p. 1.</p>



<p><a href="#_ftnref13" id="_ftn13">[13]</a>See “Druga ustawa wdrażająca DSA w Polsce czeka na podpis prezydenta”, Tabletowo.pl, 2026; Ombudsman (RPO), letter to the President of 20 September 2026 on the DSA implementing act.</p>



<p><a href="#_ftnref14" id="_ftn14">[14]</a>Act of 6 June 1997 – Criminal Code (consolidated text: Journal of Laws (Dz.U.) 2025, item 383, as amended).</p>



<p><a href="#_ftnref15" id="_ftn15">[15]</a>Sejm print no. 3268 (10th term), deputies’ bill amending the Criminal Code, 7 October 2026.</p>



<p><a href="#_ftnref16" id="_ftn16">[16]</a>Article 5(1)(b) of Directive (EU) 2024/1385 of the European Parliament and of the Council of 14 May 2024 on combating violence against women and domestic violence, OJ L, 2024/1385, 24.5.2024.</p>



<p><a href="#_ftnref17" id="_ftn17">[17]</a>Act of 23 April 1964 – Civil Code (consolidated text: Journal of Laws (Dz.U.) 2026, item 795).</p>



<p><a id="_ftn18" href="#_ftnref18">[18]</a>Reply of the Minister of Culture and National Heritage to parliamentary interpellation no. 14310, 2026, https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDR2K79/i14310-o3.pdf.</p>
<p> </p>



<p>Services</p>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>



<p>KG LEGAL KIELTYKA GLADKOWSKI offers legal support concerning AI-generated content in Poland. Our assistance covers image and personality rights, copyright licensing, data protection, consent documentation and AI Act transparency requirements.</p>



<p>We help businesses review proposed uses of synthetic media and assess responses to unauthorised use of faces or voices, including platform notices and civil remedies.</p>



<p>Contact: <a href="mailto:office@kg-legal.pl">office@kg-legal.pl</a>.</p>
<p> </p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/bringing-photos-to-life-with-ai-image-rights-deepfakes-and-the-law-in-poland-and-the-eu/">Bringing Photos to Life with AI: Image Rights, Deepfakes and the Law in Poland and the EU</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/bringing-photos-to-life-with-ai-image-rights-deepfakes-and-the-law-in-poland-and-the-eu/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Fighting Digital ID Fraud in 2026: From Industry Pilots to Statutory Trust Frameworks</title>
		<link>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/fighting-digital-id-fraud-in-2026-from-industry-pilots-to-statutory-trust-frameworks/</link>
					<comments>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/fighting-digital-id-fraud-in-2026-from-industry-pilots-to-statutory-trust-frameworks/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 19:48:13 +0000</pubDate>
				<category><![CDATA[IT, NEW TECHNOLOGIES, MEDIA AND COMMUNICATION TECHNOLOGY LAW]]></category>
		<category><![CDATA[AI Act]]></category>
		<category><![CDATA[AMLR]]></category>
		<category><![CDATA[biometric verification]]></category>
		<category><![CDATA[Continuous Access Evaluation]]></category>
		<category><![CDATA[data protection]]></category>
		<category><![CDATA[data protection impact assessment]]></category>
		<category><![CDATA[deepfake fraud]]></category>
		<category><![CDATA[digital ID fraud]]></category>
		<category><![CDATA[digital identity fraud prevention]]></category>
		<category><![CDATA[digital identity in Poland]]></category>
		<category><![CDATA[digital identity law]]></category>
		<category><![CDATA[digital identity verification]]></category>
		<category><![CDATA[digital verification services]]></category>
		<category><![CDATA[eIDAS 2.0]]></category>
		<category><![CDATA[EUDI Wallet]]></category>
		<category><![CDATA[European Digital Identity Wallet]]></category>
		<category><![CDATA[fraud data sharing]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[identity fraud]]></category>
		<category><![CDATA[identity provider due diligence]]></category>
		<category><![CDATA[identity verification contracts]]></category>
		<category><![CDATA[injection attacks]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[KYC]]></category>
		<category><![CDATA[mObywatel Europa]]></category>
		<category><![CDATA[OfDIA]]></category>
		<category><![CDATA[OpenID Shared Signals Framework]]></category>
		<category><![CDATA[Payment Services Regulation]]></category>
		<category><![CDATA[PSD3]]></category>
		<category><![CDATA[reusable digital identity]]></category>
		<category><![CDATA[RISC]]></category>
		<category><![CDATA[shared signals]]></category>
		<category><![CDATA[social engineering]]></category>
		<category><![CDATA[UK digital identity trust framework]]></category>
		<category><![CDATA[UK GDPR]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9042</guid>

					<description><![CDATA[<p>Publication date: November 17, 2026 From a 2023 pilot to a regulated market In July 2023 we attended a techUK webinar on fraud prevention in digital identity. Representatives of Synectics Solutions, Yoti and Mitek presented the &#8220;Shared Signals Pilot&#8221; (Project Shield): competing identity providers agreeing to exchange real-time alerts about compromised documents, credentials and identities. [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/fighting-digital-id-fraud-in-2026-from-industry-pilots-to-statutory-trust-frameworks/">Fighting Digital ID Fraud in 2026: From Industry Pilots to Statutory Trust Frameworks</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 17, 2026</mark></strong></p>



<h3 class="wp-block-heading"><a>From a 2023 pilot to a regulated market</a></h3>



<p>In July 2023 we attended a techUK webinar on fraud prevention in digital identity. Representatives of Synectics Solutions, Yoti and Mitek presented the &#8220;Shared Signals Pilot&#8221; (Project Shield): competing identity providers agreeing to exchange real-time alerts about compromised documents, credentials and identities. The panellists predicted that reusable digital identity would take off within three to five years, and that deepfakes would become the next major fraud vector.</p>



<span id="more-9042"></span>



<p>Three years on, both predictions have largely come true, but the landscape looks different from what anyone expected in 2023. Signal sharing has moved from a voluntary pilot to global technical standards and, in the EU payments sector, to a legal obligation. Digital identity verification in the UK now rests on a statutory framework. The EU is weeks away from its deadline for national digital identity wallets. And deepfakes are no longer a forecast but a measurable share of fraud attempts.</p>



<p>This article revisits the themes of that webinar against the legal and market position as of November 2026, with a focus on what it means for businesses operating in the UK, the EU and Poland.</p>



<h2 class="wp-block-heading"><a>The threat landscape in 2026</a></h2>



<p>The deepfake threat flagged by the webinar panellists is now mainstream. Entrust&#8217;s 2026 Identity Fraud Report, based on over 1 billion identity verifications across 195 countries, finds that deepfakes account for one in five biometric fraud attempts. Deepfaked selfie attempts rose by 58% in 2025, and injection attacks, which feed manipulated images or video directly into verification systems to bypass live capture, rose by 40% year on year.</p>



<p>Two other observations from 2023 still hold. First, different frauds need different responses: a teenager with a forged driving licence is not the same problem as an organised network reusing stolen identities at scale. Entrust describes fraud as now industrialised, running around the clock and offered &#8220;as a service&#8221;. Second, the human factor remains decisive. Social engineering and coercion, where victims are persuaded to use their own genuine credentials for the fraudster, are rising and cannot be stopped by document checks alone.</p>



<p>The practical consequence is that identity can no longer be treated as a one-off check at onboarding. It has to be monitored continuously, which is exactly where shared signals come in.</p>



<h2 class="wp-block-heading"><a>Shared signals: from pilot to global standard</a></h2>



<p>Project Shield was launched in June 2023 as a proof of concept. In Phase 1, Synectics&#8217; National SIRA platform, already used by banks, provided a dedicated pathway for Yoti and Mitek to create, send and receive signals about fake or fraudulently obtained identity documents, using test data, a real-time API and an alert system. The organisers openly acknowledged the main obstacles: privacy, data protection and the lack of a standardised framework for sharing.</p>



<p>The standardisation gap has since been closed at the technical level. In September 2025 the OpenID Foundation approved three Final Specifications: the Shared Signals Framework 1.0, the Continuous Access Evaluation Profile (CAEP) 1.0 and Risk Information Sharing and Coordination (RISC) 1.0. Together they define how one service can tell another, in real time, that a session was revoked, a credential changed or an account was compromised. Final status means the specifications are frozen and carry IP protections for implementers, which removes a key barrier to investment.</p>



<p>The legal question raised in 2023 is still the harder one. Sharing fraud intelligence means processing personal data about individuals who are suspected, not convicted, of wrongdoing. Under the GDPR and UK GDPR, any such scheme needs a clear legal basis, purpose limitation, retention limits and safeguards against wrongful flagging. As shown below, the EU has now chosen to legislate this basis directly for the payments sector.</p>



<h2 class="wp-block-heading"><a>United Kingdom: a statutory market, no national ID</a></h2>



<p>In 2023 the webinar speakers mentioned government requirements as one reason for their cooperation. Those requirements now have statutory force. Part 2 of the Data (Use and Access) Act 2025 (Royal Assent 19 June 2025) put the digital verification services (DVS) trust framework, a register of certified providers, a trust mark and an information gateway on a legal footing. Most of Part 2 came into force on 1 December 2025.</p>



<p>According to the Office for Digital Identities and Attributes (OfDIA) annual report of 14 July 2026:</p>



<ul class="wp-block-list">
<li>the DVS register listed 46 providers offering 64 certified services;</li>



<li>version 1.0 of the trust framework, the first statutory version, was published on 9 June 2026 and takes effect from 1 September 2026;</li>



<li>the &#8220;UK CertifID&#8221; trust mark was designated in March 2026 for certified, registered providers;</li>



<li>the information gateway allowing public authorities to share data with registered providers at an individual&#8217;s request awaits a Code of Practice;</li>



<li>OfDIA is reviewing the security and fraud sections of the trust framework.</li>
</ul>



<p>The public-sector picture has moved in the opposite direction. In September 2025 the government announced a national digital ID that would become mandatory for right-to-work checks. In January 2026 the mandatory element was dropped, and a public consultation ran from March to May 2026. In July 2026 the new Prime Minister, Andy Burnham, scrapped the scheme altogether. GOV.UK One Login, the government&#8217;s existing sign-in and verification service, continues to expand and had been joined by 245 services by October 2026.</p>



<p>For businesses, the result is a market led by certified private providers operating under a statutory framework, rather than a single state-issued credential. Certification and registration are becoming the practical benchmark of trustworthiness for UK identity checks.</p>



<h2 class="wp-block-heading"><a>European Union: wallets, mandatory fraud data sharing and deepfake labelling</a></h2>



<p>The EU has taken a more regulatory route, with four instruments converging on digital identity fraud.</p>



<p><strong>eIDAS 2.0 and the EU Digital Identity Wallet.</strong> Under Regulation (EU) 2024/1183, every Member State must make at least one EUDI Wallet available by 24 December 2026. Use is voluntary for individuals. From December 2027, regulated private relying parties, including banks, insurers, telecoms operators and very large online platforms, will have to accept the wallet when a user chooses to use it. Readiness is uneven: a Q1 2026 industry review rated only three Member States as almost certain to meet the deadline and four as unlikely. The wallet is designed for selective disclosure, so a user can prove a single attribute, such as being over 18, without handing over a full document. This is the &#8220;reusable ID&#8221; the 2023 panellists described, now with a legal mandate.</p>



<p><strong>The Payment Services Regulation (PSR).</strong> The final compromise texts of PSD3 and the PSR were published in April 2026, and the Council adopted its first-reading position on 29 October 2026. Publication in the Official Journal is still pending, with most rules expected to apply about 21 months after entry into force, i.e. in 2028. The PSR turns the Project Shield idea into a legal obligation: payment service providers must share fraud-related data with each other through dedicated platforms, with time-limited retention and an express legal basis under the GDPR. It also extends providers&#8217; liability for certain impersonation fraud where fraud-prevention measures are inadequate.</p>



<p><strong>The AI Act.</strong> The transparency obligations in Article 50 of Regulation (EU) 2024/1689 have applied since 2 August 2026, including the duty of deployers to disclose that image, audio or video content is a deepfake. The Digital Omnibus (Regulation (EU) 2026/1744) postponed the high-risk regime, but left Article 50 largely intact, granting only a grace period until 2 December 2026 for machine-readable marking by generative AI systems already on the market. Labelling will not stop fraudsters, who will simply ignore it, but it raises the compliance bar for legitimate providers of synthetic media tools.</p>



<p><strong>The Anti-Money Laundering Regulation (AMLR).</strong> Its key obligations apply from 10 July 2027 and expressly allow electronic identification under eIDAS, including the EUDI Wallet, for customer due diligence. For obliged entities, this links wallet acceptance directly to KYC processes.</p>



<h2 class="wp-block-heading"><a>Poland: mObywatel Europa</a></h2>



<p>Poland enters the wallet era from a strong position. The mObywatel app already has nearly 10 million users on version 2.0. In February 2026 reports suggested that the existing app did not meet the EU technical requirements and that a separate wallet app would be needed. In March 2026 the Ministry of Digital Affairs confirmed instead that the EUDI Wallet will be integrated into mObywatel, with no second app for users.</p>



<p>The wallet is being delivered by the Central Informatics Centre (COI) under the name mObywatel Europa. On 16 September 2026 the Ministry opened a free testing sandbox where businesses and institutions can integrate their services with a demonstration build. A pilot launch is planned for December 2026, while full integration may take until 2027 or 2028. Poland has also taken part in the EU large-scale pilots POTENTIAL and APTITUDE.</p>



<p>For Polish banks, payment institutions, insurers and telecoms operators, the sandbox is the practical starting point. The acceptance obligation from December 2027 will coincide closely with the AMLR (July 2027) and, later, the PSR, so integration work is best planned as a single programme rather than three separate projects.</p>



<h2 class="wp-block-heading"><a>What businesses should do now</a></h2>



<p>The central message of the 2023 webinar, that no single organisation can fight identity fraud alone, has been confirmed by both the market and the legislator. In practice, we recommend that businesses relying on remote identity checks:</p>



<ol class="wp-block-list">
<li><strong>Map their obligations by jurisdiction and date.</strong> EUDI Wallet acceptance (December 2027), AMLR customer due diligence (July 2027), AI Act Article 50 (in force since August 2026) and the PSR (expected 2028) overlap for many financial and digital businesses.</li>



<li><strong>Test early.</strong> Polish entities can use the mObywatel Europa sandbox; UK-facing businesses should check that their identity providers are certified and listed on the DVS register.</li>



<li><strong>Review vendor contracts.</strong> Agreements with identity verification providers should address deepfake and injection-attack detection, certification status, incident notification and allocation of liability for fraud losses.</li>



<li><strong>Prepare a legal basis for fraud data sharing.</strong> Before joining any signal-sharing scheme, document the legal basis, carry out a data protection impact assessment, set retention limits and provide a route for individuals to challenge a wrongful flag.</li>



<li><strong>Treat identity as continuous.</strong> Onboarding checks should be complemented by session-level and account-level signals, in line with the OpenID Shared Signals standards.</li>
</ol>



<p>As the panellists said in 2023, this requires patience and &#8220;baby steps&#8221;. The difference in 2026 is that many of those steps now come with statutory deadlines.</p>



<h2 class="wp-block-heading"><a>Sources</a></h2>



<p>techUK, <a href="https://www.techuk.org/what-we-deliver/events/fraud-prevention-in-digital-id.html" target="_blank" rel="noreferrer noopener">Fraud prevention in digital ID</a> (webinar, 20 July 2023)</p>



<p>Yoti, <a href="https://yoti.com/blog/digital-id-shared-signals-pilot-launched-to-tackle-evolving-fraud-risks" target="_blank" rel="noreferrer noopener">Digital ID Shared Signals Pilot launched to tackle evolving fraud risks</a> (2023)</p>



<p>Biometric Update, <a href="https://www.biometricupdate.com/202306/yoti-mitek-and-synectics-launch-pilot-to-fight-digital-id-fraud-with-shared-signals" target="_blank" rel="noreferrer noopener">Yoti, Mitek and Synectics launch pilot to fight digital ID fraud with shared signals</a></p>



<p>OpenID Foundation, <a href="https://openid.net/press-release-openid-foundation-finalizes-global-standards-for-real-time-identity-security/" target="_blank" rel="noreferrer noopener">Finalizes global standards for real-time identity security</a> (16 September 2025)</p>



<p>Entrust, <a href="https://www.entrust.com/resources/reports/identity-fraud-report" target="_blank" rel="noreferrer noopener">2026 Identity Fraud Report</a></p>



<p>GOV.UK, <a href="https://www.gov.uk/government/publications/office-for-digital-identities-and-attributes-2026-annual-report/ofdia-2026-annual-report-on-the-operation-of-part-2-of-data-use-and-access-act-2025" target="_blank" rel="noreferrer noopener">OfDIA 2026 Annual Report on Part 2 of the Data (Use and Access) Act 2025</a> (14 July 2026)</p>



<p>GOV.UK blog, <a href="https://enablingdigitalidentity.blog.gov.uk/2025/12/01/dvs-measures-in-the-data-act-have-come-into-force/" target="_blank" rel="noreferrer noopener">DVS measures in the Data Act have come into force</a> (1 December 2025)</p>



<p>Lewis Silkin, <a href="https://www.lewissilkin.com/en/insights/2026/03/23/uk-government-opens-consultation-on-digital-id-scheme-102mnlk" target="_blank" rel="noreferrer noopener">UK Government opens consultation on digital ID scheme</a> (March 2026)</p>



<p>Computer Weekly, <a href="https://computerweekly.com/news/366646014/Burnham-government-to-drop-digital-ID-and-tech-department" target="_blank" rel="noreferrer noopener">Burnham government to drop digital ID</a> (July 2026)</p>



<p>Tech Insider, <a href="https://tech-insider.org/uk-digital-id-scrapped-one-login-752-million-2026/" target="_blank" rel="noreferrer noopener">UK digital ID scrapped, One Login continues</a> (October 2026)</p>



<p>Namirial, <a href="https://www.namirial.com/en/blog/stories/status-check-eudi-wallet/" target="_blank" rel="noreferrer noopener">Status check: 9 months to the EUDI Wallet</a> (Q1 2026)</p>



<p>Payment Expert, <a href="https://paymentexpert.com/2026/11/10/psd3-guide-eu-payment-services/" target="_blank" rel="noreferrer noopener">PSD3 guide</a> (10 November 2026)</p>



<p>Worldline, <a href="https://worldline.com/en/home/main-navigation/resources/blogs/2026/the-scope-and-timeline-are-locked-in-for-psd3-and-psr-what-should-psps-know" target="_blank" rel="noreferrer noopener">The scope and timeline are locked in for PSD3 and PSR</a></p>



<p>IAPP, <a href="https://iapp.org/news/a/new-eu-payment-rules-could-expand-fraud-monitoring" target="_blank" rel="noreferrer noopener">New EU payment rules could expand fraud monitoring</a> (April 2026)</p>



<p>Ropes &amp; Gray, <a href="https://www.ropesgray.com/en/insights/viewpoints/2026/08/102nfqm/you-talkin-to-me-operationalising-the-eu-ai-acts-transparency-obligations" target="_blank" rel="noreferrer noopener">Operationalising the EU AI Act&#8217;s transparency obligations</a> (August 2026)</p>



<p>Reed Smith, <a href="https://www.reedsmith.com/our-insights/blogs/viewpoints/102nfqg/always-read-the-label-eu-ai-transparency-rules-and-questions-that-remain-unanswe/" target="_blank" rel="noreferrer noopener">EU AI transparency rules and questions that remain unanswered</a></p>



<p>bank.pl, <a href="https://bank.pl/?p=559565" target="_blank" rel="noreferrer noopener">IDENTT dołączył do środowiska testowego mObywatel Europa</a> (2026)</p>



<p>Telepolis, <a href="https://www.telepolis.pl/tech/aplikacje/mobywatel-europejski-portfel-tozsamosci-cyfrowej" target="_blank" rel="noreferrer noopener">mObywatel Europa od grudnia</a></p>



<p>iGrant.io, <a href="https://eudi-wallet-tracker.igrant.io/tracker/poland/" target="_blank" rel="noopener">EUDI Wallet tracker: Poland</a></p>
<p> </p>



<p>Services</p>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>




<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/fighting-digital-id-fraud-in-2026-from-industry-pilots-to-statutory-trust-frameworks/">Fighting Digital ID Fraud in 2026: From Industry Pilots to Statutory Trust Frameworks</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/fighting-digital-id-fraud-in-2026-from-industry-pilots-to-statutory-trust-frameworks/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Artificial Intelligence on Board: Are Polish and EU Law Ready for Cloud-Free Automotive AI?</title>
		<link>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/artificial-intelligence-on-board-are-polish-and-eu-law-ready-for-cloud-free-automotive-ai/</link>
					<comments>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/artificial-intelligence-on-board-are-polish-and-eu-law-ready-for-cloud-free-automotive-ai/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 14:07:16 +0000</pubDate>
				<category><![CDATA[IT, NEW TECHNOLOGIES, MEDIA AND COMMUNICATION TECHNOLOGY LAW]]></category>
		<category><![CDATA[academic spin-outs]]></category>
		<category><![CDATA[AI liability]]></category>
		<category><![CDATA[AI licensing]]></category>
		<category><![CDATA[AI supplier due diligence]]></category>
		<category><![CDATA[automotive AI in Poland]]></category>
		<category><![CDATA[automotive cybersecurity]]></category>
		<category><![CDATA[automotive edge AI]]></category>
		<category><![CDATA[automotive law]]></category>
		<category><![CDATA[connected vehicles]]></category>
		<category><![CDATA[CONSUMER PROTECTION]]></category>
		<category><![CDATA[Cyber Resilience Act]]></category>
		<category><![CDATA[Data Act]]></category>
		<category><![CDATA[data protection by design]]></category>
		<category><![CDATA[driver monitoring]]></category>
		<category><![CDATA[embedded AI]]></category>
		<category><![CDATA[EU AI Act]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[in-car voice assistants]]></category>
		<category><![CDATA[in-vehicle AI]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[OEM contracts]]></category>
		<category><![CDATA[on-device AI]]></category>
		<category><![CDATA[OTA updates]]></category>
		<category><![CDATA[Polish technology law]]></category>
		<category><![CDATA[product liability]]></category>
		<category><![CDATA[R&D agreements]]></category>
		<category><![CDATA[software updates]]></category>
		<category><![CDATA[software-defined vehicles]]></category>
		<category><![CDATA[Technology Transfer]]></category>
		<category><![CDATA[UNECE R155]]></category>
		<category><![CDATA[UNECE R156]]></category>
		<category><![CDATA[university commercialisation]]></category>
		<category><![CDATA[vehicle data]]></category>
		<category><![CDATA[vehicle type-approval]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9038</guid>

					<description><![CDATA[<p>Publication date: November 17, 2026 Legal status as of 12 November 2026 The automotive industry is increasingly turning to specialised companies from the artificial intelligence sector, and AI functions are moving from cloud servers to the vehicle’s own computers. This trend is currently most visible in the US market. From a Polish perspective, embedded in [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/artificial-intelligence-on-board-are-polish-and-eu-law-ready-for-cloud-free-automotive-ai/">Artificial Intelligence on Board: Are Polish and EU Law Ready for Cloud-Free Automotive AI?</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 17, 2026</mark></strong></p>



<p><em>Legal status as of 12 November 2026</em></p>



<p><strong>The automotive industry is increasingly turning to specialised companies from the artificial intelligence sector, and AI functions are moving from cloud servers to the vehicle’s own computers. This trend is currently most visible in the US market. From a Polish perspective, embedded in the EU legal order, the key question is whether existing rules allow such solutions to be deployed commercially and whether they support cooperation between manufacturers and academic spin-outs. The answer is yes, but on-device processing is not a regulatory shortcut: it changes how obligations are distributed, not whether they exist.</strong></p>



<span id="more-9038"></span>



<h1 class="wp-block-heading"><a>The Automotive Sector and AI: A New Model of Cooperation</a></h1>



<p>Cars have long been largely software-defined products. What is new is the extent to which manufacturers (OEMs) rely on AI models developed outside their own organisations, most often by young, narrowly specialised technology companies. One example is the multi-year partnership announced in 2026 between Mercedes-Benz and Liquid AI, a company with roots at MIT, concerning embedded in-vehicle intelligence, in particular on-device speech processing and language understanding.<a href="#_ftn1" id="_ftnref1">[1]</a> Such arrangements are becoming more common, and their common denominator is moving part of the AI computation into the vehicle itself (so-called <em>edge AI</em>).</p>



<p>The uses of AI in a car are not limited to the driver-vehicle relationship. They can be grouped as follows:</p>



<p>•&nbsp;<strong>user interaction</strong> &#8211; voice assistants, control of cabin settings, media and navigation;</p>



<p>•&nbsp;<strong>driver monitoring</strong> &#8211; detection of drowsiness and distraction and, going forward, assessment of the driver’s physical and mental condition;</p>



<p>•&nbsp;<strong>driver assistance and safety</strong> &#8211; speed control, hazard warnings, response to changing weather conditions, emergency manoeuvres;</p>



<p>•&nbsp;<strong>vehicle management</strong> &#8211; coordination of components, management of energy, fuel and fluids, predictive diagnostics;</p>



<p>•&nbsp;<strong>data-driven services</strong> &#8211; telematics, usage-based insurance, servicing and fleet management.</p>



<p>This map matters legally. Most obligations depend not on whether a system “is AI”, but on what it does, what it can access and what consequences its correct or faulty operation may have. Publicly described deployments of on-device language models concern mainly the first group, i.e.&nbsp;the in-cabin assistant, and are expressly distinguished from automated driving projects.<a href="#_ftn2" id="_ftnref2">[2]</a> No conclusions about all vehicle functions should therefore be drawn from them. The legal assessment must be carried out function by function.</p>



<h1 class="wp-block-heading"><a>From the Cloud to the Vehicle: What On-Device Processing Changes</a></h1>



<p>Edge AI means performing computation close to the data source, here on the vehicle’s computer. A model may be trained in a data centre, while the car performs only inference, i.e.&nbsp;uses the trained model to produce an output. On-device operation also does not automatically mean that the system learns from every conversation with the driver.</p>



<p>From a business perspective, moving computation into the vehicle brings independence from network coverage, lower latency and lower infrastructure costs. In practice, however, most deployments remain hybrid: simple commands are handled locally, while queries beyond the capabilities of a smaller model are sent to the cloud. “Offline” therefore describes the connectivity of a specific function, not a guarantee that no data will ever leave the car.</p>



<p>From a legal perspective, the location of computation affects data flows, transfers to third countries, exposure to incidents and the organisation of updates. It does not, however, replace an analysis of the system’s intended purpose. It is also worth distinguishing the language model from the integration layer: a well-designed assistant does not control actuators directly but selects a command from a closed catalogue, while an intermediate layer checks permissions and vehicle status and may request confirmation or refuse execution. Such an architecture makes subsequent legal classification and demonstration of compliance easier.</p>



<h1 class="wp-block-heading"><a>Classification of AI Systems in the Vehicle</a></h1>



<h2 class="wp-block-heading"><a>Model, System and Vehicle</a></h2>



<p>The AI Act<a href="#_ftn3" id="_ftnref3">[3]</a> distinguishes between an AI model, an AI system and the product in which the system is embedded. The model is a component; the system combines it with an interface, data and tools serving a specific use; the vehicle is a still broader product subject to a separate type-approval regime. Classification at one level does not determine the others.</p>



<p>The provider of the system within the meaning of the AI Act will usually be the car manufacturer placing it on the market under its own brand, even if the model was supplied by a start-up. The start-up may at the same time remain the provider of the model and, if the model meets the criteria of a general-purpose AI (GPAI) model under Article 3(63) of the AI Act, it is subject to the obligations under Article 53 (technical documentation, information for downstream integrators, a copyright compliance policy and a summary of training content). The label “foundation model” in marketing materials does not determine GPAI status, and a small on-device model may well have it. A private driver using the system purely for personal purposes is not a deployer (Article 2(10) of the AI Act); a fleet operator may be.</p>



<h2 class="wp-block-heading"><a>In-Cabin Assistant versus Safety Function</a></h2>



<p>An assistant does not become a high-risk system merely because it is installed in a vehicle. Article 6(1) of the AI Act links high risk to performing a safety function of a product covered by Union harmonisation legislation. Following the 2026 amendment,<a href="#_ftn4" id="_ftnref4">[4]</a> the provision more clearly distinguishes functions serving solely user convenience from functions whose failure endangers health and safety.</p>



<p>A sectoral route applies to the automotive industry. Vehicles covered by Regulations 2018/858 and 2019/2144 fall under Section B of Annex I, to which, under Article 2(2) of the AI Act, only selected provisions apply, while requirements for AI systems are to be introduced into type-approval legislation (Articles 107-109). There is therefore no basis for attributing to every automotive safety system the full set of obligations under Chapter III of the AI Act or CE marking; a CE mark is not vehicle type-approval. At the same time, an ordinary assistant that does not fall within this exception is subject to the general provisions of the AI Act, and the exception for an automotive system does not automatically exempt the provider of a GPAI model.</p>



<p>In practice, a conversation about music, air-conditioning control, navigation and commands affecting functions relevant to driving should be assessed separately. Even a comfort function requires safeguards if activating it in a particular vehicle state could create a hazard (e.g.&nbsp;fogged windows or reduced visibility).</p>



<h2 class="wp-block-heading"><a>Transparency and Staff AI Literacy</a></h2>



<p>Where a system interacts with humans, the provider must ensure that users are informed that they are interacting with AI at the latest at the first interaction, unless this is obvious from the context (Article 50(1) of the AI Act). This does not require a notice before every response. Good practice is to separate three messages: “you are talking to AI”, “this function requires an internet connection” and “data will be used for an additional purpose”, as each has a different legal basis. Separately, Article 4 of the AI Act requires providers and deployers to take measures to ensure AI literacy of their staff, which in the automotive context covers integration, service and complaints-handling teams.</p>



<h1 class="wp-block-heading"><a>The Driver at the Centre: Monitoring, Emotions and Insurance</a></h1>



<p>In the EU, driver monitoring is not merely a design choice. Regulation 2019/2144<a href="#_ftn5" id="_ftnref5">[5]</a> requires new vehicles to be equipped, among other things, with driver drowsiness and attention warning (DDAW) and advanced driver distraction warning (ADDW) systems, whose technical requirements are laid down in delegated regulations.<a href="#_ftn6" id="_ftnref6">[6]</a> By their nature, these systems process images or signals relating to a specific person and increasingly rely on machine learning.</p>



<p>The line runs between assessing a physical state and recognising emotions. Article 5(1)(f) of the AI Act prohibits inferring the emotions of a natural person in the workplace, except for systems intended for medical or safety reasons. A company car, a courier fleet or a carrier’s vehicle may be a workplace. Recital 18 of the AI Act clarifies that detecting physical states such as fatigue is not emotion recognition. Extending a simple drowsiness detection system to analyse the driver’s frustration or aggression therefore requires a fresh assessment rather than reliance on the previous classification.</p>



<p>Under the GDPR,<a href="#_ftn7" id="_ftnref7">[7]</a> data from a driver-facing camera does not automatically become special-category biometric data (Article 9) unless it is processed for the purpose of uniquely identifying a person. Systematic monitoring of driver behaviour, especially in an employment relationship, will however very likely require a data protection impact assessment (Article 35).</p>



<p>The most sensitive business area is the use of driving-behaviour data by insurers. The AI Act classifies as high-risk the risk assessment and pricing of life and health insurance (Annex III, point 5(c)), but not motor insurance. This does not mean a free hand: pricing based on driver profiling is subject to the GDPR, including Article 22 on decisions based solely on automated processing, and the Data Act gives the user of a vehicle the right to share data with a chosen third party, e.g.&nbsp;an insurer (Article 5).<a href="#_ftn8" id="_ftnref8">[8]</a> The US example shows the scale of the risk: in 2025 the Federal Trade Commission challenged a manufacturer’s practice of passing location and driving-behaviour data to data brokers used by insurance companies.<a href="#_ftn9" id="_ftnref9">[9]</a> In the European model, a transparent legal basis for sharing data, separate from the assistant function itself, is therefore essential.</p>



<h1 class="wp-block-heading"><a>On-Device Processing and Personal Data Protection</a></h1>



<p>Moving computation into the car can reduce the transmission of voice recordings, location and command history to external servers. It is therefore a useful measure of data protection by design and by default (Article 25 GDPR). In its guidelines on connected vehicles, the European Data Protection Board expressly recommends processing data within the vehicle wherever possible.<a href="#_ftn10" id="_ftnref10">[10]</a> The guidelines do not, however, mean that any cloud is impermissible or that every on-device solution is lawful.</p>



<p><strong>“Offline” does not mean “anonymous”.</strong> A voice recording, the content of a command, a profile identifier or location remain personal data even if they never leave the car’s memory. The purpose, legal basis and retention period must therefore be established. The data-flow map should also cover diagnostic logs, service access, synchronisation after connectivity is restored and the sale of a used vehicle.</p>



<p><strong>Roles of the parties.</strong> A manufacturer is not the controller of all data merely because it built the car, and a model provider is not automatically a processor. What matters is actual influence over the purposes and means of processing (Article 4(7) and Articles 26 and 28 GDPR). In a purely on-device model in which the provider has no access to data, it may not process users’ personal data at all, which simplifies the contract but must be documented. The household exemption applicable to the driver does not release businesses from obligations relating to their own processing.</p>



<p><strong>Legal bases.</strong> Performing the requested function, personalisation, analytics and training future model versions are separate purposes. Article 6(1)(b) GDPR covers only processing objectively necessary for the performance of a contract; listing an operation in the terms and conditions does not make it necessary. Nor can the purchaser of a vehicle validly consent on behalf of passengers and other drivers.</p>



<p><strong>Cloud and transfers.</strong> In a hybrid model, some queries are sent to servers, often outside the EEA. Articles 44-49 GDPR then apply. Handling basic commands locally reduces the scope of transfers but does not eliminate them. It is advisable to transmit only the information needed for a specific query rather than the conversation history or vehicle profile.</p>



<p><strong>Model training.</strong> According to EDPB Opinion 28/2024, a model trained on personal data does not automatically become anonymous; what matters is whether data can be extracted from the parameters or obtained through the model’s outputs.<a href="#_ftn11" id="_ftnref11">[11]</a> Deploying a ready-made model in a car does not cure defects in earlier processing, and data collected for product development requires a separate legal basis.</p>



<h1 class="wp-block-heading"><a>Data Retention, Portability and Access</a></h1>



<p><strong>Retention.</strong> An on-device architecture makes it possible to keep storage to a minimum, e.g.&nbsp;by processing voice briefly without storing the entire conversation. Retention periods should be defined for each category of data, and when the vehicle changes hands, a simple and effective function to delete the previous user’s data is essential.</p>



<p><strong>Access to information stored in the device.</strong> Independently of the GDPR, storing information in terminal equipment and gaining access to it are governed by provisions implementing Article 5(3) of the ePrivacy Directive, in Poland Article 399 of the Electronic Communications Law.<a href="#_ftn12" id="_ftnref12">[12]</a> According to EDPB Guidelines 2/2023, an entirely local operation without access by another entity does not always fall within that regime; however, prior installation of software, updates and subsequent transmission of data are relevant.<a href="#_ftn13" id="_ftnref13">[13]</a> A generic “I agree to AI” screen will not replace a description of the actual operations or an analysis of the strict-necessity exemption. Sending promotional content through the assistant must be assessed separately (Article 398 of the Electronic Communications Law).</p>



<p><strong>Data Act.</strong> A modern car is usually a connected product, and some of its digital functions are related services. The Data Act gives the user the right to access data generated by the use of the product and to share it with third parties, such as repair shops or insurers (Articles 4-5). The obligation to design products so that data is accessible to the user by default (Article 3(1)) applies to products placed on the market after 12 September 2026. Importantly, an on-device architecture does not exclude these obligations: data stored only in the vehicle may still need to be made available to the user. The Data Act does not, however, require every conversation to be recorded or model weights to be disclosed. The Commission’s guidelines on vehicle data help distinguish raw and pre-processed data, which are subject to the access right, from inferred information.<a href="#_ftn14" id="_ftnref14">[14]</a> In rental, leasing and fleet arrangements, it should be borne in mind that the owner of the vehicle is not the data subject for all the data (Article 4(12) of the Data Act).</p>



<p><strong>Portability.</strong> The right to data portability under Article 20 GDPR and the rights under the Data Act differ in scope and addressees. In practice, it is advisable to handle both regimes through a single, consistent interface that distinguishes the driver’s personal data from product data.</p>



<p><strong>Breaches.</strong> The controller notifies a personal data breach to the President of the Polish Data Protection Office (UODO) within 72 hours of becoming aware of it, unless the breach is unlikely to result in a risk to individuals (Articles 33-34 GDPR). If the provider of the assistant service is also a provider of electronic communications services, the special 24-hour regime under Article 402 of the Electronic Communications Law may apply. Equipping a car with connectivity does not in itself confer such status, however. On-device processing limits the scale of potential incidents but does not eliminate risk, e.g.&nbsp;in the event of physical access to the vehicle.</p>



<h1 class="wp-block-heading"><a>Type-Approval, Cybersecurity and Updates</a></h1>



<p><strong>Type-approval.</strong> Under Regulation 2018/858,<a href="#_ftn15" id="_ftnref15">[15]</a> the manufacturer is responsible to the approval authority (in Poland, the Transport Technical Supervision, TDT) for type-approval and conformity of production. A contract with a model provider does not transfer this public-law responsibility. AI documentation prepared by a start-up is input for integration but does not replace the information folder, technical service reports or evidence of conformity of production.</p>



<p><strong>Cybersecurity.</strong> UNECE Regulation No 155<a href="#_ftn16" id="_ftnref16">[16]</a> requires a certified cybersecurity management system (CSMS) and, for a specific vehicle type, demonstration of threat analysis, supply-chain risk management and test results. For OEMs, this means bringing the AI start-up within their own security processes, including contractual obligations concerning vulnerabilities. The Cyber Resilience Act (CRA)<a href="#_ftn17" id="_ftnref17">[17]</a> excludes products covered by Regulation 2019/2144, but not all software of automotive suppliers: a separately offered application or module may fall under the CRA, whose vulnerability reporting obligations apply from 11 September 2026 and whose main requirements apply from 11 December 2027.</p>



<p><strong>OTA updates.</strong> Edge AI requires regular model updates in vehicles already in use. UNECE Regulation No 156<a href="#_ftn18" id="_ftnref18">[18]</a> provides for a certified software update management system (SUMS), identification of software versions, assessment of an update’s impact on the approved type, protection of integrity and safe installation conditions. In the EU, these requirements apply to all new vehicles from 7 July 2026.<a href="#_ftn19" id="_ftnref19">[19]</a> Not every model update requires a new type-approval: whether an amendment or extension of the certificate is required depends on the impact of the change on approved characteristics (Articles 33-34 of Regulation 2018/858). The rationale for this assessment must be retained before the update is distributed. ISO 26262, ISO 21448 and ISO/SAE 21434 are voluntary, but in practice serve as contractual and evidentiary benchmarks.</p>



<p><strong>The offline promise.</strong> If a manufacturer advertises certain functions as working without a connection, that representation affects the assessment of the goods’ conformity with the contract (Article 43b of the Polish Consumer Rights Act).<a href="#_ftn20" id="_ftnref20">[20]</a> The trader must also supply updates necessary to keep the goods in conformity, including security updates, for a period determined by statutory criteria, not automatically for two years (Article 43k). An update that removes an advertised on-device function or starts transmitting additional data may result in lack of conformity and requires a fresh consumer and privacy review. Sales materials should indicate which commands work locally and which require a connection, an account or a subscription.</p>



<h1 class="wp-block-heading"><a>Liability for Defective Software</a></h1>



<p>The seller’s liability for the car’s conformity with the contract must be distinguished from liability for damage caused by a dangerous product (Article 449¹ et seq. of the Polish Civil Code)<a href="#_ftn21" id="_ftnref21">[21]</a> and contractual liability along the supply chain. Contractual allocation of risk between the OEM and the start-up does not limit the injured party’s rights.</p>



<p>A significant change will come with the new Product Liability Directive,<a href="#_ftn22" id="_ftnref22">[22]</a> which expressly covers software, including AI systems, updates and related digital services remaining within the manufacturer’s control. The transposition deadline is 9 December 2026, and the new rules will apply to products placed on the market after that date. The Polish implementing act is at the draft stage.<a href="#_ftn23" id="_ftnref23">[23]</a> For contracts concluded today, this means ensuring that the OEM has access to the version history, test results, vulnerability information and evidence of defect remediation, since the manufacturer will be the first target of claims, including those relating to a component supplied by a start-up. The location of computation does not in itself determine defectiveness.</p>



<h1 class="wp-block-heading"><a>Academic Spin-Outs as Suppliers of Niche Expertise</a></h1>



<p>An autonomous, “intelligent” vehicle requires many narrow competences: speech recognition in a noisy cabin, assessment of the driver’s condition, perception in difficult weather, emergency manoeuvre planning or energy optimisation. A single technology company is rarely able to develop all of them at the highest level. It is precisely in such niches that teams emerging from universities, after years of fundamental research in a specific field, have an advantage. It can therefore be argued that cooperation between manufacturers and academic spin-outs will become increasingly common, and that the vehicle of the future will integrate solutions from many specialised suppliers.</p>



<p><strong>The US model.</strong> In the United States, commercialisation of university research relies on specialised technology licensing offices, which grant licences to spin-outs (often exclusive within a defined field of use) and may accept equity in lieu of part of the licence fees.<a href="#_ftn24" id="_ftnref24">[24]</a> The roles of the research laboratory, the technology licensing office and the company itself are kept separate, and conflicts of interest of founders who are also university employees are subject to disclosure and management. This model ensures a clear chain of title, which is key for an industrial customer.</p>



<p><strong>The Polish framework.</strong> In Poland, a spin-out is not a separate legal form; it most often takes the form of a limited liability company or a simple joint-stock company, which may be formed for any lawful purpose and without any requirement that a shareholder be a researcher (Article 151 § 1 and Article 300¹ § 1 of the Commercial Companies Code).<a href="#_ftn25" id="_ftnref25">[25]</a> The Law on Higher Education and Science<a href="#_ftn26" id="_ftnref26">[26]</a> distinguishes direct commercialisation, carried out by a technology transfer centre (sale of rights or licensing), from indirect commercialisation, carried out by a university special-purpose company acquiring shares in companies implementing research results (Articles 148-150a). Articles 152-157 of that Act govern research results created within the duties of a university employee: the obligation to disclose them, the university’s decision on commercialisation, the possibility of transferring rights to the creator and the sharing of proceeds. The creator’s statutory share of proceeds is not an equity stake in the spin-out.</p>



<p>The chain of title must be traced separately for each component of the technology. Polish copyright law<a href="#_ftn27" id="_ftnref27">[27]</a> differentiates between employee works, scientific works (Article 14) and computer programs (Article 74(3), with a presumption that rights vest in the employer). Model weights, training datasets and know-how may be subject to regimes different from those applying to code. The lawfulness of training data requires separate analysis: the text and data mining exception for scientific research (Article 26² of the Copyright Act) is broader than the general exception (Article 26³) available to commercial entities. A company’s academic origin does not extend a research organisation’s privileges to its business activities.</p>



<p>In practice, the main obstacle is not a lack of legal basis but the time and uncertainty of university commercialisation procedures and an unclear chain of title. For a manufacturer or investor, due diligence on a spin-out should cover the founders’ agreements with the university, commercialisation decisions, licences and any encumbrances arising from public research funding.</p>



<h1 class="wp-block-heading"><a>The Contract between the Manufacturer and the AI Start-Up</a></h1>



<p>Cooperation between an OEM and a start-up is rarely a single contract. It usually comprises a technology licence, a joint development agreement, a software supply and maintenance agreement and sometimes an equity investment. These must be kept distinct: a licence does not transfer shares, an investment does not confer rights to the code, and a partnership is not an acquisition. From the perspective of an edge AI deployment, the contract should at least address:</p>



<p>•&nbsp;the right to install the model on devices in a defined number of vehicles and versions, to adapt it to a specific processor and to have it used by vehicle purchasers;</p>



<p>•&nbsp;rights to further training, modifications and improvements, including the possibility of using them outside the project;</p>



<p>•&nbsp;licences for third-party components and open models, whose terms must be read rather than assumed from the label “open”;</p>



<p>•&nbsp;the parties’ roles under the GDPR and the AI Act and the scope of the start-up’s access to vehicle data;</p>



<p>•&nbsp;compliance documentation to be provided to the OEM for type-approval, CSMS and SUMS purposes, together with vulnerability reporting obligations;</p>



<p>•&nbsp;rules and timelines for updates, regression testing and preservation of advertised offline functions;</p>



<p>•&nbsp;continuity of support throughout the vehicle’s life cycle, including in the event of the start-up’s insolvency or acquisition (e.g.&nbsp;escrow of code and model weights);</p>



<p>•&nbsp;allocation of liability and recourse, taking into account the new product liability regime.</p>



<h1 class="wp-block-heading"><a>Conclusions: Lessons from the US and Poland’s Readiness</a></h1>



<p>The US market is deploying on-device AI in vehicles quickly, partly because of its regulatory design. Federal vehicle safety standards in the US rely on manufacturer self-certification rather than prior type-approval. The absence of a general federal data protection statute, in turn, results in a patchwork of state laws and a growing role for ex post enforcement, as illustrated by the FTC intervention on driving-behaviour data mentioned above. For other jurisdictions, including the EU, three lessons follow: on-device processing is an effective tool for reducing privacy risk; monetisation of driver data is the area of highest regulatory and reputational risk; and narrowly specialised spin-outs are becoming natural partners for manufacturers.</p>



<p>Under Polish and EU law, commercial deployment of automotive edge AI is permissible, and this direction is in fact favoured by the principle of data protection by design. On-device solutions do not, however, release businesses from obligations under the AI Act, the Data Act, type-approval law, the CRA, consumer law and the product liability regime. They change how those obligations are distributed: they reduce exposure to cloud transfers and incidents, but increase the importance of updates, documentation and maintaining functions throughout the vehicle’s life cycle.</p>



<p>We assess the readiness of the Polish legal environment as high in terms of fundamentals (company law, university commercialisation, data protection), but incomplete in several areas. These include the pending transposition of the Product Liability Directive, the practice of the newly established AI supervisory bodies under the Act on Artificial Intelligence Systems,<a href="#_ftn28" id="_ftnref28">[28]</a> further sectoral acts introducing AI requirements into type-approval and the speed of university commercialisation procedures. For businesses, this means that competitive advantage today depends not only on the quality of the model, but also on a well-designed architecture of contracts, data and compliance.</p>



<h2 class="wp-block-heading"><a>Key Dates</a></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><tbody><tr><td><strong>Date</strong></td><td><strong>Event</strong></td></tr><tr><td>7 July 2026</td><td>Software update requirements (UN R156) for all new vehicles in the EU</td></tr><tr><td>2 August 2026</td><td>AI Act &#8211; main application of transparency obligations (Article 50)</td></tr><tr><td>11 September 2026</td><td>CRA &#8211; obligation to report actively exploited vulnerabilities and severe incidents</td></tr><tr><td>12 September 2026</td><td>Data Act &#8211; access-by-design obligation for newly placed products</td></tr><tr><td>9 December 2026</td><td>Transposition deadline for the Product Liability Directive</td></tr><tr><td>2 August 2027</td><td>AI Act &#8211; compliance deadline for GPAI models placed on the market before 2 August 2025</td></tr><tr><td>11 December 2027</td><td>CRA &#8211; main requirements apply</td></tr><tr><td>2 August 2028</td><td>AI Act &#8211; requirements for high-risk systems under Annex I (subject to the sectoral route for vehicles)</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p><a href="#_ftnref1" id="_ftn1">[1]</a> Mercedes-Benz Group, press release of 23 April 2026 on the collaboration with Liquid AI, https://group.mercedes-benz.com/technology/innovation/collaboration/liquid-ai.html; see also MIT CSAIL Alliances, Liquid AI, Startup Connect, https://cap.csail.mit.edu/node/4185.</p>



<p><a href="#_ftnref2" id="_ftn2">[2]</a> I. Bousquette, <em>Mercedes Vehicles Get an AI Upgrade</em>, The Wall Street Journal, 10 November 2026, p.&nbsp;B4.</p>



<p><a href="#_ftnref3" id="_ftn3">[3]</a> Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), OJ L, 2024/1689, 12.7.2024, as amended (the “AI Act”).</p>



<p><a href="#_ftnref4" id="_ftn4">[4]</a> Regulation (EU) 2026/1744 of the European Parliament and of the Council of 8 July 2026 amending Regulations (EU) 2024/1689, (EU) 2018/1139 and (EU) 2023/1230 as regards the simplification of the implementation of harmonised rules on artificial intelligence, OJ L, 2026/1744, 24.7.2026.</p>



<p><a href="#_ftnref5" id="_ftn5">[5]</a> Regulation (EU) 2019/2144 of the European Parliament and of the Council of 27 November 2019 on type-approval requirements for motor vehicles […] as regards their general safety, OJ L 325, 16.12.2019, p.&nbsp;1, Article 6(1).</p>



<p><a href="#_ftnref6" id="_ftn6">[6]</a> Commission Delegated Regulation (EU) 2021/1341 (DDAW) and Commission Delegated Regulation (EU) 2023/2590 (ADDW).</p>



<p><a href="#_ftnref7" id="_ftn7">[7]</a> Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 (General Data Protection Regulation), OJ L 119, 4.5.2016, p.&nbsp;1, as amended (the “GDPR”).</p>



<p><a href="#_ftnref8" id="_ftn8">[8]</a> Regulation (EU) 2023/2854 of the European Parliament and of the Council of 13 December 2023 on harmonised rules on fair access to and use of data (Data Act), OJ L, 2023/2854, 22.12.2023 (the “Data Act”).</p>



<p><a href="#_ftnref9" id="_ftn9">[9]</a> Federal Trade Commission, <em>FTC Takes Action Against General Motors for Sharing Drivers’ Precise Location and Driving Behavior Data Without Consent</em>, press release of 16 January 2025.</p>



<p><a href="#_ftnref10" id="_ftn10">[10]</a> EDPB, Guidelines 01/2020 on processing personal data in the context of connected vehicles and mobility related applications, version 2.0, 9 March 2021, paras 73-76.</p>



<p><a href="#_ftnref11" id="_ftn11">[11]</a> EDPB, Opinion 28/2024 on certain data protection aspects related to the processing of personal data in the context of AI models, 18 December 2024.</p>



<p><a href="#_ftnref12" id="_ftn12">[12]</a> Directive 2002/58/EC of the European Parliament and of the Council of 12 July 2002 (Directive on privacy and electronic communications), OJ L 201, 31.7.2002, p.&nbsp;37, as amended; Act of 12 July 2024 &#8211; Electronic Communications Law (Prawo komunikacji elektronicznej), Journal of Laws (Dz. U.) 2024, item 1221, as amended.</p>



<p><a href="#_ftnref13" id="_ftn13">[13]</a> EDPB, Guidelines 2/2023 on the Technical Scope of Art. 5(3) of the ePrivacy Directive, version 2.0, 7 October 2024.</p>



<p><a href="#_ftnref14" id="_ftn14">[14]</a> Commission Communication &#8211; Guidelines on vehicle data, accompanying Regulation (EU) 2023/2854 (Data Act), OJ C, C/2025/5026, 15.9.2025.</p>



<p><a href="#_ftnref15" id="_ftn15">[15]</a> Regulation (EU) 2018/858 of the European Parliament and of the Council of 30 May 2018 on the approval and market surveillance of motor vehicles and their trailers […], OJ L 151, 14.6.2018, p.&nbsp;1; Commission Implementing Regulation (EU) 2020/683, OJ L 163, 26.5.2020, p.&nbsp;1.</p>



<p><a href="#_ftnref16" id="_ftn16">[16]</a> UN Regulation No 155 &#8211; Uniform provisions concerning the approval of vehicles with regards to cyber security and cyber security management system [2025/5], OJ L, 2025/5, 10.1.2025.</p>



<p><a href="#_ftnref17" id="_ftn17">[17]</a> Regulation (EU) 2024/2847 of the European Parliament and of the Council of 23 October 2024 (Cyber Resilience Act), OJ L, 2024/2847, 20.11.2024, Articles 2(2)(c), 14, 69 and 71.</p>



<p><a href="#_ftnref18" id="_ftn18">[18]</a> UN Regulation No 156 &#8211; Uniform provisions concerning the approval of vehicles with regards to software update and software update management system [2021/388], OJ L 82, 9.3.2021, p.&nbsp;60; the 01 series of amendments applies from 4 June 2026.</p>



<p><a href="#_ftnref19" id="_ftn19">[19]</a> Commission Delegated Regulation (EU) 2022/2236 of 20 June 2022, OJ L 296, 16.11.2022, p.&nbsp;1, Article 2(7).</p>



<p><a href="#_ftnref20" id="_ftn20">[20]</a> Act of 30 May 2014 on Consumer Rights (ustawa o prawach konsumenta), Journal of Laws (Dz. U.) 2026, item 1244.</p>



<p><a href="#_ftnref21" id="_ftn21">[21]</a> Act of 23 April 1964 &#8211; Civil Code (Kodeks cywilny), Journal of Laws (Dz. U.) 2026, item 795.</p>



<p><a href="#_ftnref22" id="_ftn22">[22]</a> Directive (EU) 2024/2853 of the European Parliament and of the Council of 23 October 2024 on liability for defective products, OJ L, 2024/2853, 18.11.2024; corrigendum: OJ L, 2026/90364, 7.5.2026, Articles 4, 7, 11 and 21-22.</p>



<p><a href="#_ftnref23" id="_ftn23">[23]</a> Draft Act amending the Civil Code and the Code of Civil Procedure (UC163), List of legislative works of the Council of Ministers, entry of 25 August 2026.</p>



<p><a href="#_ftnref24" id="_ftn24">[24]</a> MIT Technology Licensing Office, <em>Understanding the Licensing Process</em>, https://tlo.mit.edu/understand-ip/understanding-licensing-process; MIT Policies and Procedures, 13.1 Intellectual Property and 4.4 Conflict of Interest.</p>



<p><a href="#_ftnref25" id="_ftn25">[25]</a> Act of 15 September 2000 &#8211; Commercial Companies Code (Kodeks spółek handlowych), Journal of Laws (Dz. U.) 2024, item 18, as amended.</p>



<p><a href="#_ftnref26" id="_ftn26">[26]</a> Act of 20 July 2018 &#8211; Law on Higher Education and Science (Prawo o szkolnictwie wyższym i nauce), Journal of Laws (Dz. U.) 2026, item 1362.</p>



<p><a href="#_ftnref27" id="_ftn27">[27]</a> Act of 4 February 1994 on Copyright and Related Rights (ustawa o prawie autorskim i prawach pokrewnych), Journal of Laws (Dz. U.) 2025, item 24, as amended (the “Copyright Act”); Directive (EU) 2019/790 of the European Parliament and of the Council of 17 April 2019, OJ L 130, 17.5.2019, p.&nbsp;92, Articles 3-4.</p>



<p><a id="_ftn28" href="#_ftnref28">[28]</a> Act of 3 July 2026 on Artificial Intelligence Systems (ustawa o systemach sztucznej inteligencji), Journal of Laws (Dz. U.) 2026, item 1003.</p>
<p> </p>



<h2 class="wp-block-heading">Services</h2>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>



<p>KG LEGAL KIELTYKA GLADKOWSKI offers legal support for automotive AI projects in Poland, including cooperation between manufacturers, technology suppliers and university spin-outs. Our assistance covers technology licensing, R&amp;D agreements, intellectual property, data protection, regulatory assessment and contractual allocation of liability.</p>



<p>We help clients structure arrangements for software supply, updates and ongoing support.</p>



<p>For advice on developing or deploying automotive AI solutions in Poland, contact office@kg-legal.pl.</p>
<p> </p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/artificial-intelligence-on-board-are-polish-and-eu-law-ready-for-cloud-free-automotive-ai/">Artificial Intelligence on Board: Are Polish and EU Law Ready for Cloud-Free Automotive AI?</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/artificial-intelligence-on-board-are-polish-and-eu-law-ready-for-cloud-free-automotive-ai/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Live Reporting as Evidence: Broadcast Recordings, Newsroom Logs and Journalistic Privilege in Digital Media</title>
		<link>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/live-reporting-as-evidence-broadcast-recordings-newsroom-logs-and-journalistic-privilege-in-digital-media/</link>
					<comments>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/live-reporting-as-evidence-broadcast-recordings-newsroom-logs-and-journalistic-privilege-in-digital-media/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 13:02:22 +0000</pubDate>
				<category><![CDATA[IT, NEW TECHNOLOGIES, MEDIA AND COMMUNICATION TECHNOLOGY LAW]]></category>
		<category><![CDATA[broadcast copyright]]></category>
		<category><![CDATA[broadcast evidence]]></category>
		<category><![CDATA[broadcast recordings]]></category>
		<category><![CDATA[broadcaster rights]]></category>
		<category><![CDATA[broadcasting law]]></category>
		<category><![CDATA[chain of custody]]></category>
		<category><![CDATA[confidential editorial communications]]></category>
		<category><![CDATA[criminal procedure]]></category>
		<category><![CDATA[data protection in media]]></category>
		<category><![CDATA[Digital Evidence]]></category>
		<category><![CDATA[digital media law]]></category>
		<category><![CDATA[editor-in-chief liability]]></category>
		<category><![CDATA[editorial responsibility]]></category>
		<category><![CDATA[Electronic Evidence]]></category>
		<category><![CDATA[EMFA]]></category>
		<category><![CDATA[European Media Freedom Act]]></category>
		<category><![CDATA[evidence preservation]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[journalistic privilege]]></category>
		<category><![CDATA[journalistic sources]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[law enforcement requests]]></category>
		<category><![CDATA[live broadcasting]]></category>
		<category><![CDATA[live reporting]]></category>
		<category><![CDATA[media law in Poland]]></category>
		<category><![CDATA[media liability]]></category>
		<category><![CDATA[newsroom compliance]]></category>
		<category><![CDATA[newsroom logs]]></category>
		<category><![CDATA[on-screen captions]]></category>
		<category><![CDATA[playout systems]]></category>
		<category><![CDATA[Polish press law]]></category>
		<category><![CDATA[press freedom]]></category>
		<category><![CDATA[production orders]]></category>
		<category><![CDATA[search and seizure]]></category>
		<category><![CDATA[source protection]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9033</guid>

					<description><![CDATA[<p>Publication date: November 17, 2026 Legal status as of 12 November 2026 News media increasingly operate in real time: a television broadcast, an online stream and a social media post are produced in parallel, and every editorial decision leaves a trace in IT systems. For law enforcement, this creates new sources of evidence; for newsrooms, [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/live-reporting-as-evidence-broadcast-recordings-newsroom-logs-and-journalistic-privilege-in-digital-media/">Live Reporting as Evidence: Broadcast Recordings, Newsroom Logs and Journalistic Privilege in Digital Media</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 17, 2026</mark></strong></p>



<p><em>Legal status as of 12 November 2026</em></p>



<p><strong>News media increasingly operate in real time: a television broadcast, an online stream and a social media post are produced in parallel, and every editorial decision leaves a trace in IT systems. For law enforcement, this creates new sources of evidence; for newsrooms, new risks. Taking as an example a prosecutor’s order requiring a licensed broadcaster to produce a broadcast recording and logs from its playout and graphics systems, we discuss the limits of these powers, the protection of journalistic privilege, the legal status of digital material and the rules of liability for live reporting.</strong></p>



<span id="more-9033"></span>



<h1 class="wp-block-heading"><a>Live Digital Broadcasting and Press Law</a></h1>



<p>News delivery has largely moved into the digital environment. Television broadcasts simultaneously via terrestrial, satellite, cable and internet distribution, and clips from live coverage reach social media within minutes. Streaming by online newsrooms and by journalists themselves is also growing in importance. During live coverage, viewers receive at the same time the camera image, the reporter’s words, the presenter’s commentary and on-screen news banners added in the studio. Each of these elements is created at a different point in the production chain, and each leaves a different trace in IT systems.</p>



<p>Polish press law is conceptually prepared for this shift. Article 7(2)(1) of the Press Law defines the press as including all existing means of mass communication and those emerging as a result of technical progress, including broadcasting stations, which disseminate periodical publications in print, video, audio or by any other technique.<a href="#_ftn1" id="_ftnref1">[1]</a> Press material is any text or image of an informative, journalistic, documentary or other nature that has been published or submitted for publication (Article 7(2)(4)). A news banner displayed for a few seconds, without an author’s name and generated by graphics software, is therefore press material to the same extent as a newspaper article.</p>



<p>The differences lie in public-law obligations. A broadcaster operating under a licence from the National Broadcasting Council (KRRiT) is subject to the Broadcasting Act,<a href="#_ftn2" id="_ftnref2">[2]</a> including the obligation to record and retain its output (Article 20). An online-only newsroom or the author of a social media stream is, as a rule, not subject to that obligation, although it may fall under the Press Law and, in the case of on-demand audiovisual media services or video-sharing platforms, under separate provisions of the Broadcasting Act. This distinction determines which recordings must exist at all when a prosecutor demands that they be produced.</p>



<h1 class="wp-block-heading"><a>The Case: A Demand for the Broadcast Recording and Logs</a></h1>



<p>A prosecutor’s order has recently been publicly reported, issued in proceedings concerning, among other offences, the offence under Article 223a § 1 of the Penal Code, in connection with live reporting for which the newsroom produced on-screen banners in real time. The legal basis cited was Article 217 §§ 1, 2 and 3, Article 236a and Article 180 § 1 of the Code of Criminal Procedure, read together with Article 20(1) of the Broadcasting Act. The demand was addressed to the company operating the television station and to its editor-in-chief personally, or to another authorised person. It covered:</p>



<p>1.&nbsp;<strong>a file containing the recording of the programme as broadcast</strong> (the so-called statutory recording, <em>rejestr ustawowy</em>) from a specified day, channel and time range, covering the report from the scene of a police intervention, stored on a commonly used data carrier (DVD, USB flash drive or external hard drive) in a format allowing playback without loss of quality;</p>



<p>2.&nbsp;<strong>logs from the playout system and from the system used to edit on-screen graphics</strong>, identifying account names, the personal data of the account users and their roles in the system, relating to the same programme, day and hours, stored on the same type of carrier.</p>



<p>At the same time, the prosecutor released an authorised employee from the duty of professional secrecy (<em>tajemnica służbowa</em>) with respect to the information requested (Article 180 § 1 CCP) and set a three-day deadline for compliance, citing the running of procedural time limits.</p>



<p>At first glance, this is a routine evidential measure. In fact, the order combines three categories of material with different legal status: a recording of published output, technical data about the broadcast, and information revealing the editorial process and the identity of individuals. Each requires separate assessment.</p>



<h1 class="wp-block-heading"><a>Media Freedom as the Starting Point</a></h1>



<p>Such a demand cannot be assessed solely under the Code of Criminal Procedure. The Polish Constitution guarantees freedom of the press and other means of social communication (Article 14) and freedom to express opinions and to acquire and disseminate information (Article 54), and any restriction of those freedoms must satisfy the proportionality test in Article 31(3). Equivalent guarantees follow from Article 10 of the European Convention on Human Rights and Article 11 of the EU Charter of Fundamental Rights. The European Court of Human Rights consistently treats the protection of journalistic sources as one of the basic conditions of press freedom, since without it sources may be deterred from assisting the press in informing the public.<a href="#_ftn3" id="_ftnref3">[3]</a></p>



<p>Since 8 August 2025, Article 4 of the European Media Freedom Act (EMFA)<a href="#_ftn4" id="_ftnref4">[4]</a> has applied, for the first time expressly protecting journalistic sources and confidential communications in EU law. It covers, among other things, demands for disclosure of such information and searches and seizures, including those directed at employees of a media service provider or persons who, by reason of a regular relationship with it, may hold such information (Article 4(3)(a)-(b)). A derogation is permissible only under the conditions in Article 4(4): it must be provided for in national or EU law, justified by an overriding reason of public interest, proportionate and, in principle, subject to prior authorisation by a judicial authority or an independent and impartial decision-making authority. Subsequent authorisation without undue delay is allowed only in duly justified exceptional and urgent cases.</p>



<p>The EMFA does not prohibit obtaining recordings that have already been broadcast publicly. An apparently technical demand for logs must, however, be assessed by reference to what it may actually reveal. The activity history of an account in a graphics system may show not only when a caption was displayed, but also who proposed it, who changed its wording and who was consulted on its content. That is already the territory of confidential editorial communication.</p>



<h1 class="wp-block-heading"><a>Who Owns the Digital Material?</a></h1>



<p>Newsrooms often ask whether a broadcaster may refuse to hand over a recording because it “owns” it. In criminal proceedings, the decisive factor is not ownership but control over the evidence. Article 217 § 1 CCP imposes the obligation to produce on anyone holding an item that may constitute evidence, and Article 236a CCP extends the rules on production and search, <em>mutatis mutandis</em>, to the holder and user of a device or IT system with respect to the data stored in it.<a href="#_ftn5" id="_ftnref5">[5]</a> The obligation therefore falls on whoever actually controls the file or system, regardless of who holds the economic rights in it.</p>



<p>Exclusive rights do not prevent the material from being used in proceedings, but they structure the relationships between those involved in production. A single recording typically involves:</p>



<p>•&nbsp;<strong>copyright of journalists and production staff</strong> in works created in the course of employment, which passes to the employer within the limits of the purpose of the employment contract (Article 12 of the Copyright Act);<a href="#_ftn6" id="_ftnref6">[6]</a></p>



<p>•&nbsp;<strong>the broadcaster’s related rights</strong> in its broadcasts (Article 97 of that Act);</p>



<p>•&nbsp;<strong>third-party rights</strong> in agency footage, witness recordings and content taken from social media and used in the report;</p>



<p>•&nbsp;<strong>personal data</strong> of employees recorded in the logs and of persons visible in the footage.</p>



<p>Article 33² of the Copyright Act permits the use of works for the purposes of public security and of judicial and administrative proceedings. Producing a broadcast recording to a prosecutor therefore does not require the consent of the authors or of the holders of rights in third-party material. Under the GDPR,<a href="#_ftn7" id="_ftnref7">[7]</a> disclosure of employee data in compliance with an order is based on the controller’s legal obligation (Article 6(1)(c)), and subsequent processing by the prosecution service is governed by the rules implementing Directive 2016/680.<a href="#_ftn8" id="_ftnref8">[8]</a> The journalistic exemption (Article 85 GDPR and Article 2 of the Polish Personal Data Protection Act)<a href="#_ftn9" id="_ftnref9">[9]</a> relieves the newsroom of some information obligations but does not release it from the duty to produce evidence.</p>



<p>Economic rights do, however, matter for further use of the material. A copy handed to the authorities serves the proceedings only and does not authorise its dissemination. Newsrooms should also bear in mind that the term “publisher” (<em>wydawca</em>) has a legal meaning in the Press Law (the entity carrying out the publishing process and bearing financial liability, Articles 8 and 38), distinct from the newsroom position of “programme editor” (also called <em>wydawca</em> in Polish). In practice, this overlap in terminology leads to errors in identifying the addressees of orders and the persons responsible.</p>



<h1 class="wp-block-heading"><a>The Statutory Recording: What a Broadcaster Must Retain</a></h1>



<p>Article 20(1) of the Broadcasting Act requires a broadcaster to record programmes, advertisements and other broadcasts and to retain the recordings for 28 days from transmission or, where a broadcast has become the subject of proceedings before a state authority, until those proceedings end. The details are set out in the KRRiT Regulation of 28 September 2017:<a href="#_ftn10" id="_ftnref10">[10]</a> the recording must be a digital file containing the material in full and unaltered, of a quality ensuring intelligible sound and legible images, and must be appropriately labelled and protected.</p>



<p>Three practical conclusions follow.</p>



<p>First, Article 20(1) is the basis for archiving, not for the demand. The prosecutor’s power derives from the CCP; the reference to the Broadcasting Act merely indicates that the material should exist.</p>



<p>Second, the statutory recording documents the final output that reached viewers, including sound and overlaid graphics. The reporter’s camera feed alone, without the banner added in the studio, may not reproduce the content under investigation.</p>



<p>Third, a demand for a file “without loss of quality” must be read by reference to the quality of the recording the broadcaster actually holds. The Regulation does not require retention of uncompressed source material, and lost detail cannot be recovered. Proper compliance means supplying the existing file without further conversion. Nor can the obligation in Article 20 be extended to logs of all newsroom systems: neither the Act nor the Regulation provides for 28-day retention of banner editing histories or of the mapping of accounts to employees. Whether such data exist depends on the configuration of the systems and the broadcaster’s own policy.</p>



<h1 class="wp-block-heading"><a>From Technical Terms to Legal Language</a></h1>



<p>The order, and subsequently the production record, should describe the material in a way that allows a court to establish later exactly what the evidence is, where it comes from and whether it has been altered. Terms used in newsrooms do not always have statutory equivalents, so it is worth translating them explicitly.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><tbody><tr><td><strong>Technical term</strong></td><td><strong>Legal classification</strong></td><td><strong>How to describe it in the order or record</strong></td></tr><tr><td>Broadcast signal, playout</td><td>Programme within the meaning of Art. 4(2) of the Broadcasting Act; subject of the recording under Art. 20(1)</td><td>Channel, date, time range to the second, time zone</td></tr><tr><td>Statutory recording (broadcast file)</td><td>IT data (Art. 236a CCP) recording press material</td><td>File name, format and codec, size, duration, checksum (e.g.&nbsp;SHA-256)</td></tr><tr><td>On-screen banner, news ticker</td><td>Press material (Art. 7(2)(4) Press Law), part of the programme</td><td>Wording, display time by the recording’s timecode</td></tr><tr><td>Playout system log</td><td>IT data on system events</td><td>System name and version, scope of events, period, time source</td></tr><tr><td>Graphics editing history</td><td>IT data; potentially confidential editorial communication</td><td>Type of events (creation, change, approval, transmission), period</td></tr><tr><td>User account and role</td><td>Personal data; potentially information protected by Art. 180 §§ 2-3 CCP</td><td>Account identifier, organisational assignment, confidentiality claim</td></tr><tr><td>Carrier (DVD, USB, hard drive)</td><td>Means of storing the copy, not the evidence itself</td><td>Type and labelling of the carrier, method of sealing</td></tr></tbody></table></figure>



<p>What is key to evidential value is preserving the original format and metadata, calculating a checksum at export, describing the time source and any differences between system clocks, identifying the person performing the export and the tool used, and documenting the subsequent chain of custody of the carrier. These are recommendations of good forensic practice rather than requirements laid down expressly in the KRRiT Regulation, but in a dispute over authenticity they determine whether the material is usable.</p>



<p>The limitations of each source must also be borne in mind. The broadcast recording shows the exact wording and display time of a caption, but not who wrote and approved it. The playout log documents the start and end of transmission, not the editorial decision. The editing history shows successive versions of the text but does not establish whether the account user was their sole author. A username in a log requires interpretation: the account may have been shared, an operation may have been automated, and an entry may mean writing the text as well as merely displaying it.</p>



<h1 class="wp-block-heading"><a>Production, Compulsory Seizure, Search</a></h1>



<p>Legal language knows no general concept of obtaining materials “by force”. The Code of Criminal Procedure provides for three distinct measures with separate conditions.</p>



<p><strong>Demand for production.</strong> Under Article 217 § 1 CCP, items that may constitute evidence must be handed over at the request of a court or prosecutor and, in urgent cases, also of the police or another authorised body. The person holding the item is requested to hand it over voluntarily (§ 2), and a record of the measure is drawn up (Article 217 § 3 read with Article 228).</p>



<p><strong>Compulsory seizure.</strong> If the item is not handed over voluntarily, it may be taken by compulsion (Article 217 § 5 CCP). This provision, rather than § 3, is the basis for compulsion.</p>



<p><strong>Search.</strong> Where the evidence must first be located, Articles 219-220 CCP apply. A search requires reasonable grounds to believe that the item or data sought are in a particular place and, as a rule, an order of a court or prosecutor. Acting without one is permitted only in urgent cases, subject to subsequent approval. The Polish Commissioner for Human Rights has stressed the importance of these safeguards in the seizure of a journalist’s computer.<a href="#_ftn11" id="_ftnref11">[11]</a></p>



<p>All these measures are subject to Article 227 CCP, which requires them to be carried out in accordance with their purpose, within the limits necessary, with restraint and with respect for the dignity of the persons concerned. For a television newsroom, this has practical significance: if the evidential objective can be achieved by exporting specified files and a limited range of logs, seizing servers or workstations requires particularly compelling justification.</p>



<h1 class="wp-block-heading"><a>Journalistic Privilege Is Not Professional Secrecy</a></h1>



<p>The most serious problem with the order concerns the procedure for releasing staff from confidentiality. Article 180 § 1 CCP allows a prosecutor to release a person from the duty of confidentiality connected with their profession or function, including professional secrecy. Using that term in an order does not, however, determine the actual nature of the information requested.</p>



<p>Journalistic privilege is subject to the special regime of Article 180 § 2 CCP. Release from it is possible only where it is necessary for the interests of justice and the fact in question cannot be established by other evidence. In the investigative phase, the decision lies with a court on the prosecutor’s application, not with the prosecutor alone. The same limitations apply to documents containing privileged information (Article 226 CCP). The Commissioner for Human Rights has emphasised that a demand for production of a document cannot be used to circumvent judicial review.<a href="#_ftn12" id="_ftnref12">[12]</a></p>



<p>The scope of this privilege is broad. Article 15(3) of the Press Law extends it to other employees of newsrooms, publishers and other press organisations. The National Public Prosecutor’s Office has referred in this context to, among others, IT staff and archivists.<a href="#_ftn13" id="_ftnref13">[13]</a> Addressing the demand to a system administrator rather than to a journalist therefore does not change the nature of the information the authority is seeking.</p>



<p>Article 180 § 3 CCP goes further, protecting data enabling the identification of the author of press material, a letter to the editor or other material of that kind, and of persons providing information, where they have requested that such data not be disclosed. The only exception to this prohibition concerns the offences listed in Article 240 § 1 of the Penal Code (Article 180 § 4). Article 223a § 1 of the Penal Code is not on that list. If the order also refers to “other” offences, their legal classification and connection with the protected information must be specified.</p>



<p>This does not mean that every caption writer or technical employee is an anonymous source. It must be established whether the data actually identify a protected author or informant, or reveal confidential communications. Article 180 § 5 CCP also preserves a journalist’s liability for an offence committed through publication. The conclusion for the order described is nonetheless clear: a prosecutor’s release from professional secrecy can extend only to information genuinely subject to it. It does not replace the court order required for journalistic privilege and does not lift the protection of the identity of authors and sources.</p>



<p>When documents designated by the newsroom as privileged are seized, Article 225 § 1 CCP also applies: once it is declared that they contain information subject to privilege, the authority passes them unread to the court or prosecutor in a sealed package. The exceptions in § 2, including those concerning documents held by a suspect, do not automatically remove the evidential restrictions in Article 226.</p>



<p>The importance of these safeguards is underlined by Strasbourg case law. In Sanoma Uitgevers B.V. v. the Netherlands, the Grand Chamber of the ECtHR held that interference with source protection requires prior review by an independent body capable of weighing whether the public interest outweighs the protection of the source before the investigating authority gains access to the material.<a href="#_ftn14" id="_ftnref14">[14]</a> Review after the data have been examined does not provide genuine protection.</p>



<h1 class="wp-block-heading"><a>Who Is Responsible for Live Coverage</a></h1>



<p>Establishing what was broadcast is only the first step. The second is attributing responsibility to specific individuals, which depends on their actual involvement in publication rather than on who appeared on screen or is registered as the account holder.</p>



<p>At broadcaster level, Article 13(1) of the Broadcasting Act makes the broadcaster responsible for the content of its programme service while preserving the liability of others for individual broadcasts. Article 25(1) and (4) of the Press Law sets out the duties and responsibility of the editor-in-chief. Neither provision allows an offence to be attributed automatically to the person managing the newsroom.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><tbody><tr><td><strong>Role</strong></td><td><strong>Matters to establish</strong></td></tr><tr><td>Reporter</td><td>Own words, information passed to the newsroom, involvement in drafting the banner, knowledge of its content</td></tr><tr><td>Banner author or editor</td><td>Choice of wording, change of meaning, source of information, decision to publish</td></tr><tr><td>Programme editor, duty editor</td><td>Scope of approval, instructions given, opportunity to respond to an error</td></tr><tr><td>Graphics system operator</td><td>Whether they acted technically or had editorial influence</td></tr><tr><td>Editor-in-chief</td><td>Organisation of work, supervision, involvement in publication, specific duties</td></tr></tbody></table></figure>



<p><strong>Criminal liability</strong> requires proof of the elements of the offence and the culpability of the particular individual (Article 1 § 3, Articles 8-9 and Article 18 of the Penal Code).<a href="#_ftn15" id="_ftnref15">[15]</a> However, Article 49a read with Article 37a of the Press Law must be taken into account: an editor may be liable for negligently allowing the publication of material fulfilling the elements of an offence. Since an editor is any journalist who decides or co-decides on publication (Article 7(2)(6)), this provision is not limited to the editor-in-chief and may concern the person approving banners during a live broadcast.</p>



<p><strong>Civil liability</strong> has separate foundations. The author, the editor or another person who caused the publication is liable for an infringement caused by publishing press material, jointly and severally with the publisher as regards financial liability (Article 38(1) of the Press Law). A person affected by a broadcast may seek protection of personality rights under Articles 23-24 and 448 of the Civil Code.<a href="#_ftn16" id="_ftnref16">[16]</a> The Supreme Court has accepted, in a civil case, a rebuttable factual presumption that the editor-in-chief influenced publication;<a href="#_ftn17" id="_ftnref17">[17]</a> it must not, however, be carried over into criminal liability.</p>



<p><strong>Standard of care.</strong> Article 12(1) of the Press Law requires particular diligence and reliability in gathering and using press material, including in drafting banners. In live coverage, it is essential to distinguish between the reporter’s own observation, a witness account and conjecture. If the reporter says “according to one witness” but the banner presents the information as established fact, the meaning of the message changes, and responsibility may shift to the person who removed the qualification. The pace of a live broadcast does not suspend professional standards, but it affects what could realistically be expected. The availability of reliable sources, signalling of uncertainty, response to conflicting information and prompt correction all matter. According to the resolution of a seven-judge panel of the Supreme Court of 18 February 2005, demonstrating action in defence of a socially justified interest and the exercise of particular diligence excludes the unlawfulness of an infringement of personality rights.<a href="#_ftn18" id="_ftnref18">[18]</a> Correction under Article 31a of the Press Law is a separate remedy.</p>



<h1 class="wp-block-heading"><a>The Limits of Article 223a of the Penal Code</a></h1>



<p>Article 223a § 1 of the Penal Code, in force since 1 January 2023,<a href="#_ftn19" id="_ftnref19">[19]</a> penalises publicly inciting the disclosure of information about the private life of an officer of a public security authority or of the Prison Service, where disclosure may endanger that officer or a person close to them. It should not be confused with Article 223 § 1 (active assault) or with Article 223b, which concerns the disclosure of such information itself.</p>



<p>In relation to a television report, it must be established whether the particular message contained incitement to disclose information, whether that information concerned the officer’s private life, whether its disclosure could create a danger, and who created or knowingly disseminated the message. Merely showing an intervention, describing official conduct or criticising officers does not fulfil these elements. This is particularly significant for press freedom: documenting the actions of public officials in a public place is a classic exercise of the media’s watchdog function.</p>



<p>Context also matters. Reporting that someone made a particular appeal has a different meaning from an appeal made by the newsroom itself. In Jersild v. Denmark, the ECtHR held that punishing a journalist for disseminating statements made by interviewees in a news report would seriously hamper the contribution of the press to public debate and requires particularly strong reasons.<a href="#_ftn20" id="_ftnref20">[20]</a> This is not immunity, but a requirement to assess the purpose and the report as a whole.</p>



<h1 class="wp-block-heading"><a>How a Broadcaster Can Respond</a></h1>



<p>Persons whose rights have been infringed by an order concerning production of items may file an interlocutory appeal (Article 236 § 1 CCP). In the investigative phase, it is heard by the district court in whose jurisdiction the proceedings are conducted. The deadline is seven days from announcement or service of the order (Article 460 CCP), and filing the appeal does not suspend enforcement unless the authority decides otherwise (Article 462 CCP).</p>



<p>The three-day deadline does not derive from statute; it was set by the authority. A reference to the running of procedural time limits does not lift the protection of privilege, does not replace judicial review and does not establish that the scope of the demand is proportionate. If exporting the data within that time is technically impossible, the broadcaster should promptly and specifically demonstrate this, stating the size of the archive, the export time or the need to separate protected data.</p>



<p>In practice, we recommend that broadcasters divide their response into three parts:</p>



<p>1.&nbsp;<strong>the broadcast recording</strong> &#8211; production of the existing file with a checksum and a description of its origin, which usually raises no concerns;</p>



<p>2.&nbsp;<strong>technical playout logs</strong> &#8211; production to the extent necessary to establish the time and content of the broadcast, with a description of the system and time source;</p>



<p>3.&nbsp;<strong>editing history, accounts and personal data</strong> &#8211; a claim of journalistic privilege to the extent that the data reveal confidential editorial communication or the identity of an author, together with a request to apply the procedure under Article 225 and Article 180 § 2 CCP.</p>



<p>It is also worth acting in advance: adopting a log retention policy consistent with the GDPR and editorial needs, using individual rather than shared accounts, synchronising system clocks, recording versions and approvals of banners, and putting in place an internal procedure for handling law enforcement requests with the involvement of a lawyer and the data protection officer.</p>



<h1 class="wp-block-heading"><a>Conclusions</a></h1>



<p>Digital news production means that every editorial decision leaves a trace that may become evidence. Polish law gives prosecutors effective tools to obtain broadcast recordings and data from newsroom IT systems. The same provisions, supplemented by the Constitution, the Convention and the European Media Freedom Act, nonetheless set clear limits: data revealing the editorial process and the identity of authors and sources require judicial review, not merely a prosecutor’s decision.</p>



<p>The key conclusion has two parts. An obligation to produce evidence does not mean a right to unlimited use of all the data disclosed. Conversely, establishing who performed an operation in a system does not yet determine who is responsible for the content of the broadcast. Cases involving live coverage require both analyses: a procedural assessment of whether the material was lawfully obtained and an individual assessment of each person’s involvement in publication.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p><a href="#_ftnref1" id="_ftn1">[1]</a> Act of 26 January 1984 &#8211; Press Law (Prawo prasowe), Journal of Laws (Dz. U.) 2018, item 1914, as amended.</p>



<p><a href="#_ftnref2" id="_ftn2">[2]</a> Act of 29 December 1992 on Radio and Television Broadcasting (ustawa o radiofonii i telewizji), consolidated text as amended (the “Broadcasting Act”), in particular Articles 4, 13, 20 and 33.</p>



<p><a href="#_ftnref3" id="_ftn3">[3]</a> ECtHR (Grand Chamber), Sanoma Uitgevers B.V. v. the Netherlands, judgment of 14 September 2010, application no. 38224/03; see also ECtHR (Grand Chamber), Goodwin v. the United Kingdom, judgment of 27 March 1996, application no. 17488/90.</p>



<p><a href="#_ftnref4" id="_ftn4">[4]</a> Regulation (EU) 2024/1083 of the European Parliament and of the Council of 11 April 2024 establishing a common framework for media services in the internal market (European Media Freedom Act), OJ L, 2024/1083, 17.4.2024, Articles 4 and 29.</p>



<p><a href="#_ftnref5" id="_ftn5">[5]</a> Act of 6 June 1997 &#8211; Code of Criminal Procedure (Kodeks postępowania karnego), Journal of Laws (Dz. U.) 2026, item 490, as amended (“CCP”).</p>



<p><a href="#_ftnref6" id="_ftn6">[6]</a> Act of 4 February 1994 on Copyright and Related Rights (ustawa o prawie autorskim i prawach pokrewnych), Journal of Laws (Dz. U.) 2025, item 24, as amended, in particular Articles 12, 33² and 97.</p>



<p><a href="#_ftnref7" id="_ftn7">[7]</a> Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 (General Data Protection Regulation), OJ L 119, 4.5.2016, p.&nbsp;1, as amended (“GDPR”).</p>



<p><a href="#_ftnref8" id="_ftn8">[8]</a> Directive (EU) 2016/680 of the European Parliament and of the Council of 27 April 2016, OJ L 119, 4.5.2016, p.&nbsp;89; Act of 14 December 2018 on the protection of personal data processed in connection with the prevention and combating of crime.</p>



<p><a href="#_ftnref9" id="_ftn9">[9]</a> Act of 10 May 2018 on Personal Data Protection (ustawa o ochronie danych osobowych), Journal of Laws (Dz. U.) 2019, item 1781, Article 2.</p>



<p><a href="#_ftnref10" id="_ftn10">[10]</a> Regulation of the National Broadcasting Council (KRRiT) of 28 September 2017 on the methods of recording and storing programmes, advertisements and other broadcasts by broadcasters, Journal of Laws (Dz. U.) item 1862, §§ 1-2.</p>



<p><a href="#_ftnref11" id="_ftn11">[11]</a> Commissioner for Human Rights (Rzecznik Praw Obywatelskich), intervention concerning the seizure of a journalist’s laptop, 6 October 2021.</p>



<p><a href="#_ftnref12" id="_ftn12">[12]</a> Commissioner for Human Rights, submission II.510.1143.2018 on professional secrecy in documents and Article 226 CCP.</p>



<p><a href="#_ftnref13" id="_ftn13">[13]</a> National Public Prosecutor’s Office (Prokuratura Krajowa), “Prokuratorzy w mediach o odpowiedzialności za złamanie tajemnicy dziennikarskiej” [Prosecutors in the media on liability for breach of journalistic privilege], 21 September 2016.</p>



<p><a href="#_ftnref14" id="_ftn14">[14]</a> Sanoma Uitgevers B.V. v. the Netherlands, op. cit. (note 3).</p>



<p><a href="#_ftnref15" id="_ftn15">[15]</a> Act of 6 June 1997 &#8211; Penal Code (Kodeks karny), Journal of Laws (Dz. U.) 2026, item 1342.</p>



<p><a href="#_ftnref16" id="_ftn16">[16]</a> Act of 23 April 1964 &#8211; Civil Code (Kodeks cywilny), Journal of Laws (Dz. U.) 2026, item 795.</p>



<p><a href="#_ftnref17" id="_ftn17">[17]</a> Supreme Court judgment of 2 December 2010, I CSK 11/10.</p>



<p><a href="#_ftnref18" id="_ftn18">[18]</a> Resolution of a seven-judge panel of the Supreme Court of 18 February 2005, III CZP 53/04, OSNC 2005, No.&nbsp;7-8, item 114.</p>



<p><a href="#_ftnref19" id="_ftn19">[19]</a> Act of 5 August 2022 amending the Executive Penal Code and certain other acts, Journal of Laws (Dz. U.) item 1855, Article 7(4) and Article 37.</p>



<p><a id="_ftn20" href="#_ftnref20">[20]</a> ECtHR, Jersild v. Denmark, judgment of 23 September 1994, application no. 15890/89, § 35.</p>
<p> </p>



<h2 class="wp-block-heading">Services</h2>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>


<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/live-reporting-as-evidence-broadcast-recordings-newsroom-logs-and-journalistic-privilege-in-digital-media/">Live Reporting as Evidence: Broadcast Recordings, Newsroom Logs and Journalistic Privilege in Digital Media</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/live-reporting-as-evidence-broadcast-recordings-newsroom-logs-and-journalistic-privilege-in-digital-media/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Synthetic data generation: the technology and its legal framework in the EU and Poland</title>
		<link>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/synthetic-data-generation-the-technology-and-its-legal-framework-in-the-eu-and-poland/</link>
					<comments>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/synthetic-data-generation-the-technology-and-its-legal-framework-in-the-eu-and-poland/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Mon, 16 Nov 2026 16:49:13 +0000</pubDate>
				<category><![CDATA[IT, NEW TECHNOLOGIES, MEDIA AND COMMUNICATION TECHNOLOGY LAW]]></category>
		<category><![CDATA[AI contracts]]></category>
		<category><![CDATA[AI data governance]]></category>
		<category><![CDATA[AI regulation in Poland]]></category>
		<category><![CDATA[AI training data]]></category>
		<category><![CDATA[AI Transparency]]></category>
		<category><![CDATA[AI vendor due diligence]]></category>
		<category><![CDATA[AI-generated content labelling]]></category>
		<category><![CDATA[copyright and AI]]></category>
		<category><![CDATA[data anonymisation]]></category>
		<category><![CDATA[data licensing]]></category>
		<category><![CDATA[data protection]]></category>
		<category><![CDATA[data protection impact assessment]]></category>
		<category><![CDATA[data provenance]]></category>
		<category><![CDATA[database rights]]></category>
		<category><![CDATA[EU AI Act]]></category>
		<category><![CDATA[gdpr]]></category>
		<category><![CDATA[Generative AI]]></category>
		<category><![CDATA[health data]]></category>
		<category><![CDATA[High-Risk AI Systems]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<category><![CDATA[Polish technology law]]></category>
		<category><![CDATA[pseudonymisation]]></category>
		<category><![CDATA[re-identification risk]]></category>
		<category><![CDATA[SYNTHETIC DATA]]></category>
		<category><![CDATA[synthetic data GDPR compliance]]></category>
		<category><![CDATA[synthetic data in Poland]]></category>
		<category><![CDATA[synthetic data legal framework]]></category>
		<category><![CDATA[synthetic data regulation]]></category>
		<category><![CDATA[synthetic datasets]]></category>
		<category><![CDATA[synthetic images]]></category>
		<category><![CDATA[synthetic tabular data]]></category>
		<category><![CDATA[synthetic text]]></category>
		<category><![CDATA[text and data mining]]></category>
		<category><![CDATA[trade secrets]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9031</guid>

					<description><![CDATA[<p>Publication date: November 16, 2026 Legal status as at 11 November 2026 Synthetic data, meaning text, images and tabular records produced by algorithms rather than collected from the real world, has moved from the research lab into everyday business use. It promises datasets that can be shared, tested and used to train AI without exposing [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/synthetic-data-generation-the-technology-and-its-legal-framework-in-the-eu-and-poland/">Synthetic data generation: the technology and its legal framework in the EU and Poland</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 16, 2026</mark></strong></p>



<p><em>Legal status as at 11 November 2026</em></p>



<p><strong>Synthetic data, meaning text, images and tabular records produced by algorithms rather than collected from the real world, has moved from the research lab into everyday business use. It promises datasets that can be shared, tested and used to train AI without exposing real individuals. The law, however, does not accept that promise at face value. In 2026 the European Data Protection Board stated that synthetic data is not anonymous by default, the AI Act&#8217;s transparency duties for synthetic content began to apply, and Poland established its own AI supervisory authority. This article explains how synthetic data is generated and what legal conditions its generation and use must meet.</strong></p>



<span id="more-9031"></span>



<h1 class="wp-block-heading">What synthetic data is and why the method matters legally</h1>



<p>The term covers three quite different families of techniques, and the legal analysis depends on which one is used.</p>



<ul class="wp-block-list">
<li>Rule-based (mock) data. Values are drawn from dictionaries, formats and random generators, without any real dataset as input. Libraries such as Faker and Mimesis, or older utilities such as pydbgen, produce names, addresses, dates or registration numbers for software testing.</li>



<li>Simulation. Data are produced by a model of the underlying process, for example Monte Carlo sampling or agent-based modelling (the Mesa framework), where simulated agents interact according to defined rules.</li>



<li>Data-derived synthesis. A generative model is trained on a real dataset and then sampled to produce new records that preserve the statistical properties of the original. This is the family that covers large language models, image generators and tabular synthesisers.</li>
</ul>



<p>The first two families usually raise few data protection questions, because no real person&#8217;s data enters the process. The third does: a model that has learned from personal data, copyright works or protected databases carries legal baggage from its training set, and the output may carry it too.</p>



<h1 class="wp-block-heading">Generating text: from Markov chains to large language models</h1>



<p>Natural language processing (NLP) has two branches: natural language understanding (NLU), which extracts meaning from text or speech, and natural language generation (NLG), which produces coherent text from data or a prompt. Both must respect the rules of syntax, vocabulary, morphology and semantics, and generated text should select the relevant information and present it in a logical structure. Typical uses include chatbot and voice assistant responses, suggested replies in e-mail, product descriptions for e-commerce, machine translation, summaries and narrative reports built from financial, business or Internet of Things data, transcription, and paraphrasing.</p>



<p>The methods have developed in four steps.</p>



<ul class="wp-block-list">
<li>Templates and Markov chains. The earliest systems filled the gaps in predefined text templates with data. A Markov chain is a stochastic model in which the probability of the next state depends only on the current one; applied to text, it predicts the next word from the last word entered, which is how early smartphone keyboards suggested words.</li>



<li>Recurrent neural networks (RNNs). An RNN processes a sequence element by element and feeds each output back in as input, so that earlier words are remembered when predicting the next. As sequences grow longer, training breaks down because of vanishing and exploding gradients: the weight updates propagated back through many time steps shrink towards zero, and the network can no longer learn long-range dependencies or produce long, coherent passages.</li>



<li>Long short-term memory (LSTM) networks. A variant of the RNN with three gates (input, forget and output) that decide which information to keep, discard and pass on. Selective memory reduces the vanishing gradient problem, but the architecture is computationally demanding and in practice retains context over a few hundred words.</li>



<li>Transformers. Introduced in 2017, the Transformer combines an encoder-decoder structure with an attention mechanism that relates every word in a sequence to every other word, regardless of distance. Each word keeps its own vector representation instead of the whole sentence being compressed into a single fixed-length vector, and all words are processed in parallel. This made it possible to model long-range dependencies efficiently and is the basis of all leading language models.</li>
</ul>



<p>The best-known Transformer models illustrate the main design choices.</p>



<ul class="wp-block-list">
<li>GPT (generative pre-trained transformer), developed by OpenAI, uses the decoder blocks of the Transformer and predicts the next word from all the preceding ones; the extended sequence is fed back in until the text is complete. GPT-1 (2018) showed that a model pre-trained on unlabelled text could be fine-tuned to specific tasks through transfer learning. GPT-2 and GPT-3 scaled up the data and the number of parameters; GPT-3 was trained on, among other sources, the Common Crawl web corpus.</li>



<li>BERT (bidirectional encoder representations from transformers), developed by Google, uses the encoder. It was trained on BooksCorpus and English Wikipedia with two unsupervised objectives: masked language modelling (MLM), in which randomly hidden words are predicted from the context on both sides, and next sentence prediction (NSP). Lighter or optimised variants include DistilBERT, ALBERT and RoBERTa, and BERT underlies many adaptations to Polish.</li>



<li>XLNet, from Carnegie Mellon University and Google Brain, combines BERT&#8217;s bidirectional context with autoregressive training. Through permutation language modelling it learns from all possible orderings of the words in a sentence, avoiding the artificial masking of inputs, and builds on the Transformer-XL architecture.</li>



<li>T5 (text-to-text transfer transformer), from Google, recasts every NLP task as converting one text string into another, with a prefix indicating the task. It was released in sizes from 60 million to 11 billion parameters and trained on the C4 corpus, a cleaned version of Common Crawl of about 750 GB.</li>



<li>BART, from Facebook AI (now Meta AI), is a denoising autoencoder with a bidirectional encoder and an autoregressive decoder. It learns to reconstruct text corrupted by token masking, token deletion, text infilling, sentence permutation or document rotation, and performs well in summarisation, translation and question answering.</li>
</ul>



<p>Since GPT-3, the GPT-4 generation and its successors, together with open-weight model families, have made fluent, multilingual and multimodal generation a commodity. The remaining weaknesses are no longer stylistic but factual: models can produce plausible but false statements and can reproduce fragments of their training data. For synthetic data purposes, language models are used to generate training dialogues, test documents and paraphrases, and to augment scarce datasets, for example in less widely used languages, where progress has historically lagged behind English.</p>



<h1 class="wp-block-heading">Generating images: autoencoders, GANs, Transformers and diffusion models</h1>



<p>Image generation has become accessible to anyone with a phone and an internet connection. Text-to-image generation combines language understanding with image synthesis: the model must interpret the prompt, map its terms to objects and render shapes, colours and overlapping elements consistently. Synthetic images are widely used to supplement, diversify and balance training sets, including in medical imaging, and in super-resolution, where the resolution of an image is increased while its detail is preserved.</p>



<ul class="wp-block-list">
<li>Variational autoencoders (VAEs). An encoder compresses input images into a latent representation and a decoder generates new images from it. VAEs train quickly and are useful for reducing detail or detecting anomalies, but they render fine detail poorly; today they mostly serve as components of larger systems.</li>



<li>Generative adversarial networks (GANs). A generator produces images from random noise and a discriminator learns to tell them apart from real ones; the two networks improve by competing in a zero-sum game until the discriminator can only guess. GANs are powerful but hard to train and prone to mode collapse, where the generator produces only a narrow range of outputs. Conditional GANs (cGANs) add auxiliary information, such as a class label, to steer generation.</li>



<li>CycleGAN translates images from one domain to another without paired training examples, by learning two mappings that are inverses of each other. Uses include style transfer, changing the season in a photograph and turning paintings into photographs.</li>



<li>StyleGAN, published by Nvidia in 2018, uses a mapping network and a synthesis network to control the style of the generated image at several levels of detail, and is known for highly realistic faces.</li>



<li>Transformer-based models. Image GPT (iGPT) from OpenAI treats an image as a sequence of pixels and completes it in the same way a language model completes a sentence, with impressive results at a high computational cost. The first DALL-E, a 12-billion-parameter model trained on 250 million image-text pairs, combined a Transformer decoder with elements of a variational autoencoder to generate images from text descriptions.</li>



<li>Diffusion models learn to reverse a gradual noising process and generate an image from pure noise by step-by-step denoising, guided by a classifier or, in classifier-free models such as GLIDE, directly by the text. DALL-E 2 (2022) uses the CLIP text and image encoders to produce an image representation that a diffusion decoder turns into a picture. Google&#8217;s Imagen relies on a frozen T5-XXL text encoder and a cascade of diffusion models that increase resolution.</li>
</ul>



<p>DALL-E 2 and Imagen were initially withheld from the public over misuse concerns, but were later released commercially, and openly available models such as Stable Diffusion put the technology in anyone&#8217;s hands. The same approach now extends to video and audio.</p>



<h1 class="wp-block-heading">Generating tabular data and time series</h1>



<p>For structured data, a model of the real dataset is built and then used to draw new values with similar statistical properties, so that an analyst working on the synthetic set reaches the same conclusions as on the original. The methods fall into statistical techniques and machine learning.</p>



<ul class="wp-block-list">
<li>Monte Carlo methods use repeated random sampling from specified probability distributions to model a probabilistic system; by the law of large numbers, the average result converges on the expected value as the number of trials grows. The approach is simple but only as accurate as the empirical data used to define the problem.</li>



<li>Markov chain Monte Carlo (MCMC) and Gibbs sampling generate sequences of dependent observations, which makes it possible to sample from high-dimensional distributions. Gibbs sampling draws each variable in turn from its conditional distribution, which is useful when the joint distribution is unknown or hard to sample directly.</li>



<li>Bayesian networks represent the joint distribution of a set of variables as a directed acyclic graph, with nodes for variables and edges for conditional dependencies. They are computationally efficient and remain a popular way of synthesising population data.</li>



<li>table-GAN adds a third network, a classifier, to the generator and discriminator in order to preserve the semantic integrity of generated records, and was designed with data protection and leak prevention in mind.</li>



<li>CTGAN (conditional tabular GAN) deals with mixed data types, non-Gaussian and multimodal distributions and imbalanced categories through mode-specific normalisation, a conditional generator and training by sampling.</li>



<li>CTAB-GAN adds a classifier and an improved encoding of mixed and highly skewed variables; its successor CTAB-GAN+ incorporates differential privacy, so that utility can be traded against a defined privacy budget.</li>



<li>TimeGAN preserves temporal dynamics in time series such as share prices, using four jointly trained components: an embedding function, a recovery function, a sequence generator and a sequence discriminator.</li>
</ul>



<p>More recent work applies diffusion models and language models to tables. Evaluating the quality of synthetic tabular data remains difficult, because fidelity, usefulness for machine learning and privacy have to be measured separately.</p>



<h1 class="wp-block-heading">Selected tools</h1>



<ul class="wp-block-list">
<li>Faker and Mimesis are Python libraries that generate mock data (names, addresses, dates, payment details and similar fields) for many locales; Mimesis is the faster and more comprehensive of the two. The older pydbgen offers similar functions with output to a Pandas DataFrame, an SQLite table or an Excel file. None of them models relationships found in a real dataset.</li>



<li>Mesa is a framework for agent-based modelling, in which simulated agents (cells, animals, people or organisations) interact with each other and their environment according to defined rules; its DataCollector component records model-level and agent-level variables as tables.</li>



<li>DataSynthesizer takes a real dataset and produces a structurally and statistically similar one with privacy guarantees. Its DataDescriber module learns the distributions and correlations, the DataGenerator samples from them in random, independent-attribute or correlated-attribute mode, and the ModelInspector compares input and output.</li>



<li>Synthetic Data Vault (SDV) is a family of libraries for single-table, multi-table and sequential data, using statistical and deep learning models such as CTGAN, together with metrics for assessing the quality of the result.</li>
</ul>



<p>Before commercial use, the licence terms of each tool and model should be checked, as some are distributed under source-available rather than fully open licences. Every data-derived method also faces the same trade-off: the more faithfully the synthetic set reproduces the original, the more useful it is, and the greater the risk that it reveals something about real individuals. That trade-off is where the legal analysis begins.</p>



<h1 class="wp-block-heading">Is synthetic data personal data?</h1>



<p>The GDPR does not apply to anonymous information (Recital 26). Whether a synthetic dataset qualifies depends on whether individuals in the source data remain identifiable by means reasonably likely to be used. In EDPS v SRB (C-413/23 P, judgment of 4 September 2025) the Court of Justice confirmed that identifiability is assessed in relation to the entity concerned: the same data may be personal for the party holding the key or the original records and not personal for a recipient with no realistic means of identification.</p>



<p>On 7 July 2026 the European Data Protection Board adopted draft Guidelines 02/2026 on anonymisation, the first EU-level update since the Article 29 Working Party&#8217;s Opinion 05/2014. The public consultation closed on 30 October 2026 and the final text is awaited. The draft matters for synthetic data in four respects.</p>



<ul class="wp-block-list">
<li>No presumption of anonymity. AI model outputs and synthetic data are not anonymous by default. The risk of re-identification need not be zero, but it must be insignificant in reality.</li>



<li>Three criteria. Anonymity is tested against record isolation, linkage and inference. For synthetic data the inference test is the critical one: if querying the data or the generator reveals something specific about a person, or reveals that the person was in the source dataset, anonymity is in doubt. General knowledge about a population does not count.</li>



<li>Generation is processing. Training a generator on personal data is itself processing and needs a legal basis under Article 6 GDPR and, for health or other special category data, an exemption under Article 9(2), even if the output is anonymous. Data subjects should be informed that their data will be used in this way.</li>



<li>Documentation and review. The controller must be able to demonstrate anonymity, keep a record of the tests performed and reassess when technology lowers the cost of re-identification. A contractual ban on re-identification helps but is not sufficient on its own.</li>
</ul>



<p>The same reasoning applies to the generative model. In Opinion 28/2024 the EDPB concluded that an AI model trained on personal data cannot automatically be regarded as anonymous, because personal data may be extracted from it. Companies that buy or license a synthesiser trained on someone else&#8217;s data should therefore ask how it was trained and tested.</p>



<p>The legislative picture is still moving. The Commission&#8217;s Digital Omnibus proposal of November 2025 would have narrowed the definition of personal data, but the Council&#8217;s negotiating mandate of 21 October 2026 keeps the current definition and instead proposes a specific rule on pseudonymised data and a clearer path for relying on legitimate interest in AI development. The European Parliament has not yet adopted its position, so none of this is law.</p>



<h1 class="wp-block-heading">Synthetic data under the AI Act</h1>



<p>Regulation (EU) 2024/1689 (the AI Act) treats synthetic data as a privacy-preserving alternative, not as an exemption. Three points are worth noting.</p>



<ul class="wp-block-list">
<li>Data governance. Training, validation and testing datasets for high-risk AI systems must be relevant, sufficiently representative and, as far as possible, free of errors, and their origin must be documented (Article 10). These requirements apply equally to synthetic datasets, which can inherit or amplify the biases of their source.</li>



<li>Synthetic data first. Under the new Article 4a, introduced by Regulation (EU) 2026/1744 in place of the former Article 10(5), special categories of personal data may be processed to detect and correct bias only where this cannot be achieved with other data, including synthetic or anonymised data. Article 59 applies the same logic to further processing of personal data in AI regulatory sandboxes.</li>



<li>Revised timetable. The same amending regulation, in force since 27 July 2026, postponed the high-risk obligations to 2 December 2027 for Annex III systems and 2 August 2028 for systems covered by Annex I product legislation. Obligations for providers of general-purpose AI models have applied since 2 August 2025.</li>
</ul>



<h1 class="wp-block-heading">Synthetic content: marking and labelling duties</h1>



<p>The AI Act also regulates the output side. Since 2 August 2026, under Article 50(2), providers of AI systems that generate synthetic audio, image, video or text must ensure that outputs are marked in a machine-readable format and are detectable as artificially generated. Systems already on the market before that date have until 2 December 2026 to comply. Under Article 50(4), deployers must disclose deep fakes and AI-generated text published to inform the public on matters of public interest, unless the text has undergone human review and is under editorial responsibility.</p>



<p>The Commission published a voluntary Code of Practice on marking and labelling of AI-generated content on 10 June 2026 and final guidelines on Article 50 on 20 July 2026. According to the guidelines, marking is not required, among other cases, for outputs that stay within an organisation in controlled business settings, a point of practical importance for synthetic datasets used purely internally for testing or model training. In addition, from 2 December 2026 the AI Act prohibits AI systems that generate non-consensual intimate imagery of identifiable persons.</p>



<h1 class="wp-block-heading">Copyright and database rights</h1>



<p>A generator trained on protected works or databases raises intellectual property questions at two stages.</p>



<p>Training. Reproductions made for text and data mining are permitted under Articles 3 and 4 of Directive (EU) 2019/790, the latter only where the rightholder has not reserved its rights in an appropriate manner. Poland transposed these exceptions in Articles 26² and 26³ of the Copyright and Related Rights Act with effect from 20 September 2024. Providers of general-purpose AI models must in addition maintain a copyright compliance policy and publish a summary of training content (Article 53 of the AI Act). The first case on generative AI before the Court of Justice, Like Company v Google (C-250/25), is pending. In his Opinion of 3 November 2026 Advocate General Szpunar advised the Court to declare the questions on model training inadmissible, while taking the view that real-time retrieval and reuse of press articles in chatbot answers may infringe press publishers&#8217; rights. The judgment is still to come, and first-instance rulings in national courts, such as Getty Images v Stability AI in London and GEMA v OpenAI in Munich, point in different directions.</p>



<p>Output. Purely machine-generated content is generally not protected by copyright in the EU or in Poland, because protection requires a human author&#8217;s creative contribution. A synthetic dataset may therefore need to be protected by contract and as a trade secret. Conversely, output that reproduces recognisable parts of a training work may infringe, and extraction of a substantial part of a protected database may engage the sui generis right under Directive 96/9/EC.</p>



<h1 class="wp-block-heading">Health data and other regulated sectors</h1>



<p>Synthetic data is particularly attractive in life sciences, where patient-level data is scarce and sensitive. Health data used to train a generator is special category data, so an Article 9(2) GDPR ground, a data protection impact assessment and robust re-identification testing will normally be required. The European Health Data Space Regulation (EU) 2025/327, whose rules on secondary use start to apply from March 2029, will create a formal route for access to health data for research and innovation. Where synthetic data supports the development or validation of a medical device or a regulated financial model, sectoral regulators will also expect evidence that it is representative of the real population.</p>



<h1 class="wp-block-heading">The Polish dimension</h1>



<p>The Act of 3 July 2026 on Artificial Intelligence Systems, which for the most part entered into force on 11 August 2026, established the Commission for the Development and Safety of Artificial Intelligence (KRiBSI) as the market surveillance authority and single point of contact under the AI Act. KRiBSI can conduct inspections, hear complaints, impose administrative fines and issue individual opinions on the application of the AI Act, and the Act provides a basis for regulatory sandboxes. The President of the Personal Data Protection Office (UODO) remains competent for the data protection aspects, so a project involving data-derived synthetic data may fall under the supervision of both authorities.</p>



<h1 class="wp-block-heading">Practical checklist</h1>



<ul class="wp-block-list">
<li>Identify the method: rule-based, simulated or derived from real data. Only the last normally triggers the GDPR analysis.</li>



<li>Establish the legal basis and purpose compatibility for using the source data to train the generator, and inform data subjects.</li>



<li>Test the output and the model against record isolation, linkage and inference, document the results and schedule reassessment.</li>



<li>Do not label a dataset as anonymous in contracts or privacy notices unless the assessment supports it.</li>



<li>Check the provenance and licence of the generator, the training data and any pre-trained model, including text and data mining reservations.</li>



<li>Where synthetic data feeds a high-risk AI system, document its origin, representativeness and known limitations in line with Article 10 of the AI Act.</li>



<li>Where synthetic content is released outside the organisation, apply the marking and labelling rules of Article 50.</li>



<li>Allocate responsibility in contracts: warranties on training data, re-identification prohibitions, audit rights and liability for infringing output.</li>
</ul>



<h1 class="wp-block-heading">Key sources</h1>



<ol class="wp-block-list">
<li>Regulation (EU) 2016/679 (GDPR), in particular Articles 4(1), 6, 9 and 35 and Recital 26.</li>



<li>Judgment of the Court of Justice of 4 September 2025, EDPS v SRB, C-413/23 P.</li>



<li>EDPB, draft Guidelines 02/2026 on anonymisation (adopted for consultation on 7 July 2026); EDPB Opinion 28/2024 on AI models.</li>



<li>Regulation (EU) 2024/1689 (AI Act), in particular Articles 4a, 10, 50, 53 and 59, as amended by Regulation (EU) 2026/1744.</li>



<li>Code of Practice on marking and labelling of AI-generated content (10 June 2026) and Commission Guidelines on Article 50 of the AI Act (20 July 2026).</li>



<li>Directive (EU) 2019/790, Articles 3 and 4; Directive 96/9/EC; Polish Act of 4 February 1994 on Copyright and Related Rights.</li>



<li>Opinion of Advocate General Szpunar of 3 November 2026, Like Company v Google Ireland, C-250/25.</li>



<li>Regulation (EU) 2025/327 on the European Health Data Space.</li>



<li>Polish Act of 3 July 2026 on Artificial Intelligence Systems.</li>
</ol>



<p><em>This text is for information purposes only and does not constitute legal advice.</em></p>
<p> </p>



<p>Services</p>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/synthetic-data-generation-the-technology-and-its-legal-framework-in-the-eu-and-poland/">Synthetic data generation: the technology and its legal framework in the EU and Poland</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/it-new-technologies-media-and-communication-technology-law/synthetic-data-generation-the-technology-and-its-legal-framework-in-the-eu-and-poland/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>“For Research Use Only” Is Not a Legal Shieldgg</title>
		<link>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/for-research-use-only-is-not-a-legal-shieldgg/</link>
					<comments>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/for-research-use-only-is-not-a-legal-shieldgg/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Mon, 16 Nov 2026 16:32:17 +0000</pubDate>
				<category><![CDATA[PHARMACEUTICAL, HEALTHCARE & LIFE SCIENCES LAW]]></category>
		<category><![CDATA[active pharmaceutical ingredients]]></category>
		<category><![CDATA[advertising compliance]]></category>
		<category><![CDATA[brand protection]]></category>
		<category><![CDATA[CLP]]></category>
		<category><![CDATA[CONSUMER PROTECTION]]></category>
		<category><![CDATA[cross-border e-commerce]]></category>
		<category><![CDATA[Digital Services Act]]></category>
		<category><![CDATA[DSA compliance]]></category>
		<category><![CDATA[falsified medicines]]></category>
		<category><![CDATA[GLP-1 receptor agonists]]></category>
		<category><![CDATA[influencer marketing]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[laboratory suppliers]]></category>
		<category><![CDATA[Life Sciences Law]]></category>
		<category><![CDATA[medicinal product classification]]></category>
		<category><![CDATA[medicinal products by function]]></category>
		<category><![CDATA[medicinal products by presentation]]></category>
		<category><![CDATA[notice-and-action procedures]]></category>
		<category><![CDATA[online marketplaces]]></category>
		<category><![CDATA[online medicine sales]]></category>
		<category><![CDATA[pharmaceutical advertising]]></category>
		<category><![CDATA[pharmaceutical distribution]]></category>
		<category><![CDATA[pharmaceutical law in Poland]]></category>
		<category><![CDATA[platform liability]]></category>
		<category><![CDATA[Poland]]></category>
		<category><![CDATA[prescription medicines]]></category>
		<category><![CDATA[product liability]]></category>
		<category><![CDATA[REACH]]></category>
		<category><![CDATA[Regulatory Compliance]]></category>
		<category><![CDATA[research chemicals]]></category>
		<category><![CDATA[research peptides in Poland]]></category>
		<category><![CDATA[research use only]]></category>
		<category><![CDATA[semaglutide regulation]]></category>
		<category><![CDATA[tirzepatide]]></category>
		<category><![CDATA[trade mark enforcement]]></category>
		<category><![CDATA[trader traceability]]></category>
		<category><![CDATA[unauthorised medicines]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=9029</guid>

					<description><![CDATA[<p>Publication date: November 16, 2026 Online sales of semaglutide and other active substances in Poland &#8211; regulatory exposure for sellers, marketplaces, advertisers and logistics operators Vials of semaglutide and other peptides are sold online in Poland as “research chemicals” and delivered to parcel lockers without a prescription. The label is meant to keep the product [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/for-research-use-only-is-not-a-legal-shieldgg/">“For Research Use Only” Is Not a Legal Shieldgg</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 16, 2026</mark></strong></p>



<p><em>Online sales of semaglutide and other active substances in Poland &#8211; regulatory exposure for sellers, marketplaces, advertisers and logistics operators</em></p>



<p><strong>Vials of semaglutide and other peptides are sold online in Poland as “research chemicals” and delivered to parcel lockers without a prescription. The label is meant to keep the product outside pharmaceutical law. It does not: under EU and Polish law the classification of a product follows its presentation and its effect, not the seller&#8217;s disclaimer. For businesses, the practical question is therefore not whether this trade is legal, but who in the chain &#8211; seller, marketplace, advertiser, influencer, payment or logistics provider &#8211; carries the criminal, administrative and civil risk, and how quickly Polish enforcement tools are catching up.</strong></p>



<span id="more-9029"></span>



<h1 class="wp-block-heading">Key takeaways for business</h1>



<ul class="wp-block-list">
<li>A “not for human consumption” or “research use only” disclaimer does not take a product outside the Pharmaceutical Law if the way it is presented, dosed and marketed points to use in humans.</li>



<li>Where a product meets the definition of a medicinal product and of another product category at the same time, the medicinal product regime prevails (Article 2(2) of Directive 2001/83/EC; Article 3a of the Pharmaceutical Law).</li>



<li>Sellers face criminal liability under the Pharmaceutical Law and the Criminal Code, as well as civil liability towards injured users.</li>



<li>Hosting providers and online marketplaces keep their liability exemption under the Digital Services Act (DSA) only as long as they act expeditiously once they know about an illegal offer. Since autumn 2026 Poland has a national DSA enforcement framework, and a further act on blocking orders and a register of domains has passed Parliament. Its closed catalogue of offences does not, however, cover offences under the Pharmaceutical Law.</li>



<li>The problem is less a gap in the law than fragmented and slow enforcement. Legitimate market participants &#8211; marketing authorisation holders, pharmacies, platforms and genuine laboratory suppliers &#8211; should treat this as a compliance and brand protection issue now.</li>
</ul>



<h1 class="wp-block-heading">A grey market growing next to a regulated one</h1>



<p>Online sales of active substances within the meaning of Article 2(38c) of the Polish Pharmaceutical Law<a href="#_ftn1" id="_ftnref1">[1]</a> have grown rapidly over the last few years. E-commerce allows sellers to reach a wide audience with substances of high biological activity: hormones, peptides, metabolic agents (such as semaglutide and tirzepatide), nootropics and anabolic compounds. The legality of this trade in Poland is governed by pharmaceutical, medical and criminal law.</p>



<p>The business model discussed here consists in placing on the market substances with a documented therapeutic or physiological effect while avoiding the requirements of the Pharmaceutical Law by means of a purely formal, linguistic device: the goods are described as “not for human consumption”, a “laboratory reagent”, a “substance for scientific purposes” or a “collector&#8217;s item”. Semaglutide, the active substance of authorised medicinal products such as Ozempic, Wegovy and Rybelsus, is a representative example. Alongside the legal pharmaceutical supply chain there is a grey online market in which semaglutide is sold as a lyophilised powder in vials labelled “for research purposes only”.</p>



<p>This raises a classification question with direct commercial consequences. The definition of a medicinal product (Article 2(32) of the Pharmaceutical Law) is based on the properties of the product &#8211; presented or actual &#8211; for preventing or treating disease. Marketing a substance with a proven biological effect under the guise of a chemical reagent is an attempt to circumvent administrative and criminal rules. In practice it creates an area of legal uncertainty in which freedom of economic activity and the free movement of goods meet the overriding priority of protecting public health.</p>



<h1 class="wp-block-heading">How the “research-only” model works</h1>



<p>The illegal trade in substances such as semaglutide in the Polish digital space has taken the form of an organised practice built on circumventing regulation. The number of offers to buy these sought-after substances without a prescription is rising sharply. Customers are directed to websites and social media profiles where they can order products with delivery straight to a parcel locker, which gives the buyer a sense of convenience and apparent discretion. The phenomenon is part of a wider European trend of illegal distribution of GLP-1 receptor agonists, against which the European Medicines Agency (EMA)<a href="#_ftn2" id="_ftnref2">[2]</a>, the World Health Organization (WHO) and the Polish authorities &#8211; the Chief Pharmaceutical Inspectorate (GIF) and the Office for Registration of Medicinal Products (URPL) &#8211; have issued public warnings.</p>



<p>The key to the model is the so-called “loophole”: products are labelled and positioned as “research substances”. Sellers offer them as “research peptides” or “research raw materials”, which is formally intended to remove responsibility for selling a medicinal product for human use. At the same time, the entire marketing setting &#8211; graphics, wording and tone of communication &#8211; clearly suggests a weight-loss effect and directly alludes to authorised prescription medicines. This allows sellers to sidestep the strict rules on the distribution of prescription-only medicines and makes it harder for the authorities to shut the activity down immediately.</p>



<p>The model carries direct and serious risks for the health and life of consumers. A person buying from an illegal source has no guarantee as to purity, actual composition, concentration or dose. The products are outside any quality oversight; vials may contain harmful excipients or contaminants, or doses different from those declared, which can lead to serious medical complications. In addition, transport outside a controlled cold chain may degrade the active substance, so that the final product is not only illegal but may also be ineffective or unsafe. For legitimate businesses, every such incident is also a reputational risk for the brand name that the illegal offer imitates.</p>



<h1 class="wp-block-heading">When does a product become a medicine? The two tests</h1>



<p>Classification as a medicinal product rests on two independent limbs derived from Article 1(2) of Directive 2001/83/EC<a href="#_ftn3" id="_ftnref3">[3]</a> and Article 2(32) of the Pharmaceutical Law<a href="#_ftn4" id="_ftnref4">[4]</a>: the presentation test and the function test. The first concerns how the product is perceived externally and, according to the Court of Justice of the European Union (CJEU), must be interpreted broadly. A product is a medicinal product by presentation if its packaging, leaflet, form or advertising gives an averagely well-informed consumer the impression that it has therapeutic or prophylactic properties (Case 227/82, Van Bennekom<a href="#_ftn5" id="_ftnref5">[5]</a>). The pharmaceutical form, such as capsules or tablets, is strong evidence of the seller&#8217;s intention to market the product as a medicinal product, but it is not conclusive in itself. The Court confirmed this in Case C-369/88, Delattre<a href="#_ftn6" id="_ftnref6">[6]</a>, which concerned products sold by mail order and labelled as not being medicinal products. It added that such a statement is evidence which the national court may take into account, but is not in itself conclusive &#8211; a point of direct relevance to “research use only” disclaimers. The Polish Supreme Administrative Court has reasoned along the same lines in a food supplement labelling case: a product to which disease prevention or treatment properties are attributed is not a food supplement but a medicinal product<a href="#_ftn7" id="_ftnref7">[7]</a>. On that basis the court upheld a fine imposed by the sanitary authorities, and confirmed by the Chief Sanitary Inspector, for labelling that suggested such properties.</p>



<p>The function test refers to the actual biological effect of the product on the human body, regardless of promotional claims or the manufacturer&#8217;s declarations. Here the classifying authority, including the URPL, cannot base its decision solely on the presence or quantity of a given active substance. The assessment must be made case by case, taking account of all the characteristics of the product. According to the CJEU, a product is not a medicinal product by function where, having regard to its composition, including its content of active substances, and if used as intended, it is incapable of appreciably restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action<a href="#_ftn8" id="_ftnref8">[8]</a>. This requires a detailed analysis of biological properties and of the real impact of the substance on physiological processes. The CJEU has clarified the notion of “pharmacological action” in Case C-308/11, Chemische Fabrik Kreussler<a href="#_ftn9" id="_ftnref9">[9]</a>: the substance does not have to interact with a cellular constituent of the user&#8217;s own body, and interaction with any cellular constituent present in the body, such as bacteria, may be sufficient. It has also held that substances which merely modify physiological functions without being capable of any beneficial effect on human health, and which are consumed solely to induce intoxication, are not medicinal products (Joined Cases C-358/13 and C-181/14, D. and G.<a href="#_ftn10" id="_ftnref10">[10]</a>). That limitation does not assist sellers of semaglutide: it is the active substance of authorised medicines with an established therapeutic effect.</p>



<p>The relationship between the medicinal product regime and other regulatory regimes is governed by the conflict rule in Article 2(2) of Directive 2001/83/EC, mirrored in Article 3a of the Pharmaceutical Law. Where a product, taking into account all its characteristics, may fall both within the definition of a medicinal product and within that of another product category &#8211; for example a cosmetic, a medical device or a food supplement &#8211; the medicinal product rules prevail. The CJEU has made clear that this rule applies to products whose status as a medicinal product has been scientifically established, not to products for which it merely cannot be excluded (Case C-140/07, Hecht-Pharma<a href="#_ftn11" id="_ftnref11">[11]</a>). The purpose is to ensure a high level of public health protection by subjecting such products to the authorisation and control procedures of the pharmaceutical market.</p>



<h1 class="wp-block-heading">The “research material” label under Polish law</h1>



<p>Offering a substance with the annotation “research material” or “for laboratory use” does not automatically release the seller from the requirements of Polish law. Under Article 2(38) of the Pharmaceutical Law, a substance is any matter of human, animal, plant or chemical origin. The classification of the goods depends on their actual intended use, presentation and biological profile. Labelling a product “for research purposes” therefore does not prevent the authorities from treating it as a medicinal product, a food supplement or a novel food if the circumstances show that it is intended for consumption or use in humans.</p>



<p>If the substance offered has properties for preventing or treating disease, or is presented in a way that suggests such an effect (for example through dosing information, instructions for use or social media advertising), it is subject to the Pharmaceutical Law. Placing a medicinal product on the market without a marketing authorisation is a criminal offence (Article 124 of the Pharmaceutical Law). A declaration that the product is “intended solely for research” is likely to be treated as an attempt to circumvent the law where the seller&#8217;s overall conduct shows commercial distribution to consumers.</p>



<p>Trade in genuine research substances and chemicals is subject to separate EU and national chemical safety rules, in particular the REACH<a href="#_ftn12" id="_ftnref12">[12]</a> and CLP<a href="#_ftn13" id="_ftnref13">[13]</a> Regulations. A seller of chemicals intended for laboratory research must classify and label them correctly and provide a safety data sheet. Where the substance is psychoactive, the Act on Counteracting Drug Addiction<a href="#_ftn14" id="_ftnref14">[14]</a> applies irrespective of the trade name or declared research status, with criminal sanctions and administrative measures enforced by the State Sanitary Inspection. For legitimate laboratory suppliers the point is practical: selling to verified professional customers, with proper documentation, is what distinguishes a research chemical business from a disguised consumer channel.</p>



<h1 class="wp-block-heading">Distribution, marketing and cross-border supply: where the exposure sits</h1>



<p>Distribution of semaglutide preparations outside the official pharmacy channel takes place largely online. Distributors categorise products as “research peptides” or “substances for laboratory use”, or add a “research only” clause. The supply chain is optimised for discretion and convenience: orders are placed through web shops and social media profiles, and physical delivery is made through parcel lockers or couriers, which makes it difficult for supervisory authorities to inspect consignments at the delivery stage and removes any check of the buyer&#8217;s age or identity. Storage of consignments in parcel lockers at extreme temperatures (summer heat or winter frost) may additionally degrade peptides, so that the user may inject a degraded product.</p>



<p>On the marketing side, sellers use several persuasion strategies which, despite formal “research use” disclaimers, clearly suggest a weight-loss and therapeutic effect. Advertising is optimised for search phrases such as “Ozempic alternative” or “semaglutide without prescription” and supported by promotional content on social media and internet forums. Price comparison tools and informal recommendation marketing (for example endorsement by a well-known influencer) create an impression that the purchase is common, accessible and relatively safe, although the product in fact requires medical supervision and a prescription. Advertising medicinal products that are not authorised in Poland is itself an offence (Article 129 of the Pharmaceutical Law), which is directly relevant for agencies, publishers and influencers.</p>



<p>The most complex dimension is cross-border import and falsification, in line with the global trend identified by the WHO and the EMA. The raw material or ready vials and pens reach the EU market mainly from third countries (including Asia), often bypassing EU customs procedures and pharmaceutical inspection. The products do not undergo mandatory testing of purity, concentration of the active substance or stability under cold chain conditions. Import outside the legal supply chain therefore carries a critical risk of contaminated, wrongly dosed or inactive products entering the market.</p>



<h1 class="wp-block-heading">Who is liable? Sellers, platforms and advertisers</h1>



<p>The starting point is the Pharmaceutical Law. Under Article 124, placing a medicinal product on the market, or storing it for that purpose, without a marketing authorisation is punishable by a fine, restriction of liberty or imprisonment for up to two years. Carrying on business in the trade of medicinal products without the required permit is a separate and more serious offence, punishable by a fine, restriction of liberty or imprisonment from three months to five years (Article 125(2)(2)). Retail trade in medicinal products is reserved to pharmacies (Article 68(1)), and mail-order sale is permitted only for non-prescription medicines and only by licensed pharmacies and pharmacy outlets (Article 68(3)). Prescription-only medicines such as semaglutide therefore cannot lawfully be sold by mail order at all. Supplying or storing falsified medicinal products or falsified active substances is subject to more severe penalties, up to five years&#8217; imprisonment (Article 124b), which is directly relevant to illegal web shops offering imitation pens or substances that are falsely presented as to their identity or source.</p>



<p>The position of online intermediaries is governed by the Digital Services Act<a href="#_ftn15" id="_ftnref15">[15]</a> together with national consumer protection law. The DSA maintains the principle that there is no general obligation to monitor content (Article 8). However, a hosting provider loses the liability exemption under Article 6 if, upon obtaining actual knowledge or awareness of the illegal nature of an offer (for example through a notice under Article 16), it fails to act expeditiously to remove or disable access to it. Online marketplaces must in addition verify the traceability of traders (Article 30). In Poland, the Act of 4 September 2026<a href="#_ftn16" id="_ftnref16">[16]</a>, in force since 6 November 2026, designated the President of the Office of Electronic Communications (UKE) as Digital Services Coordinator. The President of the Office of Competition and Consumer Protection (UOKiK) is the competent authority for the obligations of online platforms that allow consumers to conclude distance contracts with traders (Chapter III, Section 4 of the DSA, which includes trader traceability) and for other DSA infringements that harm consumer interests. In this respect online marketplaces are therefore supervised by UOKiK. Independently, UOKiK may impose significant fines for practices infringing collective consumer interests, and the Chief Pharmaceutical Inspector may order withdrawals and impose administrative fines under the Pharmaceutical Law.</p>



<p>Sellers also face liability under the Criminal Code for endangering life or health &#8211; in particular Article 165 § 1(2) (causing danger to the life or health of many persons by placing on the market substances harmful to health or pharmaceutical products that do not meet quality requirements) and Article 160 (exposing a person to direct danger of loss of life or serious injury). Describing products as “research peptides” does not release a business from criminal liability on the basis of a mistake of law or an appearance of legality where the products are in fact intended and advertised for human use. Finally, entities offering illegal preparations are fully liable in tort to consumers for damage to health caused by a product that is substandard, toxic or of unknown origin.</p>



<h1 class="wp-block-heading">Enforcement outlook: fragmented rules, new blocking tools</h1>



<p>The regulatory gap in the online trade in active substances does not result from a lack of rules but from their fragmentation and from enforcement difficulties. The core problem is a grey zone that exploits the “research purposes” classification. The State Pharmaceutical Inspection and law enforcement authorities face evidentiary barriers and lengthy procedures when dealing with operators who quickly change domains, jurisdictions and corporate names. A regime based on reacting after a product has been placed on the market is not effective enough against mass, automated e-commerce.</p>



<p>The legislative landscape is changing. In addition to the September 2026 act establishing national DSA oversight, Parliament has adopted a further amendment to the Act on the Provision of Electronic Services, the Act of 22 October 2026<a href="#_ftn17" id="_ftnref17">[17]</a>. It introduces orders to disable access to illegal content, issued by the President of UKE (or by the Chairman of the National Broadcasting Council for video-sharing platforms), and a register of internet domains used to disseminate such content, kept by the President of UKE. Internet access providers will have to block a registered domain within 48 hours. The act was sent to the President of Poland, whose decision was pending at the time of writing, and is to enter into force three months after publication.</p>



<p>For the trade discussed here the new mechanism has an important limit. Orders may be issued only for content linked to a closed catalogue of offences, and that catalogue does not include the offences under the Pharmaceutical Law or Article 165 of the Criminal Code. An illegal offer of “research” semaglutide can therefore be caught only indirectly, for example where it involves fraud (Article 286 of the Criminal Code) or goods bearing a counterfeit trade mark (Article 305 of the Industrial Property Law). Applications may be filed by a prosecutor, the Police, the National Revenue Administration, copyright holders and service recipients; the Chief Pharmaceutical Inspector is not named among the applicants. In our view, sector-specific measures therefore remain necessary: clear powers for the Chief Pharmaceutical Inspector to initiate rapid blocking of sites and domains offering illegal medicines, and rules on trade in peptides and other biologically active substances making clear that a “research use” declaration does not displace classification as a medicinal product where the presentation points to a therapeutic purpose.</p>



<p>A systemic response also requires close inter-agency cooperation and integrated controls at the EU&#8217;s borders. We recommend dedicated task forces bringing together the GIF, the National Revenue Administration (KAS), the Police and UOKiK to monitor cross-border courier and postal consignments delivered to parcel lockers. Legal changes should be complemented by public education, conducted together with the medical and pharmacists&#8217; self-governing bodies, on the health risks of products of unknown origin and on using only authorised online pharmacies bearing the common EU logo.</p>



<h1 class="wp-block-heading">What businesses should do now</h1>



<ul class="wp-block-list">
<li><strong>Marketplaces and hosting providers: </strong>review notice-and-action procedures and trader verification for listings of peptides, “research chemicals” and GLP-1 related keywords, and document response times.</li>



<li><strong>Marketing authorisation holders and brand owners: </strong>monitor online offers that allude to authorised brands, use DSA notices and trade mark rights (offers of goods bearing a counterfeit trade mark fall within the new blocking procedure), and report suspected falsified products to the GIF.</li>



<li><strong>Advertisers, agencies and influencers: </strong>do not promote products that allude to prescription medicines; a “research only” disclaimer in the offer does not protect the advertiser.</li>



<li><strong>Laboratory and chemical suppliers: </strong>sell to verified professional customers only, keep REACH and CLP documentation in order and avoid any presentation that suggests use in humans.</li>



<li><strong>Logistics and payment providers: </strong>include this product category in risk assessments and in cooperation procedures with the authorities.</li>
</ul>



<p><em>State of the law as at 10 November 2026. This article is for general information and does not constitute legal advice.</em></p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p><a href="#_ftnref1" id="_ftn1">[1]</a> Act of 6 September 2001 &#8211; Pharmaceutical Law (consolidated text: Journal of Laws [Dz. U.] of 2026, item 612, as amended); hereinafter the “Pharmaceutical Law”.</p>



<p><a href="#_ftnref2" id="_ftn2">[2]</a> European Medicines Agency and Heads of Medicines Agencies, “Warning about sharp rise in illegal medicines sold in the EU”, September 2025.</p>



<p><a href="#_ftnref3" id="_ftn3">[3]</a> Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67). The Directive is due to be replaced by a new directive under the EU pharmaceutical package; the Council adopted its first-reading position on 28 September 2026 and the final adoption steps were under way at the time of writing.</p>



<p><a href="#_ftnref4" id="_ftn4">[4]</a> Under Article 2(32) of the Pharmaceutical Law, a medicinal product is a substance or combination of substances presented as having properties for preventing or treating disease in humans or animals, or administered with a view to making a diagnosis or to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action.</p>



<p><a href="#_ftnref5" id="_ftn5">[5]</a> Judgment of the Court of Justice of 30 November 1983, Case 227/82, Van Bennekom, ECLI:EU:C:1983:354, paras 17-19 (decided under Directive 65/65/EEC, the predecessor of Directive 2001/83/EC).</p>



<p><a href="#_ftnref6" id="_ftn6">[6]</a> Judgment of the Court of Justice of 21 March 1991, Case C-369/88, Delattre, ECLI:EU:C:1991:137, paras 38-41 (also decided under Directive 65/65/EEC).</p>



<p><a href="#_ftnref7" id="_ftn7">[7]</a> Judgment of the Supreme Administrative Court (NSA) of 1 September 2015, II OSK 14/14, LEX no. 1987032.</p>



<p><a href="#_ftnref8" id="_ftn8">[8]</a> Judgment of the Court of Justice of 15 January 2009, Case C-140/07, Hecht-Pharma, ECLI:EU:C:2009:5, paras 39-42 and point 3 of the operative part.</p>



<p><a href="#_ftnref9" id="_ftn9">[9]</a> Judgment of the Court of Justice of 6 September 2012, Case C-308/11, Chemische Fabrik Kreussler, ECLI:EU:C:2012:548, paras 31-36.</p>



<p><a href="#_ftnref10" id="_ftn10">[10]</a> Judgment of the Court of Justice of 10 July 2014, Joined Cases C-358/13 and C-181/14, D. and G., ECLI:EU:C:2014:2060.</p>



<p><a href="#_ftnref11" id="_ftn11">[11]</a> Case C-140/07, Hecht-Pharma, cited above, paras 24-29 and point 1 of the operative part.</p>



<p><a href="#_ftnref12" id="_ftn12">[12]</a> Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).</p>



<p><a href="#_ftnref13" id="_ftn13">[13]</a> Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures (CLP).</p>



<p><a href="#_ftnref14" id="_ftn14">[14]</a> Act of 29 July 2005 on Counteracting Drug Addiction (consolidated text: Journal of Laws of 2023, item 1939, as amended).</p>



<p><a href="#_ftnref15" id="_ftn15">[15]</a> Regulation (EU) 2022/2065 of the European Parliament and of the Council of 19 October 2022 on a Single Market For Digital Services (Digital Services Act).</p>



<p><a href="#_ftnref16" id="_ftn16">[16]</a> Act of 4 September 2026 amending the Act on the Provision of Electronic Services and certain other acts (Journal of Laws of 2026, item 1296), published on 6 October 2026; see the new Articles 15a and 15b of the Act on the Provision of Electronic Services.</p>



<p><a id="_ftn17" href="#_ftnref17">[17]</a> Act of 22 October 2026 amending the Act on the Provision of Electronic Services and certain other acts (Sejm print no. 2693, text finally adopted after consideration of the Senate&#8217;s amendments), adding Articles 11a-11s to the Act on the Provision of Electronic Services; not yet published at the time of writing.</p>
<p> </p>



<h2 class="wp-block-heading">Services</h2>



<p><strong>KIELTYKA GLADKOWSKI</strong> is a Polish business law firm headquartered in Warsaw and Krakow, with a New York office under the iSTART1 brand. Building on a practice dating back to 1981, we advise clients in the following areas.</p>



<h1 class="wp-block-heading">Explore our services</h1>



<p>Select a practice area to learn more.</p>



<figure class="wp-block-table"><table class="has-luminous-vivid-amber-background-color has-background has-fixed-layout"><thead><tr><td><strong>Business<br>&amp; Finance</strong></td><td><strong>Technology<br>&amp; IP</strong></td><td><strong>Energy<br>&amp; Projects</strong></td><td><strong>Sectors &amp;<br>Cross Border</strong></td><td><strong>Private Clients<br>&amp; Disputes</strong></td></tr></thead><tbody><tr><td><a href="https://www.kg-legal.pl/investment-law-and-processes-in-poland-1/">Commercial &amp; Corporate</a> <a href="https://www.kg-legal.eu/polish-limited-liability-company-legal-support-in-operational-business-maintenance-and-representation-of-shareholders-in-court/">Polish LLCs</a> <a href="https://www.kg-legal.eu/employment-law-and-collective-labour-law-in-poland-including-employment-contracts/">Employment Law</a></td><td><a href="https://www.kg-legal.pl/it-bio-it-new-technologies-media-law-1/">IT, IP, Media &amp; New Tech</a> <a href="https://www.kg-legal.eu/trademarks-and-brand-protection/">Trademarks &amp; Brand Protection</a></td><td><a href="https://www.kg-legal.eu/green-transition/">Green Transition</a> <a href="https://www.kg-legal.eu/energy-transformation-in-poland-main-assumptions-of-the-polish-energy-policy-2040-2/">Energy Policy 2040</a></td><td><a href="https://www.kg-legal.pl/pharmaceutical-life-sciences-healthcare-law-1/">Pharma, Life Sciences &amp; Healthcare</a> <a href="https://www.kg-legal.eu/pharmaceutical-law/">Pharmaceutical Law</a></td><td><a href="https://www.kg-legal.eu/private-client-desk/">Private Client Desk</a> <a href="https://www.kg-legal.eu/hnw-and-next-gen-wealth/">HNW &amp; Next Gen Wealth</a></td></tr><tr><td><a href="https://www.kg-legal.eu/venture-capital-and-private-equity/">Venture Capital &amp; Private Equity</a> <a href="https://www.kg-legal.eu/stock-exchange-and-securities-law-in-poland/">Stock Exchange &amp; Securities</a> <a href="https://www.kg-legal.eu/markets-in-modern-and-conventional-financial-instruments-including-tokens-crypto-assets-packaged-retail-and-insurance-based-investment-products/">Financial Instruments &amp; Crypto</a></td><td><a href="https://www.kg-legal.eu/artificial-intelligence-ai-law-poland-eu/">AI Sector</a> <a href="https://www.kg-legal.eu/data-centers/">Data Centers</a></td><td><a href="https://www.kg-legal.eu/regulatory-law-of-the-energy-sector-in-poland/">Energy Sector</a> <a href="https://www.kg-legal.eu/green-energy-law-renewable-energy-law/">Renewable Energy</a></td><td><a href="https://www.kg-legal.eu/medical-devices-including-medical-devices-law-under-combined-atmps/">Medical Devices</a> <a href="https://www.kg-legal.eu/food-law/">Food Law</a></td><td><a href="https://www.kg-legal.eu/international-divorces/">International Divorces</a> <a href="https://www.kg-legal.eu/international-family-law/">International Family Law</a></td></tr><tr><td><a href="https://www.kg-legal.eu/agreements-and-contracts/">Agreements &amp; Contracts</a> <a href="https://www.kg-legal.eu/contracts-in-the-international-trade-smart-contracts/">International Trade &amp; Smart Contracts</a></td><td><a href="https://www.kg-legal.eu/data-privacy-and-data-protection/">Data Privacy &amp; Protection</a> <a href="https://www.kg-legal.pl/cybersecurity/">Cybersecurity</a></td><td><a href="https://www.kg-legal.eu/biofuels-and-biocomponents/">Biofuels &amp; Biocomponents</a> <a href="https://www.kg-legal.eu/offshore-wind-farms/">Offshore Wind</a></td><td><a href="https://www.kg-legal.eu/art-market/">Art Market</a> <a href="https://www.kg-legal.eu/legal-services-in-fashion-law/">Fashion</a></td><td><a href="https://www.kg-legal.eu/cross-border-inheritance-matters/">Cross Border Inheritance</a> <a href="https://www.kg-legal.eu/immigration-law-business-immigration-polish-passport/">Immigration &amp; Polish Passports</a></td></tr><tr><td><a href="https://www.kg-legal.eu/offshore-companies-tax-optimization/">Offshore Companies &amp; Tax</a></td><td><a href="https://www.kg-legal.eu/distributed-ledger-technology-law/">Distributed Ledger Technology</a> <a href="https://www.kg-legal.eu/metaverse-and-web3-legal-environment/">Metaverse &amp; Web3</a></td><td><a href="https://www.kg-legal.eu/greenfield-in-poland/">Greenfield Investment</a> <a href="https://www.kg-legal.eu/kieltyka-gladkowski-provides-assistance-in-the-area-of-european-partnerships-in-horizon-europe-programme/">Horizon Europe</a></td><td><a href="https://www.kg-legal.pl/cross-border-cases-1/">Cross Border Practice</a> <a href="https://www.kg-legal.eu/customs-and-tariffs-support-for-international-traders-in-poland-and-eu/">Customs &amp; Tariffs</a></td><td><a href="https://www.kg-legal.eu/asset-tracing-in-poland-for-international-creditors/">Asset Tracing in Poland</a> <a href="https://www.kg-legal.eu/asset-tracing/">Asset Tracing</a> <a href="https://www.kg-legal.eu/business-investigations-private-detective-services/">Business Investigations</a></td></tr><tr><td><a href="https://www.kg-legal.eu/dissolution-and-liquidation-of-capital-companies/">Company Dissolution &amp; Liquidation</a> <a href="https://www.kg-legal.eu/cross-border-bankruptcy-in-poland/">Cross Border Bankruptcy</a></td><td><a href="https://www.kg-legal.eu/dual-use-technology-law/">Dual Use Technology</a> <a href="https://www.kg-legal.eu/drone-uas-law/">Drones &amp; UAS</a> <a href="https://www.kg-legal.eu/defence-and-space-sector/">Defence &amp; Space</a></td><td><a href="https://www.kg-legal.eu/industrial-micro-and-public-macro-infrastructure/">Infrastructure</a> <a href="https://www.kg-legal.eu/construction/">Construction</a> <a href="https://www.kg-legal.eu/public-private-partnerships/">Public Private Partnerships</a></td><td><a href="https://www.kg-legal.eu/sworn-certified-legal-translations-of-documents-and-contracts/">Sworn &amp; Certified Legal Translations</a></td><td><a href="https://www.kg-legal.eu/litigation-and-representation-of-international-clients-before-the-polish-courts/">Litigation in Polish Courts</a> <a href="https://www.kg-legal.eu/litigation-antitrust-and-competition-law/">Litigation &amp; Competition</a></td></tr></tbody></table></figure>



<p>Service directory: <a href="https://www.kg-legal.eu/services/">kg-legal.eu/services</a></p>
<p> </p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/for-research-use-only-is-not-a-legal-shieldgg/">“For Research Use Only” Is Not a Legal Shieldgg</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/for-research-use-only-is-not-a-legal-shieldgg/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>KG Legal Kiełtyka Gładkowski named Most Trusted Cross-Border Law Firm 2026 &#8211; Poland in the European Legal Awardsdd</title>
		<link>https://www.kg-legal.eu/info/kg-legal-news/kg-legal-most-trusted-cross-border-law-firm-2026-poland/</link>
					<comments>https://www.kg-legal.eu/info/kg-legal-news/kg-legal-most-trusted-cross-border-law-firm-2026-poland/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Wed, 11 Nov 2026 15:48:01 +0000</pubDate>
				<category><![CDATA[KG LEGAL NEWS]]></category>
		<category><![CDATA[Asset Recovery]]></category>
		<category><![CDATA[Cross-Border Law Firm Poland]]></category>
		<category><![CDATA[cross-border litigation]]></category>
		<category><![CDATA[Enforcement of Foreign Judgments]]></category>
		<category><![CDATA[EU Business News]]></category>
		<category><![CDATA[European Legal Awards 2026]]></category>
		<category><![CDATA[International Arbitration]]></category>
		<category><![CDATA[International Law Firm]]></category>
		<category><![CDATA[International Legal Services]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[kglegal]]></category>
		<category><![CDATA[kiełtyka gładkowski]]></category>
		<category><![CDATA[Law Firm Awards]]></category>
		<category><![CDATA[Legal 500 EMEA]]></category>
		<category><![CDATA[Most Trusted Cross-Border Law Firm]]></category>
		<category><![CDATA[Polish Law Firm]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=8992</guid>

					<description><![CDATA[<p>Publication date: October 11, 2026 We are proud to announce that KG Legal Kiełtyka Gładkowski has been named a winner in the inaugural European Legal Awards 2026, hosted by EU Business News. The firm received the title Most Trusted Cross-Border Law Firm 2026 &#8211; Poland. About the award The European Legal Awards are a recognition [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/kg-legal-news/kg-legal-most-trusted-cross-border-law-firm-2026-poland/">KG Legal Kiełtyka Gładkowski named Most Trusted Cross-Border Law Firm 2026 &#8211; Poland in the European Legal Awardsdd</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color"><strong>Publication date: October 11, 2026</strong></mark></p>



<p>We are proud to announce that KG Legal Kiełtyka Gładkowski has been named a winner in the inaugural European Legal Awards 2026, hosted by EU Business News. The firm received the title <strong>Most Trusted Cross-Border Law Firm 2026 &#8211; Poland</strong>.</p>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="1024" height="467" src="https://www.kg-legal.eu/wp-content/uploads/2026/11/award-1024x467.png" alt="" class="wp-image-8993" srcset="https://www.kg-legal.eu/wp-content/uploads/2026/11/award-1024x467.png 1024w, https://www.kg-legal.eu/wp-content/uploads/2026/11/award-300x137.png 300w, https://www.kg-legal.eu/wp-content/uploads/2026/11/award-768x350.png 768w, https://www.kg-legal.eu/wp-content/uploads/2026/11/award.png 1367w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>About the award</strong></h2>



<span id="more-8992"></span>



<p>The European Legal Awards are a recognition programme of EU Business News, a publication of AI Global Media. The programme honours law firms and legal professionals who demonstrate excellence, adaptability and a commitment to delivering outstanding legal services across Europe in an increasingly demanding regulatory and business environment. According to the organiser, winners are selected through independent, merit-based research.</p>



<p><strong>Why this recognition matters to us</strong></p>



<p>Cross-border work has been at the core of our practice since the firm was founded. From our offices in Kraków, Warsaw and New York, a team of more than 35 lawyers advises clients from Europe, the United States, Asia and the Middle East for whom Poland is an investment market, a forum for a dispute, or a jurisdiction where rights need to be effectively enforced.</p>



<p>In practice, this includes:</p>



<ul class="wp-block-list">
<li>cross-border litigation and arbitration, including recognition and enforcement of foreign judgments and arbitral awards in Poland,</li>



<li>international asset tracing and recovery, supported by OSINT specialists and licensed cryptocurrency investigators,</li>



<li>regulatory advice for the life sciences and healthcare sector, data privacy and EU regulatory matters,</li>



<li>corporate, M&amp;A and intellectual property work with an international element,</li>



<li>international family law and private client matters.</li>
</ul>



<p>The category in which we were recognised is about trust. In cross-border matters trust carries particular weight: a client hands over a case in a legal system they often do not know, in a foreign language and at a distance. This is why we focus on clear communication, a candid assessment of risk and realistic timelines rather than promises.</p>



<p><em>“We see this award above all as a thank you to our clients and partner law firms around the world who entrust us with their Polish matters. Trust is built over years, one case at a time, and it remains our most important measure of quality,”</em> says Małgorzata Kiełtyka, co-founding partner of KG Legal.&#8221;.</p>



<p>The EU Business News award joins the firm&#8217;s existing recognitions, including continuous presence in the Legal 500 EMEA ranking since 2019 and the Legal 500 CEE Awards 2025 title of Healthcare and Life Sciences Lawyer of the Year.</p>



<p>We would like to thank our clients, our international partners and the entire KG Legal team. This recognition is shared.</p>



<p><strong>Read more:</strong></p>



<ul class="wp-block-list">
<li><a href="https://www.eubusinessnews.com/winners/kieltyka-gladkowski-kg-legal/">Winner profile at EU Business News</a></li>



<li><a href="https://www.eubusinessnews.com/eu-business-news-unveils-the-winners-of-the-inaugural-european-legal-awards/">Announcement of the European Legal Awards 2026 winners</a></li>



<li><a href="https://www.aiglobalmedialtd.com/brands/eu-business-news/" target="_blank" rel="noreferrer noopener">About EU Business News</a></li>
</ul>



<p>Contact: office@kg-legal.pl, +48 12 263 46 74, www.kg-legal.eu</p>
<p data-pm-slice="1 1 []">#KGLegal #KieltykaGladkowski #EuropeanLegalAwards2026 #EUBusinessNews #CrossBorderLaw #InternationalLaw #LawFirmAwards #PolishLawFirm #LegalExcellence #InternationalArbitration #CrossBorderLitigation #Legal500 #InternationalLegalServices #TrustedLawFirm #Poland</p>


<p>Artykuł <a href="https://www.kg-legal.eu/info/kg-legal-news/kg-legal-most-trusted-cross-border-law-firm-2026-poland/">KG Legal Kiełtyka Gładkowski named Most Trusted Cross-Border Law Firm 2026 &#8211; Poland in the European Legal Awardsdd</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/kg-legal-news/kg-legal-most-trusted-cross-border-law-firm-2026-poland/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Baskets of Equivalent Therapeutic Technologies – Rationalising Spending or Restricting Treatment Choice?</title>
		<link>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/baskets-of-equivalent-therapeutic-technologies-rationalising-spending-or-restricting-treatment-choice/</link>
					<comments>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/baskets-of-equivalent-therapeutic-technologies-rationalising-spending-or-restricting-treatment-choice/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Tue, 10 Nov 2026 18:47:20 +0000</pubDate>
				<category><![CDATA[PHARMACEUTICAL, HEALTHCARE & LIFE SCIENCES LAW]]></category>
		<category><![CDATA[access to medicines]]></category>
		<category><![CDATA[advanced therapy medicinal products]]></category>
		<category><![CDATA[AOTMiT]]></category>
		<category><![CDATA[biological medicines]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[clinical decision-making]]></category>
		<category><![CDATA[drug programmes]]></category>
		<category><![CDATA[drug reimbursement]]></category>
		<category><![CDATA[equivalent therapeutic technologies]]></category>
		<category><![CDATA[haematology]]></category>
		<category><![CDATA[health technology assessment]]></category>
		<category><![CDATA[Healthcare Regulation]]></category>
		<category><![CDATA[hospital financing]]></category>
		<category><![CDATA[hospital procurement]]></category>
		<category><![CDATA[informed consent]]></category>
		<category><![CDATA[innovative therapies]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[Life Sciences]]></category>
		<category><![CDATA[Medical Liability]]></category>
		<category><![CDATA[medicine pricing]]></category>
		<category><![CDATA[National Health Fund]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[patients’ rights]]></category>
		<category><![CDATA[personalised medicine]]></category>
		<category><![CDATA[pharmaceutical competition]]></category>
		<category><![CDATA[pharmaceutical market access]]></category>
		<category><![CDATA[physician autonomy]]></category>
		<category><![CDATA[Poland]]></category>
		<category><![CDATA[Polish law]]></category>
		<category><![CDATA[Polish pharmaceutical law]]></category>
		<category><![CDATA[price corridors]]></category>
		<category><![CDATA[reimbursement baskets]]></category>
		<category><![CDATA[reimbursement limit groups]]></category>
		<category><![CDATA[reimbursement reform]]></category>
		<category><![CDATA[risk-sharing schemes]]></category>
		<category><![CDATA[therapeutic equivalence]]></category>
		<category><![CDATA[treatment continuity]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=8989</guid>

					<description><![CDATA[<p>Publication date: October 05, 2026 Poland&#8217;s Ministry of Health wants to place medicines with different active substances in a single reimbursement limit group where they work in a similar way, and to reward hospitals for choosing the cheapest therapy available. The change is meant to bring prices down and free up funds for innovative treatment, [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/baskets-of-equivalent-therapeutic-technologies-rationalising-spending-or-restricting-treatment-choice/">Baskets of Equivalent Therapeutic Technologies – Rationalising Spending or Restricting Treatment Choice?</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: October 05, 2026</mark></strong></p>



<p><strong>Poland&#8217;s Ministry of Health wants to place medicines with different active substances in a single reimbursement limit group where they work in a similar way, and to reward hospitals for choosing the cheapest therapy available. The change is meant to bring prices down and free up funds for innovative treatment, but clinicians warn that cost equivalence is not the same as clinical equivalence. We examine how the proposed baskets of equivalent therapeutic technologies could affect physicians&#8217; autonomy, patients&#8217; rights and competition in the pharmaceutical market, and what safeguards the legislation should contain.</strong><br>KG LEGAL KIELTYKA GLADKOWSKI supports international pharmaceutical, biotechnology and healthcare businesses operating in Poland. For legal assistance with pharmaceutical regulation, reimbursement and market access, contact our team at office@kg-legal.pl.</p>



<span id="more-8989"></span>



<p><strong>Introduction</strong></p>



<p><strong><em>The aims of the reform</em></strong></p>



<p>Optimising the spending of the National Health Fund (NFZ), keeping the total reimbursement budget stable and stimulating price competition: according to its official explanatory memorandum, these are the aims of the draft amendment to the Polish Reimbursement Act, adopted by the Council of Ministers in October 2026. The draft reforms the rules on public funding of pharmacotherapy and medical devices, introducing new instruments such as baskets of equivalent therapeutic technologies and price corridors. Although it is intended to protect the economic interests of the system and improve healthcare in Poland, its content has provoked lively debate from the outset. To assess the real value of the planned changes, it is worth starting with the legal framework they are meant to replace.</p>



<p><strong><em>The previous model: individual decisions and unanimity of manufacturers</em></strong></p>



<p>Until recently, the description of a drug programme was an annex to the individual administrative decision issued to a specific manufacturer. As a result, any change to the programme – adding a new medicine, modifying patient eligibility criteria or updating the required diagnostics – required the unanimous consent of all manufacturers holding reimbursement decisions within that programme. Limit groups also played an important role; in practice they generally comprised medicines containing the same active substance, although the Act already allows, to a limited extent, medicines with different international non-proprietary names to be grouped together. In the Ministry of Health&#8217;s view, this model fostered blocked competition and monopolisation, since the objection of a single manufacturer could halt the introduction of a new therapy and thus hinder the timely adjustment of drug programmes to current clinical guidelines and patient needs.</p>



<p><strong><em>What has already changed and what is still to come</em></strong></p>



<p>The first step was an amendment that entered into force on 1 July 2026. Its priority was to move away from the former annexes to decisions and to introduce Article 16a, which removes drug programme descriptions from the decisions issued to individual companies. This was, however, only one of the changes announced in the draft. Its central proposal remains a new way of grouping medicines, namely baskets of equivalent therapeutic technologies: placing medicines with different active substances in a common limit group where they show a similar therapeutic effect and a similar mechanism of action. In addition to organisational benefits for healthcare providers, the change is meant to generate savings, on the assumption that putting alternative medicines in a single basket and financially rewarding hospitals for choosing the cheapest of them will drive prices down and reduce public expenditure.</p>



<p><strong>I. How are the baskets of equivalent therapeutic technologies meant to work?</strong></p>



<p><strong><em>Criteria for inclusion in a basket</em></strong></p>



<p>To assess whether this solution will actually achieve its stated aims, we first need to look at its mechanisms and assumptions. Under Article 15a(2) of the draft, the basic criteria for placing medicines in a common limit group are the same or similar indications or intended uses for which they are reimbursed, and similar efficacy. A basket may include a medicine with the same international non-proprietary name (i.e. meeting the criterion of an identical active substance, which is the primary criterion under the current Reimbursement Act) or a medicine with a similar therapeutic effect and a similar mechanism of action. The baskets are to apply primarily to medicinal products and foods for special medical purposes used in drug programmes. They cover advanced innovative medicines, biologics and biosimilars used in specialised hospital therapies, including oncology (including chemotherapy), haematology, rheumatology and dermatology.</p>



<p><strong><em>The procedure for setting a drug programme description</em></strong></p>



<p>The description of the drug programme within which a basket operates goes through several stages set out in Article 16a, in force since 1 July 2026:</p>



<p>1.&nbsp;&nbsp;&nbsp; the Minister of Health prepares a draft description after consulting the relevant national or regional consultant and, where justified, the relevant medical society;</p>



<p>2.&nbsp;&nbsp;&nbsp; the draft is sent to the President of the Agency for Health Technology Assessment and Tariff System (AOTMiT) for an opinion and, once the opinion is received, forwarded to the applicant;</p>



<p>3.&nbsp;&nbsp;&nbsp; the applicant is required to submit its opinion within no more than 7 days; that opinion is, however, not binding on the Minister.</p>



<p>These rules, already in force, show how the role of expert opinions in shaping drug programmes has changed: they are now the substantive basis for creating and updating programmes. The requirement of unanimity among pharmaceutical companies has been replaced by a mandatory consultation of the national or regional consultant in the relevant field of medicine and a mandatory opinion from the President of AOTMiT. This obligation applies, however, to the creation of a description; when it is later amended, the Minister may, but need not, seek these opinions. In addition, where a change to the programme description alters the target population, the President of AOTMiT calls on the applicant to supplement its health technology assessment (HTA), i.e. the analysis comparing the technology with the existing standard of care (Article 35(2a)). Consulting a medical society, by contrast, remains optional. The programme description prepared in this way is annexed to the Minister of Health&#8217;s notice on the list of reimbursed medicines, foods for special medical purposes and medical devices, published in the Minister&#8217;s official journal.</p>



<p><strong><em>The doubts: what exactly does “equivalence” mean?</em></strong></p>



<p>Although the direction of the draft seems positive at first glance, several issues may prove problematic in implementation. The first point of contention is the scope of the baskets, i.e. the criteria for their “equivalence”. The draft uses only general phrases such as “similar therapeutic effect” and “similar mechanism of action”, without any verifiable quantitative criteria. This has raised concerns among clinicians, who point out that the absence of an exhaustive list of clinical indicators may give the regulator broad discretion. This creates a real risk of equating economic equivalence with clinical equivalence. In the view of experts in the specialties covered by the programmes, grouping therapies deemed equivalent in a single basket will significantly complicate physicians&#8217; everyday practice. In the current wording of the proposed provisions, the healthcare sector therefore sees above all an economic motive.</p>



<p><strong>II. Financial incentives for hospitals to use the cheapest therapies</strong></p>



<p>These concerns appear justified, especially as the proposed basket model is closely linked to the way the NFZ settles payments for healthcare services. The system is to rely on an existing instrument, correction coefficients, which are currently used to adjust the valuation of services, for example for holding quality accreditation, meeting certain staffing standards or delivering comprehensive care programmes. The drafters give this tool a new purpose: rewarding hospitals for choosing the medicine that sets the limit base within a given basket. A hospital that, within a basket, treats a patient with the drug technology with the lowest average cost per day of therapy, or with the product selected in a tender as the most price-competitive, is to receive a more favourable correction coefficient. In practice, the mechanism therefore encourages hospitals to be guided by the lowest unit price.</p>



<p>Formally, all products included in a given basket remain on the reimbursement list, as follows from Article 37 of the Reimbursement Act. The problem is therefore not a narrower range of available medicines, but a possible restriction of physicians&#8217; freedom of decision and autonomy. This risk is particularly real given the chronic underfunding of hospitals, where management decisions may be driven by the need to stabilise finances and tilt towards the cheapest medicine in the hospital&#8217;s public tender.</p>



<p><strong>III. Cost equivalence versus clinical equivalence</strong></p>



<p><strong><em>Same line of treatment does not mean interchangeable</em></strong></p>



<p>The key question in assessing equivalence baskets is whether the same line of treatment and the same indication are enough to consider medicines equivalent. Medical experts and national consultants answer this firmly in the negative: belonging to the same line of therapy does not mean that medicines are clinically interchangeable. They may have different chemical structures and differ in, among other things, toxicity profile, metabolism or route of administration. The basket mechanism therefore cannot be equated with safe generic or biosimilar substitution. Whereas generics and biosimilars involve demonstrated bioequivalence (or, for biosimilars, demonstrated biosimilarity) of the same active substance, distinct therapeutic technologies show only comparable efficacy in averaged populations. What does this mean in practice?</p>



<p>The different characteristics of products are particularly significant in fields where treatment efficacy relies on molecularly targeted therapies, such as oncology and haematology. The cheapest medicine in a basket may be less precisely targeted at a specific genetic mutation than a more expensive one that does not set the limit base. More generally, adverse reactions must also be considered, as their frequency and severity may differ between medicines in the same basket. The negative consequences of selecting a product in this way may be especially severe for frail patients.</p>



<p><strong><em>A patient is not a population average</em></strong></p>



<p>The burden of choosing a one-size-fits-all, economically advantageous solution therefore grows with the degree to which a patient&#8217;s needs are individual. Previous therapies often affect the immune system and the body&#8217;s response to subsequent treatment, so the sequence of therapies is crucial. Widespread use of a single medicine also carries a risk of interactions in patients with comorbidities, which may sometimes absolutely rule out the use of a given product. Moreover, choosing a suboptimal medicine at an early stage may make it impossible to use the most effective therapy in a later line. All of this shows the possible consequences of a simplified assessment of equivalence and underlines the importance of personalised medicine, which should not give way to a hospital&#8217;s economic pressures.</p>



<p>The methodology of the studies on which medicines are authorised, and subsequently reimbursed, is based on population statistics. Similar average efficacy across a study sample cannot be equated with efficacy in an individual patient. Analysis of a patient&#8217;s individual biological profile cannot be reduced to simplifications introduced to make product selection easier; it should take individual predispositions into account so as to minimise the risk of ineffective treatment or, worse, serious complications.</p>



<p><strong>IV. Physician autonomy and responsibility for the choice of therapy</strong></p>



<p><strong><em>Due diligence versus economic pressure</em></strong></p>



<p>Taking the patient&#8217;s individual situation into account, as part of acting in accordance with current medical knowledge, is a statutory duty of physicians under the Act on the Professions of Physician and Dentist and, at the same time, a deontological duty under the Code of Medical Ethics (KEL). Since physicians must practise in accordance with current medical knowledge, using the methods and means available and with due diligence, they should not use the cheapest medicine in a basket if it does not comply with current clinical guidelines for the particular disease subtype. Imposing such a product for cost-saving reasons would be contrary to the standards set by Article 4 of the Act on the Professions of Physician and Dentist, the Code of Medical Ethics and Article 6 of the Act on Patient Rights and the Patient Ombudsman. These provisions guarantee physicians freedom to choose the methods they consider most effective. Rewarding hospitals for using the tender-winning medicine may, however, lead to a situation in which physicians&#8217; formal autonomy is in practice curtailed by market mechanisms and economic considerations.</p>



<p><strong><em>Who bears the consequences?</em></strong></p>



<p>An independent public healthcare institution (SPZOZ) covers its operating costs from its own revenue and must cover any net loss itself. If debt ratios are at risk of being exceeded, hospital management may be forced to issue internal instructions and design tender procedures so that only the cheapest medicines in a given basket are used, placing administrative pressure on physicians. If, as a result, a patient suffers serious adverse reactions where current medical knowledge called for a different product, the physician may face professional liability before a medical court and criminal liability and, depending on the legal basis on which they provide services, civil liability. The healthcare provider is also liable for damage resulting from the provision of services or the unlawful failure to provide them: for physicians employed under an employment contract, it is generally the provider that is liable to the patient (Article 430 of the Civil Code in conjunction with Article 120 of the Labour Code), while for physicians engaged under civil-law contracts it is jointly and severally liable with the physician (Article 27(7) of the Act on Medical Activity). Such an event may also constitute a culpable infringement of the patient&#8217;s right to services consistent with current medical knowledge, giving rise to a claim for compensation for non-pecuniary harm under Article 4 of the Act on Patient Rights.</p>



<p><strong><em>How can physicians protect themselves?</em></strong></p>



<p>To avoid breaching the law, a physician may, and sometimes should, depart from the economically preferred technology. In doing so, the physician must give the patient accessible information about the proposed treatment methods, their risks and expected benefits, which includes the reasons for choosing a specific therapy. Choosing a personalised therapy that departs from the hospital&#8217;s economic standard should be documented in detail in the medical record, together with the substantive medical justification.</p>



<p><strong>V. Patients&#8217; rights and the principle of individualised treatment</strong></p>



<p><strong><em>Informed consent requires full information</em></strong></p>



<p>Polish law thus imposes specific duties on physicians towards patients. Besides treatment consistent with current medical knowledge and tailored to the specific condition, i.e. personalised treatment, patients have the right to information about their health, diagnosis and possible treatment options, including the alternatives available within the basket. From this perspective, patients should also know whether the choice of a particular medicine results from its clinical profile or from the facility&#8217;s organisational and financial constraints. This information is not an empty formality but a condition of informed consent. A patient may consent to, or refuse, specific healthcare services only after receiving the full information specified in Article 9 of the Act on Patient Rights. If a patient consents without having received this information in an accessible and comprehensible form, the consent is defective and the medical intervention is, as a rule, unlawful.</p>



<p><strong><em>The risk of unequal access to therapy</em></strong></p>



<p>The legal position of patients in Poland is grounded both in statute and in Article 68 of the Constitution, which guarantees the right to health protection and equal access to publicly funded healthcare services. In practice, however, these principles face obstacles. Besides the risk of a hidden barrier to access resulting from the drive to balance the budget, there is a risk that the level of care will vary between patients. Equivalence baskets, combined with rewarding hospitals for choosing the medicine that won a local tender, may lead to fragmentation of treatment. Imagine that hospital A in one region selects medicine X in its tender, while hospital B in a neighbouring region selects medicine Y. Two patients with identical biological and clinical profiles may then receive different medicines simply because one was admitted to hospital A and the other to hospital B. Making geography and the outcome of a tender the deciding factor in treatment could raise serious doubts as to compliance with the constitutional principle of equal access to healthcare services (Article 68(2) of the Constitution).</p>



<p><strong>VI. Could the mechanism restrict competition in the pharmaceutical market?</strong></p>



<p><strong><em>Market concentration around the tender winner</em></strong></p>



<p>From the Ministry of Health&#8217;s perspective, creating common limit groups for medicines with similar therapeutic effects is meant to break down artificial monopolies and introduce price competition between manufacturers. Introducing baskets may, however, also have a less desirable effect: strong pressure to choose the most economically advantageous product. Medicines will formally remain on the reimbursement list, but a large share of orders will go to the winner of the hospital tender. This would mean market concentration around the medicine setting the limit base, even though the basket also includes other, more expensive options.</p>



<p><strong><em>Unit price is not the whole cost of therapy</em></strong></p>



<p>It is also worth looking more closely at the economics of the solution. The most financially advantageous options in tender procedures and in setting the limit base are determined using a fairly narrow criterion: the official selling price or the price per dose unit. Relying solely on this indicator can be misleading, as it ignores additional costs related, for example, to the pharmaceutical form and route of administration and, in some cases, to medicines that mitigate adverse reactions or the need to switch therapy when the first product does not deliver the expected results.</p>



<p><strong><em>Risk-sharing discounts as the benchmark for further cuts</em></strong></p>



<p>Existing risk-sharing schemes (RSS) also take on a new significance. The draft provides that the mandatory 25% price reduction after protection expires is to be calculated from the effective price, i.e. the price net of the confidential RSS discount. Whereas the idea behind these instruments was to separate the official selling price from the actual cost to the budget, once the proposed changes take effect the discount would become a fixed benchmark for further cuts. Paradoxically, those who stand to lose most are the companies that have so far been the most flexible in price negotiations.</p>



<p>Across the system as a whole, the cumulative price pressure – mandatory 25% reductions after protection expires and price corridor requirements – may lead some manufacturers to withdraw from the reimbursement list because it is no longer profitable. The draft&#8217;s option of extending the settlement period for outcome-based RSS to as long as 10 years does not solve the problem. Given the costs of manufacturing, transport and certification, selling a medicine in Poland may become loss-making for a manufacturer, and to limit losses manufacturers may stop offering large RSS discounts when launching new therapies, knowing that a discount granted today will be used in a few years as the basis for a forced, drastic price cut. A solution meant to increase price competition may thus restrict competition in another area and even jeopardise the continuity of supply of medicines to patients.</p>



<p><strong>VII. Potential benefits – the drafters&#8217; arguments</strong></p>



<p><strong><em>Price pressure and cost-effectiveness</em></strong></p>



<p>How do the drafters justify the proposed changes in the face of clinicians&#8217; objections? The Ministry of Health&#8217;s arguments include several important elements: aligning the legal framework with market realities, creating mechanisms for flexible management of the total reimbursement budget (CBR) and improving cost-effectiveness. Flexible design of limit groups is meant to exert price pressure, bring prices closer to market levels and strengthen hospitals&#8217; negotiating position when purchasing medicines at prices close to the limit base. Inclusion in a common limit group, and indirectly the level of funding, would no longer be determined by the active substance alone but by a broader clinical profile, so that large price disparities would gradually even out. The amendment therefore aims to reduce the costs of inpatient care on many levels.</p>



<p><strong><em>Where are the savings meant to go?</em></strong></p>



<p>According to the Ministry of Health, the savings are to fund new, innovative therapies: technologically advanced medicines whose use places a significant burden on the budget over the longer term. These include in particular targeted therapies in oncology and haematology, advanced therapy medicinal products (ATMPs) and highly innovative drug technologies (TLWI). Clinical experts and representatives of the pharmaceutical industry stress, however, that translating these savings into genuinely better access to treatment will require additional safeguards, so that legitimate aims are not reduced to a mere battle over price.</p>



<p><strong>VIII. What safeguards should the legislation contain?</strong></p>



<p><strong><em>Precise equivalence criteria</em></strong></p>



<p>A safe implementation of the new rules therefore requires solutions that reconcile rationalised spending with a guarantee of personalised medical care. First and foremost, precise criteria for creating baskets should be considered, so that baskets are not based on a general similarity of indications and on regulatory discretion. Membership of a common limit group should be determined by demonstrated clinical equivalence, not merely by belonging to the same line of treatment. A comprehensive health technology assessment (HTA) covering the molecular profile of the disease, mechanism of action, metabolism, route of administration, toxicity profile and sequencing of therapies would be an effective preventive measure.</p>



<p><strong><em>Expert involvement and ongoing monitoring</em></strong></p>



<p>Since such an assessment requires specialist medical knowledge, it seems natural that specialists from the relevant fields of medicine must take part in it. The rules in force since 1 July 2026 require the national or regional consultant to be consulted when a drug programme description is created, but not when it is amended. Given the risks arising from an improperly conducted procedure, it would be justified to extend this obligation to amendments and to make consultation with medical societies and patient organisations mandatory as well. Beyond precise rules on determining the composition of baskets, there must also be oversight of how they operate and monitoring of the efficacy and safety of therapies, with the possibility of modifying a basket. The legislation should require AOTMiT to carry out periodic reviews of existing limit groups for hidden costs of hospitalisation, treatment of complications and rates of treatment discontinuation, based on reliable NFZ registry data. It should also provide for an appeal procedure against drug programme descriptions published in the Minister of Health&#8217;s notice, together with a list of entities entitled to lodge formal objections. The lack of an appeal route has also been raised by INFARMA, which, after the public consultation closed, called for the baskets to be removed from the draft.</p>



<p><strong><em>Protecting the individual patient</em></strong></p>



<p>The most important matter to be regulated remains the protection of health as the paramount value that the amendment is ultimately meant to serve. To this end, the drafters could add a transparent and fast procedure for exempting a patient from the basket mechanism where justified by the patient&#8217;s individual clinical profile, as well as a guarantee of continuity of treatment: the right to continue therapy with a given drug technology until the end of the treatment cycle if it has already been started. Physicians&#8217; decisions on how to conduct treatment should be driven above all by the patient&#8217;s interest and should not have adverse financial consequences for the hospital if the chosen medicine is not the cheapest. If a hospital in which a physician individualised the therapy and gave substantive reasons for it in the medical record retained the right to full payment for the service without a reduced correction coefficient, the influence of economic considerations on treatment decisions would be significantly weakened.</p>



<p><strong>Conclusion</strong></p>



<p>The Ministry of Health&#8217;s aim of optimising the budget and freeing up funds for breakthrough innovations, including ATMPs and TLWI technologies, is justified from the perspective of public finance management. The analysis shows, however, that the drafters should do more to strike a balance between optimising public spending, physicians&#8217; autonomy and patients&#8217; right to personalised therapy. The mechanisms proposed in the current wording of the draft may bring hospitals&#8217; financial constraints into conflict with physicians&#8217; statutory and ethical duty to provide medical services with due diligence. Care must be taken to ensure that economic pressure on inpatient care does not result in merely formal improvements in access to advanced therapies. This can be achieved by supplementing the draft with the safeguards discussed above. Equivalence baskets could then benefit the public healthcare system on several levels without restricting the rights of patients, whom the Reimbursement Act is, after all, meant to protect.</p>
<p> </p>


<p>Artykuł <a href="https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/baskets-of-equivalent-therapeutic-technologies-rationalising-spending-or-restricting-treatment-choice/">Baskets of Equivalent Therapeutic Technologies – Rationalising Spending or Restricting Treatment Choice?</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/pharmaceutical-healthcare-life-sciences-law/baskets-of-equivalent-therapeutic-technologies-rationalising-spending-or-restricting-treatment-choice/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>The Northolt Treaty: What the UK-Poland Security and Defence Partnership Means for the Defence Sector</title>
		<link>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/the-northolt-treaty-what-the-uk-poland-security-and-defence-partnership-means-for-the-defence-sector/</link>
					<comments>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/the-northolt-treaty-what-the-uk-poland-security-and-defence-partnership-means-for-the-defence-sector/#respond</comments>
		
		<dc:creator><![CDATA[jakub]]></dc:creator>
		<pubDate>Wed, 04 Nov 2026 14:15:02 +0000</pubDate>
				<category><![CDATA[INVESTMENT LAW AND PROCESSES IN POLAND]]></category>
		<category><![CDATA[Air Defence]]></category>
		<category><![CDATA[Ammunition Production]]></category>
		<category><![CDATA[Classified Information]]></category>
		<category><![CDATA[Counter-Drone Systems]]></category>
		<category><![CDATA[Critical Infrastructure]]></category>
		<category><![CDATA[Cross-Border Partnerships]]></category>
		<category><![CDATA[Defence Contracts]]></category>
		<category><![CDATA[Defence Cooperation]]></category>
		<category><![CDATA[Defence Industry]]></category>
		<category><![CDATA[Defence Innovation]]></category>
		<category><![CDATA[Defence Procurement]]></category>
		<category><![CDATA[Defence Supply Chains]]></category>
		<category><![CDATA[Dual-Use Technologies]]></category>
		<category><![CDATA[export controls]]></category>
		<category><![CDATA[Export Licensing]]></category>
		<category><![CDATA[Foreign direct investment]]></category>
		<category><![CDATA[Industrial Security]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Investment Screening]]></category>
		<category><![CDATA[Joint Procurement]]></category>
		<category><![CDATA[Joint ventures]]></category>
		<category><![CDATA[KG Legal]]></category>
		<category><![CDATA[kglegal]]></category>
		<category><![CDATA[Miecznik Frigates]]></category>
		<category><![CDATA[Missile Systems]]></category>
		<category><![CDATA[nato]]></category>
		<category><![CDATA[Northolt Treaty]]></category>
		<category><![CDATA[Poland]]></category>
		<category><![CDATA[Polish law]]></category>
		<category><![CDATA[Sanctions Compliance]]></category>
		<category><![CDATA[Security and Defence Partnership]]></category>
		<category><![CDATA[Security Clearances]]></category>
		<category><![CDATA[Supply Chain Security]]></category>
		<category><![CDATA[Technology Transfer]]></category>
		<category><![CDATA[Treaty Ratification]]></category>
		<category><![CDATA[UK-Poland Relations]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[Warsaw Defence Plan]]></category>
		<guid isPermaLink="false">https://www.kg-legal.eu/?p=8980</guid>

					<description><![CDATA[<p>Publication date: November 04, 2026 On 4 November 2026 the Polish statute of 18 September 2026 consenting to the ratification of the Treaty between the Republic of Poland and the United Kingdom on a Security and Defence Partnership, known as the Northolt Treaty, was signed. The remaining steps are ratification and the exchange of notifications [&#8230;]</p>
<p>Artykuł <a href="https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/the-northolt-treaty-what-the-uk-poland-security-and-defence-partnership-means-for-the-defence-sector/">The Northolt Treaty: What the UK-Poland Security and Defence Partnership Means for the Defence Sector</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong><mark style="background-color:rgba(0, 0, 0, 0)" class="has-inline-color has-vivid-cyan-blue-color">Publication date: November 04, 2026</mark></strong></p>



<p>On 4 November 2026 the Polish statute of 18 September 2026 consenting to the ratification of the Treaty between the Republic of Poland and the United Kingdom on a Security and Defence Partnership, known as the Northolt Treaty, was signed. The remaining steps are ratification and the exchange of notifications between Warsaw and London; the Treaty enters into force 30 days after the later notification.</p>





<figure class="wp-block-video"><video controls src="https://www.kg-legal.eu/wp-content/uploads/2026/11/IMG_6051.mov"></video></figure>



<span id="more-8980"></span>



<p>For defence companies, the headline is not only the bilateral mutual assistance clause. The Treaty commits both governments to align defence-industrial and export strategies, procure jointly, remove regulatory barriers to joint programmes and secure supply chains. The first implementing instrument, the Warsaw Defence Plan of 27 October 2026, already names concrete programmes: next-generation air defence missiles, large-calibre ammunition, drones and counter-drone systems, and the Miecznik frigates.</p>



<h2 class="wp-block-heading">The Treaty at a glance</h2>



<p>The Treaty was signed by Prime Ministers Donald Tusk and Keir Starmer on 27 May 2026 at RAF Northolt, the wartime base of the Polish 303 Squadron. It has 12 articles and builds on the 2017 UK-Poland Treaty on Defence and Security Cooperation and the 2023 Joint Declaration on the 2030 Strategic Partnership.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Article</td><td>Subject</td><td>Key point for industry</td></tr></thead><tbody><tr><td>1</td><td>Foreign and security policy</td><td>Coordinated sanctions policy; use of the EU-UK Security and Defence Partnership of 19 May 2025</td></tr><tr><td>2</td><td>Defence and security</td><td>Mutual assistance clause; joint procurement; aligned industrial and export strategies; R&amp;D and technology transfer</td></tr><tr><td>3</td><td>National security</td><td>Hybrid threats, sabotage, hostile drones, FIMI, critical infrastructure, organised crime, migrant smuggling</td></tr><tr><td>4</td><td>Economic security</td><td>Supply chain resilience, dual-use transport infrastructure, investment dialogue, research security</td></tr><tr><td>5</td><td>Energy and climate security</td><td>Protection of offshore energy infrastructure; civil nuclear; reducing Russian inputs in nuclear supply chains</td></tr><tr><td>6</td><td>Governance</td><td>Senior officials&#8217; coordination mechanism; prime ministers review implementation every two years</td></tr><tr><td>7-12</td><td>Final clauses</td><td>Executed under national law; disputes by negotiation only; six months&#8217; notice of termination; entry into force 30 days after the later notification</td></tr></tbody></table></figure>



<p>Article 8 allows the Treaty to be extended to Guernsey, Jersey and the Isle of Man by an exchange of notes.</p>



<h2 class="wp-block-heading">Ratification: where things stand</h2>



<p>Poland ratifies with prior consent given by statute, because the Treaty is a political and military alliance under Article 89(1)(1) of the Constitution and touches matters reserved to statute under Article 89(1)(5). The ratification statute has two articles: consent to ratification, and entry into force on the day after publication. The government shortened the vacatio legis to speed up implementation.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Date</td><td>Step</td></tr></thead><tbody><tr><td>4 Nov 2026</td><td>Ratification statute signed; ratification and exchange of notifications to follow</td></tr><tr><td>27 Oct 2026</td><td>Defence ministers sign the Warsaw Defence Plan, the first implementing plan</td></tr><tr><td>18 Sep 2026</td><td>Sejm adopts the ratification statute</td></tr><tr><td>22 Jul 2026</td><td>Government bill submitted to the Sejm (print no. 2840)</td></tr><tr><td>23 Jun 2026</td><td>UK government lays the Treaty before Parliament (Command Paper CS Poland No. 1/2026) under the CRaG Act 2010</td></tr><tr><td>27 May 2026</td><td>Treaty signed at RAF Northolt; 14 landmark projects published</td></tr></tbody></table></figure>



<p>The UK Command Paper dates the Treaty &#8220;London, 26 May 2026&#8221;, while Polish documents use 27 May, the date of the signing ceremony. At the time of writing we have not seen confirmation that either party has deposited its notification, so the Treaty is not yet in force.</p>



<h2 class="wp-block-heading">A bilateral mutual assistance clause</h2>



<p>Under Article 2(5), if either party suffers an armed attack, the other commits to provide assistance, including by military means, in accordance with Article 5 of the North Atlantic Treaty. The clause adds a bilateral layer to NATO collective defence rather than replacing it, mirroring the treaties the UK signed with France and Germany and Poland&#8217;s 2025 Nancy Treaty with France.</p>



<p>Article 2 also commits both states to:</p>



<ul class="wp-block-list">
<li>interchangeability and interoperability of their armed forces across all domains, through joint training, education, exercises and multinational structures in both countries;</li>



<li>providing the forces, capabilities and infrastructure needed for NATO defence plans, with a focus on the eastern flank;</li>



<li>defence spending in line with NATO targets and innovative defence financing solutions;</li>



<li>closer cooperation on cyber capabilities and on emerging technologies, including dual-use technologies, AI and space;</li>



<li>a stronger liaison officer network and new agreements on the mobility of military personnel;</li>



<li>an annual strategic dialogue of ministers, chiefs of defence and senior officials, including on nuclear matters within NATO.</li>
</ul>



<h2 class="wp-block-heading">The defence-industrial core</h2>



<p>Article 2(6) is the provision defence companies should read first. Recognising the value of security of supply for national programmes and a reliable order pipeline for defence firms, the parties commit to:</p>



<ol class="wp-block-list">
<li>greater alignment of their defence-industrial and export strategies, with future partnerships in mind;</li>



<li>developing and maintaining interchangeability capabilities;</li>



<li>joint procurement;</li>



<li>identifying and minimising regulatory barriers to joint programmes;</li>



<li>better dialogue and cooperation between their defence companies;</li>



<li>discussing supply chain risks and how to counter them.</li>
</ol>



<h3 class="wp-block-heading">Landmark projects and the Warsaw Defence Plan</h3>



<p>On signature the governments published 14 priority projects. Those most relevant to industry are below, together with how the Warsaw Defence Plan of 27 October 2026 (the first phase of defence cooperation under the Treaty) takes them forward.</p>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><td>Area</td><td>Treaty landmark project (May 2026)</td><td>Warsaw Defence Plan (Oct 2026)</td></tr></thead><tbody><tr><td>Complex weapons</td><td>Joint development and manufacture of next-generation missiles across air-to-air, ground-based air defence and land</td><td>Next-generation air defence missiles; builds on Poland&#8217;s Narew procurement from MBDA UK</td></tr><tr><td>Defence industry</td><td>Coordinated procurement, workforce mobility, support for third-country exports, technology transfer</td><td>Closer procurement coordination; education, training and workforce mobility</td></tr><tr><td>Ammunition</td><td>Expanded large-calibre production, with government-enabled knowledge and technology transfer</td><td>BAE Systems and PGZ to expand large-calibre ammunition capacity</td></tr><tr><td>Land and eastern flank</td><td>Strategic Land Partnership; exercises on counter-drone, EW and missile defence</td><td>Steadfast Defender, Polish Dragon, Joint Warrior; drone and counter-drone co-development</td></tr><tr><td>Maritime</td><td>North Sea and Baltic security; joint training for next-generation frigate crews; air defence missile procurement</td><td>Lessons shared between Type 31 and Miecznik (common design); more Baltic activity</td></tr><tr><td>Cyber</td><td>Military defensive cyber and civilian cyber deterrence</td><td>Cyber security and resilience of defence and civilian sites</td></tr><tr><td>Counter-drone (civil)</td><td>Joint task force developing detection and mitigation tools</td><td>Covered by drone and counter-drone line above</td></tr></tbody></table></figure>



<p>Other landmark projects cover sanctions coordination, a counter-hybrid cooperation agreement and working group, FIMI, irregular migration, science and technology (quantum, space), health security (including CBRN and medical evacuation), energy security and diplomatic exchanges.</p>



<h2 class="wp-block-heading">Beyond the battlefield: pillars that touch defence supply chains</h2>



<ul class="wp-block-list">
<li><strong>Hybrid threats and sabotage (Art. 3(5)).</strong> The parties will share strategies against sabotage and the hostile use of AI and drones, and may support each other in responding to specific incidents. Defence sites and suppliers are obvious targets.</li>



<li><strong>Critical infrastructure (Art. 3(1), 3(7), 5(6)).</strong> Cooperation covers land and maritime infrastructure, including offshore energy assets, incident response and repair capabilities.</li>



<li><strong>Sanctions (Art. 1(6)).</strong> Closer coordination of sanctions implementation and enforcement, including on the shadow fleet. Expect tighter, more aligned UK and EU enforcement affecting dual-use and component flows.</li>



<li><strong>Customs and organised crime (Art. 3(2)).</strong> Joint action against serious cross-border crime, including advance cargo information and pre-arrival risk analysis, and illicit trade in firearms.</li>



<li><strong>Economic security (Art. 4).</strong> Dialogue on supply chain dependencies, dual-use technologies and research security, regular talks on barriers to trade and investment, and dual-use transport infrastructure for civil and military use.</li>



<li><strong>Energy (Art. 5).</strong> Support for civil nuclear power and steps to reduce Russian involvement in civil nuclear supply chains.</li>
</ul>



<h2 class="wp-block-heading">Legal nature: a framework, not a rulebook</h2>



<p>The Polish government describes the Treaty as political in character. According to the explanatory memorandum, it concerns cooperation between state authorities and does not directly affect natural or legal persons, does not directly regulate matters governed by domestic law, and requires no implementing legislation. The Ministry for EU Affairs confirmed that it is compatible with EU law.</p>



<p>The Treaty creates no direct financial obligations. Any costs for the Ministry of National Defence will be met within the defence spending limit under Article 40 of the Homeland Defence Act of 11 March 2022, without additional budget requests.</p>



<p>In practice, this means that nothing changes overnight in procurement law, export control or security clearance rules. The opportunities will come through the implementing instruments: defence cooperation plans such as the Warsaw Defence Plan, programme-level agreements, and the project pipeline reviewed under the Article 6 governance mechanism. Existing instruments remain the operative legal base, notably the 2017 Treaty and the 2006 UK-Poland Agreement on the Mutual Protection of Classified Information (amended in 2017).</p>



<h2 class="wp-block-heading">What this means for defence companies</h2>



<ol class="wp-block-list">
<li><strong>Teaming and joint ventures.</strong> Joint procurement and aligned export strategies favour UK-Polish consortia. Structure IP ownership, background and foreground licences, work share and exit rights at the outset, and test the structure against Polish FDI screening rules where a UK investor takes a stake in a Polish defence entity.</li>



<li><strong>Polish procurement.</strong> Joint programmes will still run through Polish defence and security procurement rules, government-to-government routes and, where relevant, offset arrangements. Map early which route a programme will use and what local content or technology transfer the Polish side will expect.</li>



<li><strong>Export controls and licensing.</strong> Alignment of export strategies does not replace national licensing. Polish controls on strategic goods, UK export licences, ITAR content in shared supply chains and the Polish licensing regime for trade in arms all continue to apply; build licensing time into programme schedules.</li>



<li><strong>Security of information.</strong> Joint work on missiles, frigates or cyber needs facility and personnel clearances on both sides under the 2006 classified information agreement. Start industrial security accreditation well before contract award.</li>



<li><strong>Supply chain and sanctions compliance.</strong> Expect closer UK-Polish scrutiny of supply chain dependencies, Russian-origin inputs and sanctions circumvention. Refresh screening, end-use and end-user controls, and contractual audit rights.</li>



<li><strong>EU funding interface.</strong> Poland&#8217;s programmes are also financed through EU instruments such as its SAFE loan agreement with the European Commission. UK participation in EU-funded procurement depends on separate EU-UK arrangements and eligibility rules, so check them for each programme.</li>



<li><strong>Critical infrastructure and hybrid risk.</strong> Defence sites and suppliers fall within the Treaty&#8217;s hybrid and sabotage focus. Review cyber incident reporting duties, physical security and contractual allocation of hybrid-attack risk.</li>
</ol>



<h2 class="wp-block-heading">Outlook</h2>



<p>Once notifications are exchanged, the Treaty will sit alongside Poland&#8217;s treaty with France and its planned agreement with Germany as a pillar of Warsaw&#8217;s bilateral security network inside NATO. The near-term signals to watch are the first biennial prime ministerial review under Article 6, new programme agreements under the Warsaw Defence Plan, and any new agreements on military mobility or the transfer of prisoners announced under Articles 2 and 3.</p>



<p>KG Legal advises Polish and foreign clients on corporate and M&amp;A transactions, EU regulatory matters and cross-border disputes. If you are planning a UK-Polish teaming arrangement, a joint venture or an investment in the Polish defence sector, contact KG LEGAL KIELTYKA GLADKOWSKI at <a href="mailto:office@kg-legal.pl">office@kg-legal.pl</a>.</p>



<p><em>This article is for general information only and is not legal advice.</em></p>



<h2 class="wp-block-heading">Sources</h2>



<ul>
<li><a href="https://api.sejm.gov.pl/sejm/term10/prints/2840/2840.pdf">Sejm print no. 2840: government bill and explanatory memorandum</a></li>
<li><a href="https://www.infor.pl/prawo/nowosci-prawne/7592156,traktat-miedzy-polska-a-wielka-brytania-dot-bezpieczenstwa-i-obronnosci-z-27-maja-2026-r-tresc-jakie-postanowienia-zawiera.html">Treaty text, Polish version (Infor.pl, with link to the English version on gov.pl)</a></li>
<li><a href="https://www.gov.uk/government/news/security-and-defence-partnership-treaty-the-projects-the-uk-and-poland-will-deliver-together">UK: the projects the UK and Poland will deliver together</a></li>
<li><a href="https://gov.uk/government/news/uk-and-poland-strengthen-defences-on-europes-eastern-flank--2">UK (MoD): UK and Poland strengthen defences on Europe&#8217;s Eastern flank, Warsaw Defence Plan</a></li>
<li><a href="https://api.parliament.uk/view/treaty/TqnOB3V8">UK Parliament treaty tracker: Poland No. 1 (2026)</a></li>
<li><a href="https://www.polsatnews.pl/wiadomosc/2026-11-04/karol-nawrocki-podpisal-piec-ustaw-jest-komunikat-kancelarii-prezydenta/">PolsatNews: ratification statute signed, 4 November 2026</a></li>
<li><a href="https://www.portalsamorzadowy.pl/polityka-i-spoleczenstwo/prezydent-podpisal-ustawe-ws-ratyfikacji-traktatu-obronnego-z-wielka-brytania-aktualizacja,682948.html">Portal Samorządowy (PAP): ratification statute signed</a></li>
</ul>



<h2 class="wp-block-heading"></h2>



<h2 class="wp-block-heading"> </h2>






<p>Artykuł <a href="https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/the-northolt-treaty-what-the-uk-poland-security-and-defence-partnership-means-for-the-defence-sector/">The Northolt Treaty: What the UK-Poland Security and Defence Partnership Means for the Defence Sector</a> pochodzi z serwisu <a href="https://www.kg-legal.eu">KIELTYKA GLADKOWSKI LEGAL | CROSS BORDER POLISH LAW FIRM RANKED IN THE LEGAL 500 EMEA SINCE 2019</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.kg-legal.eu/info/investment-law-and-processes-in-poland/the-northolt-treaty-what-the-uk-poland-security-and-defence-partnership-means-for-the-defence-sector/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
